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The 3' Untranslated Region of the Sheep PrP Gene 
Abstract 
Transmissible spongiform encephalopathies (TSEs) form a family of fatal 
neurodegenerative diseases which affect both man and animals. TSEs are associated with 
spongiform change in the central nervous system (Masters and Gajdusek, 1982; Bastian, 
1991) and aggregation of a host protein PrP, the expression of which is central to the 
understanding of susceptibility to TSEs (Review: Prusiner 1994). The PrP protein is 
found in two isoforms: the normal cellular form, designated as PrPC,  and the abnormal 
form, PrP, found only in diseased animals (Meyer et al., 1986; Oesch et al., 1985). 
PrP sc accumulates in amyloid plaques, discrete areas or intracellular deposits (Lantos, 
1991). TSEs are transmissible by experimental and accidental inoculation with infected 
tissue and there is strong evidence for genetic control of disease incidence. The use of 
transgenic models in recent years has shown that there is a relationship between PrP 
expression level and disease progression. Lower-than-normal expression leads to 
extended incubation period and clinical phase (Beuler, 1993; Manson et al., 1994). In 
contrast, overexpression shortens incubation period and generates novel neurological 
syndromes associated with degeneration of skeletal muscle, peripheral nerves and the 
CNS (Westaway et al., 1994b). Natural differences in expression of PrPC  resulting from 
a variety of mutations within the promoter, enhancer, intron or non-coding sequences 
could therefore play a part in determining whether a host is either susceptible or resistant 
to disease. 
This project was designed to investigate the potential of the sheep PrP gene 3'- 
untranslated region (UTR) to control expression of a reporter gene in an in vitro system 
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and in neuroblastoma (N2a) cells of mouse origin. Interest in this region of the PrP gene 
arose results from sheep PrP genetic studies (Hunter et al., 1991) and PrP mRNA 
(Hunter et al., 1994b) and protein studies (Horiuchi et al., 1995). In this project 
sequence analysis of the PrP gene 3' UTR region (el allele) showed that it was 
polymorphic with respect to the naturally occurring el and e3 allele and contained A,T -
rich motifs and potential alternative polyadenylation signals. The 3'UTR of PrP was 
found to reduce translatability of a linked chloramphenicol acetyl transferase (CAT) 
reporter gene by some 2-fold in N2a cells, although this effect was not detectable in a 
cell-free system. Deletion of 2.8kb of the 3.2kb 3'UTR relieved the inhibitory effect in 
vivo. Further constructs were made by unidirectional deletions in the 3' UTR and the 
results indicated that the above inhibitory effect is probably caused by sequences within 
a 1kb central portion of the 3'UTR. However, the alternative possibility that it reflects 
an unspecific effect, correlated merely with the length of the 3'UTR tail on the mRNA, 
has not been excluded. Additional experiments showed by deletion and site directed 
mutagensis that an alternative polyadenylation signal ATTAAAdiscovered at position 
1522 can be used in 3' end processing of RNA in N2a cells. These findings may have 
implications both for the expression of the PrP gene in the natural host of scrapie and 
for development and progression of disease. However, these implications would have 
to be explored in the natural host, not least because both PrP transcription and 
transmission of the disease differ in important ways between mouse and sheep. 
Two main approaches were used in this project 
In the first of these, equimolar concentrations of in vitro transcribed RNA differing in 
the length and orientation of the 3'UTR of sheep PrP were in vitro translated. Results 
suggest that the 3' UTR had no effect upon the levels of methionine [35 S] labelled CAT 
VI 
protein, as measured by scanning autoradiogram of SIDS gels with a densitometer. 
In vivo studies were carried out in neuroblastoma cell lines (N2a). Transient transfection 
of N2a cells with chimaeric CAT constructs possessing a 2794bp deletion in the 3' UTR 
of the PrP showed a significant increase in the translatability of CAT transcripts. When 
compared with constructs possessing the full length 3'UTR or a 1.2 kb deletion derivative. 
Additional in vivo studies showed that an alternative polyadenylation signal, 2 Kb from 
the etablished site was sufficient for 3' end processing. To connect such findings with 
disease requires an understanding of the expression of PrP in the natural host, the sheep. 
Natural transmission between animals, including maternal transmission, occurs in sheep 
but not in mice. Moreover it is known that the expression pattern is different in sheep 
from that in mice as there are two peripheral mRNAs only in the former. This is likely 
be 
to, e1evant for transmission of natural scrapie, which must be transmitted via a peripheral 
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(1.1) Introduction 
Scrapie is a fatal, transmissible neurode generative disease of sheep which occurs naturally. 
It was the first known and is the best studied of the group of transmissible 
neurode generative diseases often described as the transmissible spongiform 
encephalopathies (TSE5). Examples of TSEs of animals and humans are shown in Table 
1. TSEs are unusual because they may arise spontaneously in the population without any 
apparent cause, the so called sporadic forms (Brown, 1988; Hsiao & Prusiner, 1990; Owen 
et al., 1990), or they can be familial, tightly linked to mutations (Hsiao et al., 1989). In 
either case the disease can be transmitted by inoculation to laboratory animals. TSEs have 
gained increased media attention and have become the focus of public and economic 
interest because of the occurrence of bovine spongiform encephalopathy (B SE), the so 
called "mad-cow disease", and the possibility of transmission of the disease from animals 
to humans (Collinge and Rossor 1996; Will et al., 1996). Initial terminology of scrapie was 
based on descriptive terms that had arisen in relation to common clinical features. The 
naturally occurring disease was described in England as "rubbers" or "the gogles", in France 
as "la tremblance" (the tremble), in Germany as "Gnubberkrankheit" (itching disease) and 
"Traberkrankheit" (trotting disease). Scrapie was a Scottish term and was the first TSE 
described, although its infectious nature was not recognised until 1938 (Cuille and Chelle, 
1938). Scrapie has been endemic in the United Kingdom for at least 200 years and the 
average age of sheep at appearance of scrapie symptoms is 3.5 years, with most animals 
affected between 2.5 and 4.5 years (Stamp, 1962; Dickinson et al., 1960. 
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Disease Natural host 
Kuru Humans 
Creutzfeldt-Jacob disease Humans 
Gerstmann- Straussler-Scheinker syndrome Humans 
Fatal familial insomnia Humans 
Scrapie Sheep and goats 
Transmissible mink encephalopathy Mink 
Chronic wasting disease Mule deer and elk 
Bovine spongiform encephalopathy Cattle 
Feline spongiform encephalopathy Cats 
Exotic ungulate encephalopathy Nyala and greater kudu 
Table 1. Examples of transmissible spongiform encephalopathies and their 
natural hosts 
(1.2) Aetiology 
The aetiology of sheep scrapie has been debated for many years. Parry (1962) concluded 
that natural scrapie is an autosomal recessive genetic disorder which is also experimentally 
transmissible. Other have suggested that natural scrapie is the result of an infection with 
susceptibility and resistance controlled genetically by the host (Dickinson et al., 1965, 1971; 
Brotherston et al., 1968). 
Oral/ alimentary transmission has been suggested as a route for the natural spread of scrapie 
in sheep (Hadlow et al., 1982), but the source of infection is unclear. Oral/ alimentary 
transmission has also been proposed as the route of infection of other TSEs such as BSE 
(Wilesmith et al., 1988), transmissible mink encephalopathy (Hartsough and Burger, 1965) 
and Kuru (Gadjusek, 196. Little is known about the transmission of natural scrapie 
between sheep, although it is believed that vertical transmission from ewe to lamb does 
occur (Kimberlin, 1990; Schreuder, 1994). However the data that supports maternal 
transmission in sheep, date from a time when the genetics of disease susceptibility was 
poorly understood and the work needs to be repeated (Ridley and Baker 1995; Will 1995). 
The current view is that scrapie is an infectious disease where host genetic factors play a 
central role (Dickinson & Outram, 1988; Hunter, 1996). Recent data suggest that the scrapie 
agent can replicate in mites and that mites may represent a self-sustaining reservoir vector 
for scrapie agents (Wisniewski et al., 1996). Nematode larvae have also been postulated to 
play a part in transmission (Clouscard et al., 1995). 
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(1.3) Clinical Signs and Diagnosis 
Scrapie is not easy to study in the field: its appearance can not be predicted, there is no in 
vitro detection system for the infectious agent or preclinical, non-invasive diagnostic test. 
The term scrapie was used to describe the scratching behaviour often seen in infected sheep. 
Other indicators include loss of co-ordination and altered gait (Stamp, 1967). Diagnosis of 
scrapie in sheep has been primarily based on the histopathologic finding of neuronal and 
neuropil vacuolation in the brains of clinically affected sheep. However diagnostic problems 
arise, because vacuolation can be minimal or absent in suspected cases of scrapie or, 
conversely, when neuronal vacuolation is detected in healthy animals (Fraser, 1976; Zlotnik 
and Rennie 1958; Zlotnik, 1958). More reliable diagnostic tests are now based upon the 
presence of an abnormal protein designated PrPSC  in diseased animals (Van Keuen et al., 
1995). 
(1.4) Biochemistry of the PrP Protein 
(1.4.1) PrPC 
Central to all TSEs is a protein called PrP. In non-infected animals PrP protein is designated 
as PrPC  and is a 33-35 kDa host encoded membrane glycoprotein (Oesch et al., 1985; Stahl 
et al., 1987). The sheep PrP protein is 256 amino acids long and contains five tandem 
repeats of an eight amino acid motif (Pro-His-Gly-Gly-Gly-Trp-Gly-Gln) between residues 
10 
54 and 95. Maturation of the PrP precursor protein involves a number of modifications of 
the primary translation product. Maturation of the hamster PrP protein is shown in Figure 
1. An N-terminal signal sequence of 22 amino acids is cleaved off the primary translation 
product, glycosylation occurs at two asparagine residues, numbers 181 and 197, 23 C-
terminal amino acids are removed while a glycosyl phosphatidylinositol (GPI) residue is 
attached to a serine residue at codon 231 and a disulphide bond occurs between cysteine 
179 and cysteine 214. 
Primary translation product 	 181 
117 
 131 
22aa 	209 a 	 23 a 
signal 
	
	 GPI attachment 
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c 	 CHO CHO 




Molecular modelling has been used to try to predict the structure of the normal protein 
based on its amino acid sequence (Cohen et al., 1995). Although calculations imply that the 
protein folds into a compact structure having four helices at its core (Cohen et al., 1995), 
NMR studies of recombinant PrP protein residues 121-231 (PrP 121-23 1) have shown the 
potential for 3 alpha helices and a 2 stranded anti-parallel beta sheet (Riek et al., 1996) in 
this region of the molecule. 
(1.4.2) PrPSC 
An isoform of PrPC  designated as PrPSC  accumulates in the central nervous system and 
lymphoid tissues of sheep during the development of scrapie (Rubenstein et al., 1987; 
Ikegami et al., 1991). Conversion of PrPC  to PrP sc occurs after exposure of the host to 
scrapie agent. PrPSC  is a biochemical marker for scrapie and related diseases, and it can also 
be used as a marker for infectivity. PrPSC  can be differentiated from PrPC  biochemically, 
firstly by sedimentation after detergent treatment and secondly by its partial resistance to 
proteases. Protease K digestion completely digests PrPC  but with PrPS  the resistant core 
PrP27-30 remains after digestion. The N-terminus of PrP 27-30 is frayed and ranges from 
residues 73-90 (Figure 2.) (McKinley et al., 1983; Meyer et al., 1986; Hope et al., 1986, 
1988a, 1988b). 
I 	I Mature PrPC 	 CHO CHO 	 0 	complete 
I 	 0 
aa 	
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protease  I 209  K 00 I digestion 
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Figure 2. Operational definition of PrP. PrPSC  is operationally defined as containing 
a protease K resistant core while PrPC  is completely sensitive to digestion. 
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PrPSC has been detected in the brain by immunohistochemistry (DeArmond et al., 1992; 
Manson et al., 1992), and in extracts of brain by electron microscopy as fibrils (Merz et al., 
1981) or amorphous aggregates (Manuelidis and Manuelidis, 1986) or by SDS-PAGE 
immunoblotting (Diringer et al., 1988; Rubenstein et al., 1986; Kascsak et al., 1987; Brown 
et al., 1986). Infectivity co-purifies, to some degree at least, with PrP during subcellular 
fractionation and several groups have reported a stoichiometry of about 100, 000 molecules 
of PrPSC  per infectious particle using rodent models of these diseases (Diringer et al., 1988; 
Prusiner, 1991; Scott et al., 1991; Bolton and Bendheim, 1991). 
Models for the Conversion of PrPC  to  PrPS 
Models for the conversion of PrPC  to PrPSC  and the nature of the infectious agent (Section 
1.5.2) are the cause of intense debate and should be discussed separately. However, the 
central issue revolves around the idea that PrP sc is itself the infectious agent (protein-only 
model) generated either from a mutant PrP gene or converted from endogenous PrPC  by 
some sort of template process seeded by PrPSC  from an exogenous source. These models do 
not include a requirement for nucleic acid but its involvement in the conversion of PrPC  to 
PrP, replication and infectivity cannot be excluded (Section 1.5.2), and so others believe 
that the involvement of PrP sc in infectivity is not so fundamental and that other factors are 
involved. The ability of PrPprotein alone to be both infectious and self replicating has not 
been experimentally proven although various attempts have been made to confirm this. 
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There is general agreement that PrPC  and PrPSC  differ primarily by conformation and several 
theories exist as to how the PrP protein comes to be misfolded and form aggregates. 
Conversion of PrPC  to PrP sc is thought to be due to a post translational event. Circular 
dichroism studies indicate that there is a higher number of beta sheets and reduced number 
of alpha helices in the disease specific protein (PrPS)  when compared with PrPC  (Gasset et 
al., 1992, 1993). NMR on the other hand studies have shown that PrPC  contains a two-
stranded anti-parallel beta sheet and three alpha helices (Riek et al., 1996). The 
experimental demonstration of a beta sheet in PrPC  is in contrast with theoretical model 
building predictions of an all helical structure of PrPC  (Cohen et al., 1995; Pan et al., 1993) 
and may be important for the initiation of the transition from PrPC  to PrP Sc 
Using a simplified model, there may be various stages in transition that PrP protein 
undergoes: the normal cellular PrP' to the scrapie isoform (PrPS)  and polymerisation then 
to scrapie amyloid fibres which accumulate extracellularly in the brain (Gajdusek, 1988; 
Prusiner, 1992). 
The seeded nucleation model holds that PrP sc formation is a kinetic event dependent 
primarily on seeded nucleation, much like protein crystallization (Come et al., 1993, Jarret 
& Lansbury, 1993). When a crystal is put into supersaturated solution, that crystal can act 
as the seed for dissolved molecules to join and increase the size of the crystal. In the 
nucleation model PrPC  is postulated to unfold slightly, forming PrPU  and exposing a 
hydrophobic stretch of amino acids to the solvent. PrPU  dimerizes and a dimer has been 
isolated from mouse neuroblastoma cells expressing hamster PrP (Priola et al., 1995). 
N. 
Dimers appeared to be covalently linked and stable to several strongly denaturing reagents 
including boiling in SDS. Interestingly, the dimer showed properties of both PrPC  and  PrPSC 
in that it was protease sensitive, yet also tended to form aggregates. It was suggested that 
the dimer molecule may be an intermediate state in PrPSC  formation (Priola et al., 1995). 
Furthermore, in a cell free system the protease sensitive dimer is capable of being converted 
to the protease resistant form in the presence of PrPSC  purified from scrapie-infected hamster 
brains (Kocisko et al., 1994). 
According to the seeded nucleation model described in Figure 3, dimer aggregation offers 
a means to the formation of an ordered structure which could act as a seed, or be acted 
upon by a seed of PrPSC  (Priola et al., 1995). In the protein-only model for infection, the 
seed would be introduced from outside after which rapid aggregation of endogenous PrP" 
would begin. Sporadic TSEs, on the other hand, would depend on spontaneous seed 
formation from endogenous PrPU  dimers. Equilibrium between PrPC  and PrP' could easily 
depend on the cellular environment and be influenced by, for example, pH (Brown et al., 
1991 
Synthesis 
C _____  2 PrP 	- 2 PrP U 
) 
D im ers 
Degradation 
Exogenous. infection 
Seed PrP Sc  
A ggregation  
"nucleus" 	 n(PrP Sc 
Figure 3 Seeded Nucleation Model. Hypothetical model for the conversion of 
P rPC to PrP. 
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Other investigators suggest that the PrP protein can exist in a meta stable state capable of 
collapse to either of two more permanent states (Prusiner and DeArmond 1995). In this 
model PrPC  assumes a partially unfolded intermediate called PrP*,  which can then become 
PrP or be degraded, or resume the PrPC  form (Figure 4). In addition, PrPSC  would be able 
to serve as a template for the conversion of PrP*  into PrPS.  The slow step is considered 
to be formation of PrP*.  Under normal conditions the concentration of PrP*  is low and 
formation of PrPSC  is not significant. However, at some threshold level there would be 
enough PrPSC  present to form a complex with any PrP*  that forms, thus converting it to 
PrPSC .  Infection with PrP would act as a template to promote the conversion of PrP*  into 
PrPSC .  Sporadic disorders would arise through events which cause an increase in the 
frequency of PrP*,  and subsequently PrP, such as a mutation in the PrP gene ora rare 
chance interaction with a co-factor. 
Exogenous infection 
Synthesis 
rP C 	PrP* 	 PrP*/Prpsc 	 2PrPSC 
Degradation 
Figure 4. A conformational model for conversion of PrPC  to PrPS 
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(1.4.4) Protein X and Heat Shock Proteins 
Studies of the effect of scrapie on the distribution and expression of various heat shock 
proteins (hsps) in scrap le-in fected cells revealed differences in comparison with healthy 
cells. While the majority of chaperones (proteins involved in folding and unfolding of 
proteins) are constitutively expressed and found in abundance in cells under normal 
conditions (Gething & Sambrook, 1992), some of the heat shock proteins are highly induced 
under cell stress. Hsp73 is constitutively expressed and is usually found in the cytoplasm. 
Exposure of neuroblastoma cells to stress results in the translocation of both hsp72 and 
hsp73 into the nucleus of the cell. In contrast to normal neuroblastoma cells, 
scrapie-infected cells exposed to stress inducing conditions, failed to translocate hsp73 into 
the nucleus and it is speculated that hsp73 may form a tight complex with PrPSC  (Tatzelt et 
al., 1995). The hsp70 proteins (hsp 73 and lisp 72) have been described as undergoing a 
host of interactions with proteins, binding both folded and unfolded proteins (Ziegelhoffer 
et al., 1996) and these interactions may be important in PrPSC  formation. Recent reports 
using the 2 hybrid system have shown that the alpha helical domains of PrPC  interact 
specifically with lisp 60 (Edenhofer et al., 1996). 
Results of the CD studies suggest that PrPC  contains approximately 42% alpha helix and 
virtually no beta sheet, but PrPSC  contains 30% alpha helix and 43% beta sheet (Pan et al., 
1993). Despite the recent NMR studies of recombinant PrP which suggest more beta sheet 
may be present in PrPC,  the CD studies are still current and argue that the conversion of 
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alpha helices into beta sheets underlies the formation of PrPS.  Transgenic studies have 
suggested that beta sheet of PrPSC  binds to alpha helices of PrPC while the PrPC/PrPSC 
complex binds to a macromolecule (provisionally designated protein X) through residues 
of PrPC  and it is also possible that PrPSC  is protein X. The formation of PrPSc  would be a 
specific, tightly regulated process mediated by protein X which might act as a molecular 
chaperone in the refolding of PrPC  into  PrPSC  (Telling et al., 1995). A model has been put 
forward that describes an infectious dimer of PrPS  which binds to an as yet unidentified 
Protein X (Figure 5), forming a heterotrimeric complex that would bind with PrPC  to form 
a heterotetramer. The heterotetramer would facilitate conversion of PrPC  to  PrPSc  while 
protein X dissociates. The homotrimeric PrPSC  complex could then act as a template to 
facilitate the formation of another PrPSC  molecule from PrPC  by binding another PrPC 
molecule. Protein X could then facilitate the dissociation of the PrPSC  homotetramer into two 
infectious PrPSc  homodimers and form the heterotrimeric PrPSVX  complex, thus completing 
the replication cycle. 
Heterotrimeric complex 	C 	 Heterotetramer complex 
Sc 	 ±PrP 
(2 PrP + Protein X) 	 (2 PrP 
Sc 




4 PrPSc 	 3 PrP' 	 PrPc 
Homotetramer complex 	 H omotrimer complex 
Figure 5. A hypothetical scheme for the involvement of protein X in the 
conversion of PrPC  to PrP. 
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The conversion of a protease sensitive to a resistant species of PrP protein can be performed 
in vitro by mixing PrPC  and PrPSC  (Kocisko et. al., 1994). This should lead to a more 
factually based model for PrP conversion. These results have been extended to include in 
vitro formation of different types of scrapie-like proteins starting from a common PrP 
precursor (Kocisko et al., 1994). All of these reactions were dependent on the use of 
guanidinium to unfold the template PrPSC  protein slightly, but not enough to diminish its 
associated infectivity. Production of mammalian PrPSC  from  PrPC  in vitro is very inefficient, 
for instance a system in which the ratio of PrPC:PrPSC  (both from the same species) was 1:50 
yielded only trace amounts of PrPSC  de novo (Kocisko et. al., 1994) and new infectivity 
produced would be much too small to detect by bioassay against background levels. The 
long time course for in vitro formation of protease resistant PrP combined with the 
inefficiency of the reaction and the requirement for slightly unfolding the template PrPSC 
molecule, suggest a requirement for conditions in the cell that are optimal for this process. 
A co-factor such as a chaperone may also be required. Perhaps if a complete cell-free 
system were set up, for instance one which contained purified protein X or had a purified 
heat shock protein added to the system, a more efficient in vitro conversion might be 
achieved. Similarly, if PrPC  to  PrPSC  conformation changes occur in the endocytotic pathway 
as suggested by Mayer et al., 1986, then in vitro experiments with extracts of 
endosome-lysosomes might increase the efficiency of the process. 
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(1.4.5) The Importance of Post-translational Modifications 
After discovery that PrPC  and  PrPS  were encoded by the same gene (Oesch et al., 1985) a 
search began for a post-translational modification that could give rise to the difference 
between the two isoforms. However, both isoforms are modified covalently in a very similar 
fashion. The PrP protein undergoes several post translational modifications before either 
being degraded as PrPC  or transformed into PrPSC  and accumulated. 
A signal sequence present near the C-terminus targets PrP protein synthesis to the 
endoplasmic reticulum (ER), where the sequence is cleaved leaving Ser at codon 231 as 
a site for attachment of a glycosyl-phosphatidylinositol (GPI) group. Addition of GPI serves 
to anchor to the cell surface and GPI is present on both PrPC  and PrP 27-30 (the protease 
resistant core of PrPSC).  However synthesis of a truncated PrP lacking the GPI anchor 
attachment signal still allowing in the production of PrPSC  in vivo thus eliminating GPI as 
a necessary factor for PrPSC  production (Rogers et al., 1993). The truncated PrPC  protein 
could not be detected which is thought to be due to the rapid digestion of PrPC  protein as, 
lacking the GPI attachment site, it may be secreted. 
PrP protein also undergoes glycosylation in the golgi. There are two consensus sites for 
asparagine linked glycosylation near the C-terminus of the PrP protein. Examination of the 
various forms of the PrP protein revealed that P rPC ,  PrP&, and PrP 27-30 are all 
glycosylated (Endo et al., 1989). While a myriad of different oligosaccharide structures are 
possible on the PrP protein (Endo et al., 1989), it is doubtful that these play a role in the 
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transformation of PrPC  into  PrPSc,  since a scrapie-infected cell line which can support PrPSC 
production, still does so in the presence of agents which block N-linked glycosylation 
(Taraboulos et al., 1990). The same conclusions have been reached by other methods, for 
instance by use of site directed mutagenesis to eliminate the sites of N-linked glycosylation 
(Caughey et al., 1995). PrPS  is still produced in the absence of sites for N-linked 
glycosylation suggesting that glycosylation is not an essential element in the transformation 
of PrPC into PrP. However, in the in vivo situation glycosylation may be important for 
stability and transport to the cell surface (Petersen et al., 1996). 
(1.4.6) Neurotoxicity of PrP Peptides, PrPSC  and  PrPSC  in Brain Grafts 
The abnormal form of the PrP protein (PrP) and a synthetic peptide of PrP (residues 106-
126) are cytotoxic in vitro (Forloni et al., 1993; Brown et al., 1994; Selvaggini et al., 1993). 
The peptide PrP 106-126 has a beta-sheet secondary structure and forms amyloid-like fibrils 
(Tagliavini et al., 1994). The cytoxicity Of the PrP peptide (PrP 106-126) was found to be 
dependent upon its state of aggregation, on continued cellular expression of PrPC  (Hope et 
al., 1996) and possibly also on the presence of microglial cells (Brown et al., 1996). These 
findings suggest that the region corresponding to residues 106-126 of the human PrP is 
important for neurotoxicity, and that cerebral accumulations of peptides including this 
domain may be responsible for the neuropathological changes that occur in PrP-related 
encephalopathies, such as GSS and CJD (Chen et al., 1995). 
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To determine whether scrapie pathology in mice comes about by neurotoxicity of PrP, 
acute depletion of PrPC,  or some other mechanism, neural tissue overexpressing PrPC  was 
grafted into the brains of scrapie-resistant mice lacking a PrP gene (PrP-null mice), and 
inoculated with brain homogenates from scrapie infected animals (Aguzzi et al., 1996). 
Infected grafts developed all the pathological changes normally associated with scrapie in 
mice (spongiosis, gliosis and neuronal death), and contained high amounts of PrPSC  and 
infectivity, while neighbouring cells remained unaffected. The life span of the infected mice 
was not reduced, and no neurological symptoms developed. Surprisingly, graft-borne PrP sc  
migrated from the transplants in amounts sufficient to induce the formation of plaque-like 
deposits of PrP in the host brain outside the graft region. However even 16 months after 
infection, no pathological changes were seen in the PrP-null tissue immediately adjacent to 
the grafts and to such deposits. Therefore, in this case, availability of endogenous PrPC  to 
the infectious agent, rather than deposition of PrPS,  correlated directly with scrapie 
neurotoxicity in vivo. 
(1.5.1) Infectious Process 
Events in the infectious process such as the site of entry and primary multiplication of the 
agent, and the mechanism by which the agent is transported to the CNS remain obscure. 
Research has shown that the agent will pass along peripheral nerves and hence will travel 
in this way from a site of absorption to the brain (Farquhar et al., 1994 ) 
Hadlow et al., (1979) found high infectivity titres in the brain, the spinal cord and the 
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peripheral nervous system of scrapie affected sheep. Infectivity was also demonstrated at 
lower levels in ileum, colon, spleen, lymph node, tonsil, sciatic nerve and thymus (in order 
of decreasing concentrations). Despite relatively low titres, scrapie infectivity can be 
detected in non-neuronal tissues (Hadlow et al., 1982), and PrPSC  is also found in non-
neuronal tissues of scrapie infected sheep (Ikegami et al., 1991). 
(1.5.2) The Infectious Agent 
The nature of the agent causing TSE has generated intense discussion for more than a 
quarter of a century. There are three hypotheses for the nature of the infectious agent: 
The virus model; this model suggests that a nucleic acid encodes for pathogenic strain 
information and for the viral coat protein. 
The prion model or protein-only model: this model suggests that PrPSC  alone is the 
infectious agent and does not require a nucleic acid molecule. 
The virino model; this model suggests that the pathogenic strain information is encoded 
by an agent-specific molecule (probably a nucleic acid) which is protected by a host 
encoded protein. 
Virus-like structures have been shown by electron microscopy to be present in fractions 
from scrapie hamster brain, however their involvement in TSEs remains to be established 
(Diringer et al., 1994). It has been speculated that an information molecule (nucleic acid) 
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is involved in infectivity and/or the conversion of PrP' to PrPS,  although no candidate 
nucleic acid has yet been found (Sommerville, 1991). 
Perhaps the strongest case for the presence of an information molecule associated with the 
infectious agent comes from the finding of multiple strains or distinct isolates of the 
infectious agent defined by specific incubation times, distribution of vacuolar lesions and 
patterns of PrP sc accumulation (Dickinson et al., 1968; Fraser and Dickinson 1973; Hecker 
et al., 1992). 
There is no shortage of data that supports the view that the abnormally modified host-
encoded cellular protein PrPSC  is a major and necessary component of the infectious agent 
(Review: Prusiner, 1995). Recent data supporting the prion hypothesis include observations 
that PrPC  will convert into protease resistant forms when incubated with preexisting PrP 
in a cell-free system (Kocisko et al., 1994, 1995; Bessen et al. 1995; Caughey et al., 1995). 
However, it is not known whether new scrapie infectivity is generated upon conversion of 
PrPCto  these protease resistant forms (Section 1.4.4). 
The unresolved issue is whether nucleic acid is an essential component of the infectious 
agent. Biophysical and chemical studies have led to the hypothesis that the agent's 
infectivity is not susceptible to insults that would be expected to modify or hydrolyse 
polynucleotides, while treatment with protein denaturants reduces infectivity. (Milson et al., 
1976; Prusiner et al., 1981; Diener et al., 1982; McKinley et al., 1983; Bellinger-Kawahara 
et al., 1987). 
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(1.5.3) Strain Variation in Models 
There are clear results indicating that, like conventional microorganisms, the infectious 
scrapie particle exhibits strain differences. Isolates show different incubation times, 
neuropathology, ease of transmission to new species (Kimberlin and Walker, 1978), 
clinical manifestations and susceptibility to thermal inactivation (Dickinson and Taylor, 
1978). Scrapie isolates have been transmitted to mice (Dickinson and Meikle, 1971; 
Bruce et al., 1991), sheep (Foster and Dickinson, 1988) and hamsters (Kimberlin and 
Walker, 1978; Kimberlin et al., 1989), while CJD isolates have been transmitted to 
mice (Mori et al., 1989; Kitamoto et al., 1990) and transmissible mink encephalopathy 
to hamsters (Kimberlin et al., 1986). There are currently about 20 phenotypically distinct 
strains isolated in mice by serially passaging scrapie or BSE from a wide range of 
sheep, goat and cattle sources (Bruce, 1993). 
Mouse models provide a convenient system to analyse strain variation. The Sinc gene 
has two alleles (s7 and p7) in mice and is the most important gene controlling 
incubation time from inoculation to clinical disease (Dickinson et al., 1968). Good 
evidence suggests that the Sinc gene encodes the PrP protein, for example the s7 allele 
is linked to the PrP variant with leucine at codon 108 and threonine at codon 189 while 
the p7 allele has PrP with phenylalanine at codon 108 and valine at 189 (Westaway et 
al., 1987; Hunter et al., 1992). Transgenic studies also support the congruency of Sinc 
and PrP (Westaway et al., 1991). 
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Primary transmissions of TSE strains from natural hosts to mice result in very prolonged 
incubation periods, and, and in some cases, no disease at all. This is referred to as the 
"species barrier". However, subsequent passage through mice to mice of a single Sinc 
genotype results in a precise characteristic neuropathology and incubation period (Bruce 
et al., 1991, Bruce, 1993; Fraser and Dickinson, 1968; Kimberlin et al., 1989). 
Recent transmission experiments from several unrelated sources of BSE from cattle to 
inbred mice gave strikingly similar pathology and incubation periods. Interestingly, 
transmissions from other new TSE sources (cats, kudu and nyala) gave similar results 
to BSE from cattle suggesting a similar source of infection. However, these results 
differed in incubation periods and pathology from transmission experiments when 
scrapie of sheep was injected into inbred mice (Fraser et al., 1992; Bruce et al., 1994). 
The modification and/ or selection of a particular strain might have resulted from the 
passage through cattle of scrapie affected tissue. 
(1.5.4) PrP conformation and strain variation 
Because efforts to find nucleic acids associated with infectivity have been unrewarding, 
the prion, or protein only hypothesis offers another explanation of strain variation. One 
possibility is that PrP proteins can adopt multiple conformations. Folding in one way 
might convert PrPC  to PrPSC  highly efficiently, giving rise to short incubation times. 
Folding in another way might cause the conversion to work less efficiently. Similarly, 
one "conformer" might be attracted to neuronal populations in one part of the brain, 
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whereas another might be attracted to neurons elsewhere, thus producing different 
symptoms. Considering that PrP can fold in at least two ways, it would not be surprising 
to find it can collapse into other structures as well (Prusiner and DeArmond 1995). 
(1.6) Molecular Biology of PrP Expression 
(1.6.1) PrP Gene Structure 
Location of the human PrP gene to the short arm of chromosome 20 (Liao et al., 1986; 
Sparkles et al., 1986; Puckett et al., 1991) and that of mice to the homologous region of 
chromosome 2 (Sparkles et al., 1986) implies that the gene was likely to be present 
before speciation of mammals. The PrP open reading frame (ORF) consists of a single 
exon in all known mammalian and avian PrP genes. Mouse (Westaway et al., 1994b) and 
sheep (Westaway et al., 1994a) PrP genes encompass 3 exons and 2 introns whereas the 
hamster and human PrP genes encompass only 2 exons and 1 intron (Puckett et al., 1991: 
Oesch et al., 1985). In all known PrP genes, the ORF and the 3' untranslated region 
(3'UTR) are contained within one exon, the farthest one downstream from the promoter 
in each case. The PrP ORFs are similar in length (about 760bp) (Goldmann et al., 1991) 
while the length of the 3' UTR is more variable. The additional exons code for the 5' 
UTR. (Figure 6). 
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Sheep PrP gene structure 
Exoni Introni Exon2 	
Intron2 
Human PrP gene structure 
Exon 1 
Figure 6. Schematic diagram of sheep and human PrP gene structure. Note 
that sheep have 3 exons and 2 introns while humans have 2 exons and 1 intron. 
(1.6.2) Genetic Linkage of PrP and Susceptibility 
Host genes control the incubation period of scrapie from infection to clinical disease and 
death. In mice, the major gene controlling the incubation period is Sinc (scrapie 
incubation period) which has two alleles, s7 and p7 (Dickinson et al., 1968). Studies 
of genetic linkage (Westway et al.,1989; Hunter et al., 1992) and transgenic mice (Hsaio 
et al., 1990; Prusiner et al., 1990) have suggested that the PrP gene is the gene Sinc in 
mice which controls the length of the incubation period of scrapie, but this is not yet 
conclusive (Westway et al., 1991). All SincS7  mouse strains tested encode PrP protein 
with leucine at codon 108 and threonine at codon 189, whereas in all Sin c" 7 mouse 
strains the PrP protein has phenylalanine at codon 108 and valine at codon 189. The 
sheep homologue of Sinc is called Sip and also has two alleles , sA and pA (Dickinson 
and Outram, 1988). Sip is defined as the gene which controls the incubation period in 
NPU Cheviots following experimental inoculation with a scrapie isolate named SSBPI1. 
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Polymorphisms of the PrP gene are so tightly linked to different incubation times that 
it is thought to be the same gene as Sip. 
(1.6.3) Polymorphisms In the Sheep PrP Open reading frame 
Several polymorphisms have been described in the PrP gene of sheep several (Figure 





















met met 	leu his arg 
thr thr phe gin 
Figure 7. Schematic diagram showing the known polymorphisms in the 
sheep PrP open reading frame. 
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(1 .6.4) Experimental Scrapie 
Studies in which sheep have been injected with brain homogenate from scrapie infected 
sheep have shown that several factors determine whether the inoculated sheep develops 
scrapie: PrP genotype, route of inoculation, scrapie source and the breed (Review: 
Hunter, 1996). In NPU Cheviot sheep a range of experimental scrapie experiments have 
been carried out to assess whether there is any linkage of PrP ORF polymorphisms with 
susceptibility to scrapie (Figure 8). It was found that upon subcutaneous injection with 
a scrapie isolate SSBP/1, sheep that encode valine at codon 136 (V 136) in the PrP ORF 
on both alleles had short incubation periods while heterozygotes, sheep encoding valine 
at codon 136 on one allele and alanine on the other (VA 136), had longer incubation 
periods. In contrast alanine homozygotes (AA 136) were resistant to experimental scrapie 
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Figure 8. PrP genotypes of NPU Cheviots and incidence of experimental scrapie upon 
subcutaneous inoculation with SSBP/l. 
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However, when another scrapie isolate CH1641 or a BSE isolate was intracerebrally 
injected into Cheviot sheep an association of disease incidence was found not with 
codon 136 but primarily with codon 171 (figure 9). Animals homozygous for glutamine 
at codon 171 (QQ171) had short incubation periods while those having one allele with 
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Figure 9. PrP genotypes of NPU Cheviots and incidence of experimental scrapie upon 
intracerebral inoculation with BSE. 
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(1.6.5) Natural Scrapie 
With natural scrapie the source, route, time and dose of infection are unknown and all 
could affect incidence and age-at-death of scrapie. Nevertheless there is strong evidence 
in sheep of the importance of PrP genotype in controlling disease incidence, including the 
polymorphisms at codon 136 (Goldmann etal., 1991; Maciulis et al., 1992; Hunter et al., 
1993; Laplanche et al., 1993; Hunter et al., 1994a; Belt et al., 1995; Clouscard et al., 
1995; Ikeda et al., 1995) and codons 154 and 171 (Laplanche et al., 1993; Goldmann et 
al., 1994; Westaway et al., 1994a; Belt et al., 1995; Hunter et al., 1996). 
For example, in NPU Cheviot sheep, the genotype VV 136RR 154QQ 171 succumbs to natural 
scrapie at 700-900 days of age. Heterozygotes, VA 136RR 154QQ 171 also develop natural 
scrapie but live longer (1100-1200 days). Animals which are VA 136 will survive if also 
heterozygous at either codon 154 (HR 154) or codon 171 (RQ 171 ) despite these genotypes 
being susceptible to experimental challenge with SSBP/l (Hunter et al., 1996). All AA 136 
genotypes are apparently resistant in this outbreak of natural scrapie. Not all sheep 
breeds, or outbreaks, exhibit precisely the same PrP genetics, however. 
In two separate studies of natural scrapie in Romanovs (Laplanche et al., 1993; Clouscard 
et al., 1995) an association of the V 136 PrP allele of the PrP gene was found with 
incidence of disease (Laplanche et al., 1993) while in another the association with 
disease was with glutamine at codon 171 on both alleles of the PrP gene (Clouscard et 
al., 1995). In Suffolk sheep V 136 is a rare allele (Hunter et al., 1996) and in studies of 
Suffolk sheep in the US, and Japan it was found that sheep affected with natural scrapie 
were all QQ171 (Westaway et al., 1994a; Ikeda et al., 1995). 
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(1.6.6) Polymorphisms in the 3'UTR of the Sheep PrP gene 
An Eco RI restriction fragment el (6.8 kb) of the sheep PrP gene (Figure 10) has been 
associated with the Sip sA allele and its relative susceptibility phenotype in NPU Cheviot 
(Hunter et al., 1989, 1991) and USA Cheviot sheep (Maciulis et al., 1992) following 
injection with SSBP/1 scrapie. Swaledale sheep affected with natural scrapie also have 
high frequencies of el (Hunter et al., 1993). In a study of 160 naturally infected sheep 
of 32 breeds and cross breeds from the U.K. PrP-el was found to be present in up to 
92% of the animals (Hunter et al., 1992). PrP-el is relatively rare in healthy age-matched 
controls which have higher frequencies of a shorter corresponding fragment, e3 (4.4 kb). 
A similar high frequency of el in scrapie sheep was also found in Suffolk sheep in Japan 
(Muramatsu et al., 1992). The polymorphic Eco RI site which gives rise to el and e3 lies 
in the 3' untranslated region (UTR) of the PrP gene and its persistent association with 
scrapie incidence has given rise to the idea that the 3'UTR may play some role in disease 
incidence through control of expression of the gene. However, the association between 
el and disease could well be due to the linked missense mutation affecting codon 171, 
while not dismissing the possible correlation with 3' UTR polymorphisms. 
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Figure 10. Schematic representation of the Eco RI restriction sites in the PrP 
gene. Polymorphic site is boxed and give rise to fragments el and e3. 
(1.6.7) Transgenic Studies 
A wealth of new information has been gained from transgenic mouse studies with and 
without endogenous PrP. Analysis of transgenic models in recent years has shown that 
there is a relationship between PrP expression level and disease progression. Lower-than-
normal expression leads to extended incubation period and clinical phase (Beuler, 1993; 
Manson et al., 1994). In contrast, overexpression shortens incubation period or generates 
novel neurological syndromes associated with degeneration of skeletal muscle, peripheral 
nerves and the CNS (Westaway et al., 1994b). 
Healthy transgenic mice with both copies of the PrP gene inactivated by homologous 
recombination (Bueler et al., 1992) cannot so far be infected with scrapie (Bueler et 
al.,1993; Prusiner et al.,1993). In hemizygotes the presence of one copy of the PrP gene 
resulted in susceptibility to scrapie but with longer incubation periods compared with 
wild type mice (Bueler et al.,1993). Consequently, PrP gene expression appears essential 
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for disease and neuropathology. 
Although the normal function of PrP remains unknown, it has been proposed that PrP 
protein is required for normal synaptic transmission following the observation that long 
term potentiation (LTP) is weakened in PrP-null mice. Stimulus protocols which induce 
LTP in wild type and hemizygous mice induce only short lasting potentiation (STP) in 
PrP-null mice (Collinge et al., 1994). Other hypotheses suggest the involvement of PrP 
in circadian rhythms (Tobler et al., 1996) and in the long-term survival of Purkinje 
neurons (Saaguchi et al., 1996). 
Earlier experiments involved the use of transgenic mice expressing high copy numbers 
of the hamster PrP gene in addition to the endogenous mouse PrP gene (Prusiner et al., 
1990; Scott et al., 1989). By inoculation of these mice with hamster scrapie it was found 
that the incubation time was inversely proportional to the level of hamster PrP transcripts 
and hamster PrPC  concentration in transgenic mouse brains. At the same time, a direct 
correlation was found between the incubation time and the dose of hamster scrapie 
inoculated. Scrapie titre at the time of clinical illness was independent of the incubation 
time suggesting that the normal "species barrier", which prevents hamster scrapie 
affecting mice, is overcome by giving mice the hamster PrP gene. The PrP genes of 
Syrian hamsters and mice encode proteins differing at 16 positions, so these residues are 
candidates for the control of the species barrier and can now be analysed. 
Proline at position 102 is found in all mammalian PrP genes sequenced so far while a 
missense mutation leading to a proline to leucine substitution at this position is linked 
to GSS in affected families (Hsiao et al., 1989). Transgenic mice expressing an 
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equivalent mutation at position 101 (position 102 in humans 101 in mice) , displayed 
spontaneous neurological disease with pathology indistinguishable from murine scrapie 
(Hsiao et al., 1990). It was therefore suggested that the primary lesion in GSS is the 
proline to leucine change at codon 102. 
An alternative explanation of the response of these transgenic mice relates to the multiple 
copies of the transgene inserted into the mouse genome. Transgenic mice carrying 
multiple copies of the hamster PrP gene have hamster scrapie incubation periods inversely 
related to the number of transgene copies (Prusiner et al., 1990). The codon 102 (proline 
to leucine) transgenic mice also carrying many copies of the transgene could simply have 
been rendered exquisitely susceptible to a contaminating scrapie agent. It is also known 
that multiple copies of normal PrP genes can result in illness (muscle myopathy) in 
transgenic mice (Westaway et al., 1994b). 
Transgenic mice expressing the different sheep PrP proteins are currently being made 
(Hunter et al, in progress). The use of gene targetting to replace the endogenous mouse 
PrP gene coding region with that of sheep should avoid the problems experienced with 
multi-copy PrP transgenes. However the associations of particular PrP amino acid variants 
with disease remain simply strong correlations without any real understanding of the 
biochemical (if any) of these single amino acid changes. In a completely different 
approach, investigations are being carried out into whether the PrP amino acid 
polymorphisms, which contribute to differences in survival times (in vivo), influence the 
in vitro conversion kinetics of PrPC  into PrPSC  (Bosers et al., 1996). 
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(1.6.8) Introns 
The large intron of PrP genes varies from 10-14 kb in size depending on the species 
(Basler et al., 1986; Bueler et al., 1992; Westaway et al., 1994a). Transgenic mice 
transcribing a PrP gene without an intron failed to express PrP protein and it has been 
speculated that the intron may have a significant role in PrP expression (Scott et al., 
1989). However, another study has shown that a PrP mini-gene without an intron can 
express PrP protein (Race et al., 1995). Since introns are required for expression in other 
systems the PrP intron may be in some cases exerting a general rather than a specific 
effect on PrP protein expression (Brinster et al., 1988; Buchman and Berg, 1988). A 
relationship between splicing and 3' processing has been suggested (Robberson et al., 
1990) and may account for the inability to detect PrP mRNA in transgenic mice lacking 
an intron (Fisher et al., 1996). 
(1.6.9) Promoter Analysis 
The expression of many eukaryotic protein-coding genes is controlled at the level of 
transcription. In these cases, the amount of mRNA in the cell is determined principally 
by the rate of initiation of transcription from the promoter which gives rise to the 
message. Over 40 different protein subunits regulate transcription by RNA polymerase 
II at specific promoters. The core subunits of eukaryotic RNA polmerase II are able to 
catalyze RNA synthesis, but are not capable of gene specific transcription . Instead, a 
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host of accessory or general transcription factors work in concert with RNA polymerase 
II to bring about promoter recognition and accurate transcription initiation (for reviews 
see Zawel and Reinberg, 1995; Tjian et al., 1996). The most prominent core promoter 
element is the TATA box, typically located upstream (-25 to -30) of the transcription 
initiation sites of many eukaryotic genes. PrP genes in animals and human lack a TATA 
box in the 5'-flanking region upstream of the transcriptional start sites (Basler et al., 1986; 
Westaway et al., 1994a; Puckett et al., 1991; Onodera et al., 1996). Functional 
transcriptional regulatory elements in the rat PrP gene were precisely localised by a series 
of 5' deletion mutants. Deletion analysis showed that an inverted CCAAT and adjoining 
Sp-1 binding sequences may be involved in the control of in transcription of the rat PrP 
gene (Onodera et al., 1996). These sequences have been shown to play a important role 
in numerous viral and eukaryotic genes (Chodosh et al., 1988; Briggs et al., 1986). 
The sheep PrP gene shares four motifs over 250 nucleotides in the promoter region with 
Syrian hamster and human PrP genes (Basler et al., 1986; Puckett et al., 1991). These 
motifs may correspond to binding sites for functional transcription factors. The sheep 
promoter sequence diverges between these motifs and the mRNA start sites. It includes 
an AP-2-like consensus sequence, whereas the Spi and AP-1 sites present in the rodent 
and human genes are absent (Westaway et al., 1994). These differences might account 
for the difference in PrP mRNA levels between rodents and sheep. The PrP mRNA in 
mice and hamster spleens was found to be less than 1% of that in the brain (Caughey et 
al., 1988), while PrP mRNA in the sheep spleen was estimated to be about 10% of 
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that in the brain (Horiuchi et at., 1995). 
(1.6.10) Transcription Start Sites 
Human PrP gene transcription exhibits a single start site resulting in a homogeneous 
population of PrP mRNA with 136 nucleotides of 5' leader sequence in brain tissue 
(Puckett et al., 1991). In contrast, the hamster gene has multiple start sites within a 
330bp promoter region producing a heterogenous mRNA population with 5' leader 
sequences of 150-300 nucleotides in brain tissue (Basler et al., 1986; Westaway et al., 
1987). Similar multiple start sites have been shown for rat PrP transcripts (Onadera et 
at., 1996). 
(1.6.11) Transcriptional regulation 
There is no evidence of gross changes in the PrP mRNA levels (by Northern analysis) 
during disease development. However, subtle changes may occur. Potential transcription 
regulation can be seen during embryonic development and may account for differences 
between mRNA levels in the brain and peripheral tissues. Northern analysis in mice has 
shown low levels of PrP mRNA in the kidney, heart, lung and spleen, while high levels 
have been found in the brain, specifically within neuronal cells (Oesch et al., 1985; 
Manson et al., 1992 and Brown et al., 1990). Similarly, expression in the sheep is also 
widespread with the highest levels of mRNA found in the brain (Hunter et al 1993b; 
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Iketa et al 1995) and is detectable in developing lambs before birth (Hunter et al 1993b). 
Rat PrP mRNA levels increase threefold during embryonic development from embryonic 
day 20 to adult day 70 (Lieberburg, 1987). Similar changes in PrP expression during 
development have been shown in mice (Manson et al., 1991). 
Treatment ofPCl2 (rat) cells with nerve growth factor (NGF) has been shown to increase 
the levels of PrP mRNA by 9 fold without affecting of mRNA stability (Mobley et al., 
1988). 
(1.6.12) The Sheep PrP Promoter 
It has been shown that minor sequence differences in promoter regions can lead to 
important phenotypic differences in vivo. For instance susceptibility to cerebral malaria 
is associated with a point mutation in the promoter of TNF-alpha (McGuire et al., 1994). 
The promoter and exon I sequences of mouse and sheep PrP genes exhibit surprisingly 
low overall homology (Westaway et al., 1994a) and have quite different putative 
transcription factor binding sites and sequence motifs. Existing transgenic mice 
harbouring several copies of the sheep PrP gene (Westaway et al., 1994b) have proved 
that the basic elements of transcription initiation are recognized in mouse, but the 
regulation of these multicopy transgenes has not been investigated. The replacement of 
the 5' gene flanking region of mouse PrP with the homologous region of the sheep PrP 
gene is an experiment which is now being carried out (Hunter et al., in progress), so that 
mouse PrP protein expression should be controlled from a sheep PrP promoter. The 
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resulting expression pattern of PrP mRNA and the distribution of PrP protein within the 
CNS and peripheral tissues will then be studied. 
(1.6.13) The 3' UTR 
The 3'untranslated region (UTR) is often the largest part of an mRNA and is defined as 
the region after the stop codon and before the site of polyadenylation. In the last several 
years this region has turned out to be central to post-transcriptional regulation of some 
mRNAs. RNA processing, export from the nucleus, mRNA stability, and intracellular 
localization and translation can be all regulated by the 3' UTR (Jansen et al., 1995). 
Gene expression is often regulated at the level of transcription but changes in the level 
of protein do not always correlate with the transcriptional rate, suggesting the operation 
of post transcriptional control mechanisms. The majority of studies on post-
transcriptional control of mRNA expression have involved early embryos because 
maternally inherited mRNA and not DNA transcription is pivotal (Review: Macdonald 
and Smibert 1996). The first few hours of embryonic development, in most organisms, 
are marked by an absence of transcription. Thus the fully grown oocyte, in order to 
furnish itself with the necessary proteins and enzymes required during early 
embryogenesis (and particularly during early cell division), accumulates stockpiles of 
both proteins and mRNA. During meiotic maturation, or after fertilisation, gene 
expression is regulated by mobilising these protein and message stores. The 3' UTR has 
been shown in different cases to be "sufficient" and "necessary" for mRNA localisation, 
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mRNA stability and translational regulation, both dependent on and independent of 
polyadenylation. Many eukaryotic mRNAs contain regulatory elements within the 3' 
UTR and interact with specific cytoplasmic proteins that modulate stability or 
translational competence 
(1.6.14) Post Transcriptional Control of PrP mRNA Expression During 
Disease 
Several studies have suggested that PrP expression would be regulated at the post-
transcriptional level and have analysed PrP expression during disease, in vitro and during 
normal conditions. 
Normal PrP (PrPC)  is a protease-sensitive cell surface glycoprotein anchored in the 
membrane by a glycoinositol phospholipid (Stahl et al., 1987). During the course of 
disease PrPSC  accumulates in and around cells of the brain as protease-resistant deposits. 
Accumulation of PrPSC  cannot be explained by differences in PrP mRNA stability or the 
rate of transcription in mice (Pfeifer et al., 1993) and may result from changes in 
post-transcriptional control. 
In rat brain, 30% of PrP mRNA is thought to be sequestered in ribonucleoprotein 
particles (mRNPs) and is therefore potentially subject to translational regulation by 
attenuated initiation (Denman et al., 1991). Release of sequestered mRNA could result 
in the higher levels of PrP protein found in scrapie affected rat brains (Figure 11). A 
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model has been put forward to explain the inhibition of translation initiation by 
phosphorylation and binding of a protein to a specific 3' UTR motif independent upon 
polyadenylation (Figure 11). The model suggests that binding of the specific protein to 
the 3 'UTR acts as a nucleation signal for other proteins to bind to the mRNA, wrapping 
it up in a particle (mRNP) in which the RNA is inaccessible to the translational 
machinery. Possible candidates for proteins involved are the so-called Y-box proteins 
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Figure 11. Mechanism of inhibition of translation initiation by the binding 
of protein to a specific 3'UTR motif. Binding of specific proteins to the 3' UTR 
leads to the formation of mRNP and transla,tional attenuation. Transcripts associated with 
polysomes are normally translationally competent. 
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(1.6.15) PrP expression in cell cultures 
A variety of cell types have been tested for their ability to produce PrP transcripts, and 
synthesize PrP protein using PrP genes inserted into expression vectors. Neuroblastoma 
cells and various fibroblastic cell lines have PrP mRNA levels similar to those of mouse 
and hamster brain but the levels of PrPC  are less than 10% of those found in the brain 
(Scott et al., 1988). Fibroblasts or HJC glioma cells transfected with expression vectors 
containing PrP cDNA failed to increase significantly either the PrP mRNA or protein 
levels. Removal of most of the sequences flanking the PrP ORF and insertion into the 
SV40-derived expression vector, led to increased protein production in monkey COS-7 
cells. It is not known whether the improved expression of PrP using the SV40 vector 
system is a consequence of removing most of the flanking sequences from the PrP ORF 
or simply the result of a more appropriate host cell background for expression of PrP 
(Scott et al., 1988). 
In a similar vein, using a fragment of PrP cDNA cloned from scrapie-infected mouse 
brain (Chesebro et al., 1985; Locht et al., 1986), a plasmid expression vector was 
constructed containing the metallothionine promoter and an SV40 polyadenylation site. 
Upon transfection into mouse C127 epithelial/ fibroblast cells (Caughey et al., 1988b), 
Northern analysis showed that PrP mRNAs encoded by both the plasmid and the 
endogenous cellular PrP gene were expressed, with the former being less abundant. 
Despite the relatively low levels of plasmid-encoded PrP mRNA, metabolic labelling and 
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PrP immunopreciptation experiments showed that the plasmid encoded mRNA was 
more efficiently translated than the endogenous PrP mRNA, suggesting that, if the 
scrapie brain and C127 PrP mRNAs are identical initially, removal or replacement of 
portions of the original noncoding regions with the metallothionine promoter at the 5' 
end and/ or the SV40 sequences at the 3' end might enhance their translational activity. 
One model has been put forward that explains in simple terms how the binding of 
specific proteins to cis-acting 3' UTR signals might be central to a mechanism 
controlling translation that involves polyadenylation of transcripts. The model assumes 
that binding of specific proteins to the cis-acting 3' UTR signals, such as the cytoplasmic 
polyadenylation elements (CPE) (McGrew and Richter, 1990) or adenylation control 
elements (ACE) (Bachvarova, 1992) found in vertebrate oocyte mRNAs, is central to the 
mechanism of control of translation involving polyadenylation. As shown in Figure 12 
the trans-acting protein may be a negative repressor (or positive activator) binding to 
the 3' UTR to block (or activate) polyadenylation. Modification of the protein by 
phosphorylation/ dephosphorylation, might diminish (or enhance) its affinity for the RNA 
and hence activate (or inactivate) polyadenylation and translation. 
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ORF 3' UTR 	CPE kAAAAAAAAAA 
Cytoplasmic adenylation 
and translational activation 
ORF 	3' UTR 	CPE IAA 
10 
Figure 12. Schematic representation depicting the protein! 3'UTR interaction 
regulating translation dependent upon polyadenylation. 
(1.6.16) Protein! 3'UTR interaction regulating translation and polyadenylation. 
All eukaryotic cellular mRNA transcripts, with the exception of histone messengers, are 
provided with a poly (A) tail in the nucleus. After entering the cytoplasm, the poly (A) tail 
is progressively shortened as the mRNA ages. Very unstable mRNA species, such as those 
encoding the myc and fos proto-oncogenes, are deadenylated far more rapidly than the average 
mRNA (Review: Bachvarova, 1992). A wealth of evidence indicates that, besides to having 
a stabilizing influence on mRNA, long poly (A) tails are stimulatory for translation, both in 
vitro and in vivo (Wickens, 1992). 
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In those cases where translational activation is dependent on polyadenylation, it seems to be 
the dynamic process of extension of the poly A tail that regulates translation. A 3' UTR 
element AAUAAA is required for polyadenylation in addition to a second determinant which 
in Xenopus oocytes is UUUUUAU (Mc Grew et al., 1989; Fox et al., 1989) and in mouse 
oocytes, AUUUUAAU (Salles et al., 1992). Changes in the length of the poly (A) tail have 
been shown to be central in most cytoplasmic post-transcriptional control of gene expression. 
In the amphibian Xenopus laevis, experimental data have shown the importance of the poly 
(A) tail in translational initiation. Firstly, poly (A) mRNAs are recruited efficiently and 
effectively into polysomes for translation upon injection into oocytes when comparisons are 
made with non-polyadenylated mRNAs (Galili et al., 1988). Secondly recruitment of poly (A) 
mRNA into polysomes is coupled to elongation of the poly (A) tail during maturation of the 
oocyte into a fertilizable egg. Correspondingly in early embryos, deadenylation is coupled to 
mRNA release from the polysomes (Hyman and Wormington, 1988 ; McGrew et al., 1989 
Paris and Philippe, 1990). Storage of cytoplasmic mRNA and activation during maturation of 
the oocyte have also been shown in mice (Vassalli et al., 1989) and Drosophila (Wharton and 
Struhl, 1991). 
Other models have described how the 3' poly (A) tail and the 5'-terminal cap may interact 
to control translational activation (Kuge and Richter, 1995; Dubnau and Struhl, 1996; Rivera-
Pomar et al., 1996). These models are reinforced by a number of studies showing that: (i) poly 
(A) and the cap act in concert to stimulate translation (Gallie, 1991); (ii) cap ribose 
methylation of mRNA occurs at a time of sea urchin development that is coincident with 
polyadenylation and translational activation (Caldwell and Emerson, 1985); and (iii) vaccinia 
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virus poly (A) polymerase (PAP) forms a heteroduplex with cap-specific 2'-0-
methyltransferase (Schnierle et al., 1992). 
(1.6.17) Sheep PrP transcription and translation 
Comparisons of PrP mRNA and PrPC  levels have been made in sheep tissues. It was shown 
that the brain expressed PrP mRNA at a level about fivefold higher than in the kidney. On 
the other hand the brain contained at least fortyfold more PrPC  than the kidney. Consequently, 
in sheep there is potentially an 8 fold increase in the translational efficiency of PrP in brain 
realtive to kidney (Horiuchi et al., 1995). Another hypothesis is that the mRNA in brain is 
more stable than that in the other somatic tissues. 
(1.6.18) mRNA Stability 
Post-transcriptional control of gene expression can be achieved by changing the stability of 
mRNA. The stability of an mRNA influences gene expression by affecting the steady state 
level of the mRNA, and the rate at which the mRNA disappears following transcriptional 
repression and accumulates following transcriptional induction. 
There are at least 4 determinants on an RNA molecule that determine stability: AU (AUUUA) 
rich regions, poly (A) tracts, stems and loops and coding region determinants. mRNA binding 
proteins are thought to be involved in the decay process by interacting with these 
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determinants. 
mRNAs whose 3' UTRs contain AU-rich segments or AU-plus U rich segments are generally 
unstable. A complex formed between the poly (A) tract and poly(A)-binding-protein is thought 
to protect most or all of the mRNAs of mammalian cells from rapid degradation. Located 
within the 3' UTR or near the 3'-terminus of some mRNAs [eg. the mRNAs encoding the 
transferrin receptor (Swenson and Walden 1994)] are stem-loop elements, which are 
hypothesized to function as binding sites for regulatory proteins. Figure 13(b) outlines the 
transferrin receptor mRNA, whose 3' UTR contains several stem-loop regions (iron-response 
elements). These bind an iron regulatory protein which protects the mRNA from 
endonucleolytic attack. A complicated and large stem-loop structure within the 3' UTR of the 
insulin-like growth factor II includes an RNase cleavage site (Scheper et al., 1996). Portions 
of the coding regions of fos (Wellington et al., 1993) and myc (Yielding et al., 1996) mRNAs 
appear to be protein-binding sites, while beta-tubulin mRNAs function by an unknown process 
regulated in cis- through translation of the mRNA, and in trans- through the concentration of 
tubulin monomers in the cytoplasm (Ross, 1996). 
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a 	 (AUUU) —(U) —poly A) 
b 
Figure 13. Sequences or structures in mRNAs that affect half-lives. Rectangles and lines 
denote coding and untranslated regions, respectively. 
(a) AU- and U-rich regions, and the poly(A) tract, (b) Stem-loop elements as protein-binding 
sites, (c) Stem-loop regions as cleavage sites and (d) mRNA stability determinants in coding 
3'UTR-sequences that are AU rich have been shown to be associated with instability in many 
short lived mRNAs, including those coding for lymphokines and proto-oncogenes (Caput et 
al., 1986) and deletion within this region resulted in an increase in stability in these normally 
short lived mRNAs (Raymond et al., 1989; Wilson and Treisman 1988; Peppel et al., 1991). 
Conversely insertion of AU-rich sequences into the UTR of genes with normal stability leads 
to decreased mRNA stability (Shaw and Kamen, 1986; Raymond et al., 1989; Vakalopoulou 
et al., 1991; Shyu et al., 1989). It has been proposed that Au-A. a 34 kDa protein with specific 
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binding capacity for AUUUA multimers, is part of a complex that is a substrate of 
nucleocytoplasmic transport or/and cytoplasmic metabolism. Exchanges of other RNA 
binding proteins for Au-A on AUUUA sequences in the cytoplasm could regulate mRNA 
degradation (Katz et al ., 1994). A recent study suggests that the pentamer AUUUA is 
not in itself sufficient for determining instability. Instead, the nonamer UUAUUUAUU 
is the minimal AU-rich motif that effectively destabilizes mRNA (Zubiaga etal., 1995). 
Not many studies have been made on the stability of PrP mRNA. However it has been 
shown that the stabilities of PrP mRNA in uninfected and scrap ie-infected N2a cells do 
not significantly differ (Pfeifer et al., 1993) and this is in accord with studies that show 
that during infection, PrP mRNA levels do not differ markedly from levels found in non-
infected hamsters and mice (Oesch et al., 1985, Chesebro et al., 1985; Robakis et al., 
1986; Caughey et al., 1987). 
(1.6.19) The 3' UTR of sheep PrP 
Scrapie is a natural disease of sheep but occurs in mice only following experimental 
challenge. Moreover the pattern of PrP mRNA expression is different in sheep and mice 
(Hunter et al., 1994b). Study of PrP gene expression in sheep may therefore provide 
information more relevant to the understanding of natural scrapie. Analysis of recent 
publications (Review: Vassalli and Stutz, 1995) has shown that the 3' UTR of a number 
of genes is a repository for elements involved in controlling gene expresion at the post-
transcriptional level. 
The sheep exon containing the open reading frame coding for PrP is about 4 kb in size 
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(Goldmann et al., 1990) which is about twice as large as the equivalent exon in humans 
(2.35 kb) (Liao et al., 1986; Puckett et al., 1991) and rodents (2 kb) (Oesch et al., 1985; 
Basler et al., 1986; Locht et al., 1986; Westaway et al., 1987). Since the open reading 
frame coding for PrP protein is about 760bp in all genes so far studied, it is the 3'UTR 
that accounts for the increase in mRNA length. 
In sheep brain there is a single PrP mRNA of 4.6 kb, whereas in peripheral tissues (eg, 
spleen, kidney) the 4.6 kb mRNA is accompanied by a smaller (2.1 kb) PrP mRNA 
(Hunter et al., 1994b; Horiuchi et al., 1995). When this PhD project was starting 
oligonucleotide hybridisation studies had suggested that the difference between the PrP 
transcripts was in the length of the 3' UTR (Figure 14). The 2.1 kb mRNA was therefore 
thought to lack several features present in the 4.6 kb transcript including a highly 
conserved region at the 3' end of the UTR (Goldmann et al., 1990) and therefore might 
be subject to quite different expression controls. 
The differences between the two transcripts could therefore play a part in the spread of the 
infectious particle from the peripheral to the central nervous system. Thus an analysis of the 
3' UTR may lead to a better understanding of the disease process. Interestingly, the mRNA 
for the Alzheimer's disease amyloid protein precursor also has two forms produced by 
alternative polyadenylation. The longer mRNA is translated more efficiently than the shorter 
one, and the evidence indicates that the region between the two polyadenylation sites is 
stimulatory for translation (Sauvage et al., 1992). 
In transgenic studies PrP levels have been shown to be central to the timing of disease (Bueler 
et al., 1995; Manson et al., 1995). Thus polymorphisms in the sheep PrP 3' UTR might affect 
protein levels and the time of onset at, or susceptibility to scrapie (Hunter et al., unpublished). 
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Aims of this thesis 
The aims of the work described in this thesis are as follows: 
(1) Sequence analysis of the 3' UTR of the sheep PrP gene. 
(2) Investigation of the potential of PrP gene 3' UTR sequences to control expression of a 
reportergene. There were two main approaches: use of 
a Cell free system. 
aTissue culture system. 
In both systems, subclones of the sheep PrP 3'UTR were inserted 3' of the chloramphenicol 
acetyl transferase (CAT) gene and the effects on CAT synthesis were studied. 
(3) Testing whether the region approximately 2kb upstream from the established 
polyadenylation site was sufficient to mediate 3' end processing. 
ri 
Chapter 2 	MATERIALS AND METHODS 
MATERIALS 
(2.1) Chemicals and enzymes 
All chemicals and enzymes were purchased from Sigma, Gibco-BRL, Boehringer 
Mannheim, Promega or Pharmacia and stored at the appropriate temperature and conditions 
according to the manufacturer's instructions. Solutions were made in accordance to recipes 
in the appendix of this thesis. Where possible they all were autoclaved before use, then 
stored in appropriate aliquots and conditions. Water was routinely obtained from a Millipore 
milli-QUF system and then subsequently autoclaved. 
(2.2) Strains of E.coli used in this study 
Strain Genotype 
CMK 603 thr, leu, thi, supE, recBC, T1R, T5R, 
hsdR, (lac-pro)del. 
F'lacl9 , 1acZAMJ5 pro+ 
D115a F'/endA 1,hsdRl 7(rk-mk+), supE44, thi-1, 
recAl, gyrA(Na1R), relAl, i\(1acZYA- 
argF) Ui 69, (phi80d1ac(1acZAM1 5) 
Strains CMK 603 and UH5a were used tor routine transformations. 
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GENERAL METHODS 
(2.3) Phenol Extraction 
Proteins were removed from DNA solutions by carrying out phenol extractions. An equal 
volume of (1:1) phenol/chloroform was added to the nucleic solution to be purified. The 
mixture was vortexed vigourously for 1 minute. Microcentrifugation (13000 rpm) was then 
carried out for 5 mins. The upper aqueous layer was removed and transferred to a fresh 
tube. 
(2.4) Ethanol Precipitation 
Salts were removed from DNA solutions by ethanol preciptation. To the nucleic acid sample 
were added 1/10 volume of 3M sodium acetate and 2 volumes of 100% ethanol. The 
mixture was vortexed for 30 seconds. The nucleic acid was then pelleted in a 
microcentrifuge (13000 rpm) for 10 minutes and washed in 70 % ethanol. The pellet was 
allowed to air dry and finally dissolved in TE buffer or water. 
(2.5) Determination of nucleic acid concentration and purity 
Quantitation of DNA was carried out by spectrophotometric measurement of the amount of 
ultraviolet irradiation absorbed by the nucleotide bases. Absorbance readings were taken at 
wavelengths of 260nm and 280nm. The reading at 260nm allows calculation of the 
concentration of nucleic acid in the sample. An OD of 1.0 corresponds to approximately 
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50 tg/ml for double stranded DNA, 40 ug/mi for single stranded DNA and RNA, and 33 
.tg/ml for synthetic DNA oligonucleotides (Sambrook et al., 1989). The ratio between the 
readings at 260nm and 280nm (0D 260/0D 280) provides an estimate of the purity of the 
nucleic acid. Pure preparations of DNA have an 0D 260/0D 280 value of 1.8 to 2. Pure 
preparations of RNA have an 0D 260/0D 280 value of more than 2. Solutions with 0D 260/0D 280 
significantly lower than the values given were re-purified by phenol extraction and ethanol 
precipitation. 
METHODS USED IN CLONING 
Plasmid cloning often involves the following steps: preparation, isolation and ligation of the 
vector and insert DNA, transformation of E. coli with the ligated products, screening of 
transformants by restriction analysis and partial sequencing. 
(2.6) Restriction Enzyme Digests 
Restriction endonuclease digestions were performed in the buffers supplied with the enzyme 
and according to the manufacturer's instructions. Typically, reactions were carried out at 
specified temperatures for 1 hour in a total volume of 20 ji1 containing 1-2 jig DNA and 
5 units of enzyme. The DNA was then analysed by agarose gel electrophoresis to ensure 
that the restriction digestion had gone to completion. 
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(e.g. 
(2.7) Blunt-ending DNA fragments 
For cloning experiments, it was sometimes necessary to fill 5' overhangs or remove 3' 
overhangs generated by restriction endonuclease to produce blunt ends as described in 
Sambrook et al., (1989). 
Filling in 5' overhangs 
To fill 5' overhangs, reactions were carried out for 15 min in the buffer supplied with the 
enzyme, at room temperature, in a mix containing the following: 1tl of 0.5mM each dNTP, 
20 jil of sterile water in which was dissolved 2 ig of DNA to be modified, and 2 units of 
DNA polymerase I (Klenow fragment). The reaction was stopped by heating to 75 0C for 
10 mm. 
Removal of 3' overhangs 
To remove 3' overhangs, reactions were carried out for 15 mins in the buffer supplied with 
the enzyme, at 11 °C, in a mix containing the following: lj.tl of 0.5 mM dNTP , 20 jil of 
water in which was dissolved 2 jig DNA and 10 units of T4 DNA polymerase. The reaction 
was stopped by heating to 75 0C for 10 mm. 
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(2.8) Separation of DNA fragments on agarose gels 
Agarose gel electrophoresis as described by Sambrook et al., (1989) was employed to check 
the progression of a restriction enzyme digestion, to quickly determine the yield and purity 
of a DNA solution or PCR reaction, and to fractionate DNA molecules, for subsequent 
elution from the gel. 
(1) Preparation and running of a 1% agarose gel 
The gel cassette and chamber were rinsed in sterile water. For a 100 ml gel, 1 g agarose 
was melted in 100 ml 1X TAE. The solution was cooled to 65 °C, 1 ml 10 mg/ml ethidium 
bromide was added while stirring, and the gel was cast. TAE buffer (1X) was used as 
running buffer. Separation was carried out at 60 mA and continued until the bromophenol 
blue front had migrated 75 % the length of the gel. 
(2)Preparation of DNA samples 
To the DNA sample was added one tenth volume of lOx sample buffer (50 % glycerol, 1 
mM EDTA, pH8.0, 0.25 % bromophenol blue, 0.25 % xylene cyanol), and the mixture was 
loaded on to the previously prepared agarose gel. 
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(2.10) Isolation of DNA fragments from agarose gels 
Three techniques were commonly used and were equally efficient for the recovery of 
restriction fragments from agarose gels for ligation reactions: 
(1) Sephaglas, (2) Low melting temperature agarose, (3) Centrifugation through 
chromatography paper 
Sephaglas (Pharmacia) 
The Sephaglas kit (Pharmacia) was used to isolate DNA fragments from agarose gels. 
Stored DNA bands were excised from agarose gels with a sterile razor blade under UV 
illumination and weighed. One volume of gel solubilizer was added to the gel slice in a 
microfuge tube and left for 10 minutes at 60°C and then 5 j.tl of Sephaglas were added per 
ig of DNA isolated (estimated based upon the known amount loaded) and again left for 
10 minutes at room temperature. The Sephaglas with bound DNA was pelleted by 
centrifugation in a microfuge (13000 rpm) for 1 minute. The supernatant was discarded and 
the pellet washed in 500 j.il ethanol. The washing in ethanol was repeated 3 times. Finally 
the DNA was eluted in 20 j.tl water. 
Low melting temperature agarose 
DNA fragments were eluted from low- melting temperature agarose gels (Sambrook et al., 
1989). The band of interest was excised with a sterile razor blade, placed in a 
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microcentrifuge tube, frozen at -70°C for 10 seconds, and then melted at 60°C. Then, an 
equal volume of TE-saturated phenol was added to the melted gel slice, shaken for 30 
seconds, the mixture again frozen and thawed. After the second thawing, the tube was 
centrifuged (13000 rpm) and the aqueous layer removed to a new tube. 
(3) Centrifugation through chromatography paper 
DNA bands were excised from agarose gels after electrophoresis and sliced into smaller 
pieces with a sterile razor blade before centrifuging through blotting paper (Weichenham, 
1991) as follows. Two 1.5 ml microfuge tubes with their lids removed were placed one 
inside the other. The upper tube was punctured at the base with a 19 gauge needle. A 2 cm 
square of Whatman 3MM paper was wrapped round the inside of the upper tube forming 
a cup-like structure. The gel pieces containing the DNA fragments were placed in this cup 
and centrifuged at 13000 X g for 1 mm, thus forcing the DNA into the lower tube, along 
with the electrophoresis buffer. The DNA was purified by phenol-chloroform extraction and 




Ligations were carried out according to the instructions and in the buffer supplied by the 
ligase manufacturer at 4 0C for 6 hours in sterile microfuge tubes containing 100 ng vector 
DNA, 100 ng insert DNA, and 1 Weiss unit T4 DNA ligase in a total volume of 20 p1 
(2.12) Preparation of competent cells 
Two techniques were commonly used and were equally efficient for the preparation of 
frozen competent cells: 
Calcium chloride method 
Rubidium chloride method 
Transformation efficiencies usually exceeded lx 106  transformants jig' of DNA. 
(1) Calcium chloride method 
According to the method of Cohen et al., (1972), a single colony of E.coli was cultured 
over night in 50 ml LB medium at 37 0C with moderate shaking. Of the resulting culture, 
4 ml were used to inoculate 400 ml LB medium which wete incubated at 37 0C with 
vigorous shaking to an OD 600nm of approximately 0.35. The next step involved three 
successive centrfugations (each 3000 rpm for 7 mm) and after each round of centrifugation 
the cells were resuspended in 50, 20 and 2 ml respectively of 0.1 M CaCl 2 . The final 2 ml 
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of now ompetent cells were dispensed into prechilled, sterile microfuge tubes and flash 
frozen immediately and then stored at -70 °C. 
(2) Rubidium chloride method 
According to the method of Sambrook et al., (1989), a single colony of E.coli was cultured 
overnight in 50 ml LB medium at 37 °C with moderate shaking. lml of the resulting culture 
was used to inoculate 100 ml Psi broth which was incubated at 37 0C with vigourous 
shaking to an OD 600nm of approximately 0.35. The culture was then left on ice for 15 
minutes before the cells were pelleted in a 50 ml Costar tube at 3000 X g for 10 mins. The 
supernatant was discarded and the pellet resuspended in 40 ml of TthI (30 mM rubidium 
chloride, 100 mM calcium chloride, 10 mM manganese chloride, 50 mM glycerol, adjusted 
to pH 5.8 with dilute acetic acid). The cells were pelleted as before, and resuspended in 4 
ml of TfbII (MOPS 0.21g, 10 mM calcium chloride, 75 mM rubidium chloride, 10 mM 
glycerol, adjusted to pH 6.5 with dilute NaOH) and left on ice for 15 mm. Aliquots (0.5 ml) 
of cells were dispensed into microfuge tubes, flash frozen in liquid nitrogen and stored at - 
70°C 
(2.13) Transformation 
Transformation was carried out on ice for 30 mins by the addition of 10-20 ng of ligated 
DNA products to competent cells (thawed on ice). The cell/DNA mixture was heated to 
42°C for 2 minutes in a water bath and cooled on ice for 1 minute. 1 ml of LB was then 
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added followed by incubation at 37°C with gentle shaking for 1 hour to allow the expression 
of plasmid-encoded drug resistance. Finally, 300 j.t1 of the transformed cells were plated out 
onto LB plates supplemented with 100 tg/ml ampicillin and incubated at 37°C for 16 hours. 
IDENTIFICATION OF POSITIVE CLONES 
(2.14) Colony blotting + hybridisation 
In order to detect positive clones, a colony blotting method was used based on the 
procedure of Grunstein and Hogness (1975). A circular membrane (Hybond-N) was laid on 
top of agar plates containing the bacterial colonies to be screened. The membrane was 
removed with sterile forceps and soaked colony side up first on denaturing solution (0.2M 
NaOH, 1% SDS), left for 6 mins, and secondly soaked in neutralising solution (2.55M 
Potassium acetate pH 4.8) for 3 mins. The membrane was then washed in 2X SSC and left 
to dry on 3MM paper. Membranes were then fixed by UV irradiation to 0.4 J/cm 2 
The membrane was prehybridised in 30ml of oligonucleotide prehybridisation solution (15 
ml 6X SSC, 0.1% SDS, lx Denhardts, 5 mg boiled sheared herring sperm DNA and 33 ml 
sterile water) at 65°C overnight in a box in a shaking water bath. The relevant probe was 
then added to 10 ml of fresh prehybridisation solution and the membrane sealed with it into 
a clean polythene bag. Hybridisation took place overnight at 42°C. Washing of membranes 
was in 0.1 x SSC, 0.1% SDS for 30 mins at 42°C. 
(2.15) Mini-prep of plasmid DNA: alkaline lysis method 
To identify bacterial colonies containing the plasmid of interest, only small amounts of 
plasmid DNA are required (3 pig). This method is based upon that of Birnboim and Doly 
(1979): Transformants were picked from a LB agar plate and grown overnight at 37°C in 
5 ml LB supplemented with 100 .tg/ml ampicillin. The bacterial cells were pelleted in a 
microcentrifuge (13000 rpm) for 20 seconds. The supernatant was discarded and the pellet 
resuspended in 100 jil of a solution containing 25 mM Tris-HCI, pH8, 10 mM EDTA and 
50mM glucose. To lyse the cells 200 tl of a solution containing 0.2M NaOH, 1% SDS 
were then added, mixed and left for 10 min at room temperature. To neutralise the lysate 
and renature plasmid DNA, 150 tl 3 M potassium acetate were added and mixed. The cell 
debris and chromosomal DNA were pelleted in a microcentrifuge (13000 rpm) and the 
supernatant was transferred into a fresh tube. The plasmid DNA was ethanol precipitated 
and dissolved in TE buffer and restriction analysis was performed to identify the plasmid 
of interest. 
Wel 
(2.16) Large scale preparation of plasmid DNA 
Large scale preparation of plasmid DNA was required for DNA sequencing, transfections, 
in vitro transcription, probe preparation and cloning. This method is based upon procedures 
of Birnboim and Doly (1979). 
E.coli cells containing the plasmid of interest were cultured overnight at 37 °C, with 
vigorous shaking, in 500 ml of LB supplemented with lOOjig/ml ampicillin. The bacteria 
were pelleted by centrifugation at 5000 rpm for 15 minutes in a Beckman JA-14 rotor and 
then resuspended in 18 ml of a solution containing 25 mM Tris-HC1, p118, 10 mM EDTA 
and 50 mM glucose. To lyse the cells, 40 ml of a solution containing 0.2 M NaOH, 1% 
SDS were added, mixed and left for 10 min at room temperature. The lysate was neutralised 
and the plasmid DNA renatured by adding 30 ml of 3 M potassium acetate. The cell debris 
and most chromosomal DNA were then pelleted by centrifugation at 5000 rpm for 15 
minutes. The supernantant was transferred into Falcon tubes and DNA recovered by ethanol 
precipitation, centrifuged for 10 min at 3000 rpm in a GH 3.7 rotor and dissolved in 8 ml 
TE buffer. To this DNA solution, 8.8 g of CsC1 and 0.8 ml ethidium bromide (10 mg/ml) 
were added and dissolved. The nucleic acid solution was transfered into a Beckman quick-
seal tube and sealed. Centrifugation was carried out at 58000 rpm for 16 hours in a NVT65 
near-vertical rotor. 
The lower band containing the supercoiled plasmid DNA was removed with a 19 gauge 
needle attached to a syringe and sequentially extracted with an equal volume of butanol 
KII 
until the pink colour was gone. The nucleic acid solution was finally ethanol precipitated 
according to section 2.4. 
(2.17) Double strand DNA seauencing 
Dideoxy sequencing of double stranded DNA was carried out using the Sequenase Version 
2.0 system (U.S.B/ Amersham). Specific oligonucleotides designed and used as primer are 
shown in Section 2.18. 
Alkaline denaturation of 3 tg of plasmid DNA was carried out by the addition of 0.1 
volume of 2 M NaOH and 2 mM EDTA. The solutions was then neutralised with 2 jil 3 
M sodium acetate. The denatured plasmid DNA was finally ethanol precipitated. 1 pmol of 
the primer and 2 tl Sequenase reaction buffer (200 mM Tris-HC1 pH 7.5, 100 MM  MgCl2 , 
250 mM NaCl) were added to the DNA template to a final volume of 10 j.tl, before being 
heated for 5 mins at 65 °C. The reaction was then allowed to cool to 37°C before placing 
on ice. 
At room temperature the following were added to the reaction and left for 2 mins: lj.tl 0.1 
M DTT, 2 pA 1:15 diluted labelling mix (7.5 jiM dGTP, 7.5 jiM dCTP and 7.5 jiM dTTP), 
0.5 pA (a 35 S) dATP (10 Ci per pA) and 2 jil 1:6 diluted Sequenase. Aliquots of 3.5 j.il were 
mixed with the appropriate termination mix at 37°C and left at that temperature for 5 mins. 
Reactions were terminated by the addition of 4 j.tl of stop solution (95 % formamide, 20 
mM EDTA, 0.05% bromophenol blue and 0.05% xylene cyanol FF). Samples were heated 
to 75°C before loading onto a prewarmed and pre-run 6% polyacrylamide gel. 
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(2.18a) Synthetic oligonucleotides used as primers for sequencing the 3' 
PrP UTR 
Primer 	nncif inn 	sent 
13008 824 TTCTCATAGFAGGATAGGGGC 
MO 976 TTACAGCACTGGGAAATG 
W7 1023 GFFCAGGGTAATCGAG 
BOl 1 1242 ACACAGACGTCTC'FFGATA1JTCC 
A029 1348 AATACCCGTCTCCTGTAAA 
5261 1603 CCCTACACTCTCAACCTGACATTTCTT 
A046 1934 CGTCAGGTACCACAGCGTCTCAG 
W6 2346 TCTGTGATAAGACATGA 
W10 2588 AGTGGGCAGAGGAGCCT 
6146 2644 GUATJ'CCTGTTATT 
6145 2970 TGATCAAG'ITFGTCAAA 
W13 3064 CAGTAG1TITAACTCT 
474 2317 GTGGGTACGATACAATAACGTAGATG 
12615 3569 TTFGATGACCCAGCATG 
A042 3960 CT1TATGCGTACACGAA 
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(2.18) Polyacrylamide urea denaturing gels 
Polyacrylamide denaturing urea gels were poured using 6% (w/v) acrylamide/bis-acrylamide 
(19:1), 8 M urea and 0.5 volume of TBE. To set the gels, 0.2% Temed (N,N,N,N-
Tetram ethylene -diamine) and 0.04% (w/v) ammonium persulphate were added. DNA 
sequencing products were analysed by electrophoresis on 20 cm x 40 cm polyacrylamide-
urea denaturing gels. Gels were pre-run in 0.5 x TBE for at least 15 min to reach operating 
temperatures and then the wells were washed to remove excess urea. Immediately before 
electrophoresis the sequencing reactions were heated to 75 °C for 2 mins to ensure that the 
DNA products were denatured. The heated sequencing samples were loaded onto the gel 
which was subjected to 40mA constant current for 1.5 to 5 hours. After electrophoresis, the 
glass plates were separated and the gels soaked in 10% acetic acid for 10 mins. The gel was 
then transferred to a sheet of Whatman 3MM paper and dried for 30 mins at 80 °C under 
vacuum. 
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RADIOLABELLING OF DNA 
(2.19) Random trimer extension using 32P- dCTP 
This technique was used for labelling restriction fragments of double stranded DNA for use 
as probes. Using a method largely based on that of Feinberg and Vogeistein (1983,84) the 
DNA was restricted with the appropriate enzyme and run on low melting point agarose. The 
desired band was cut out and boiled in 500 tl of sterile water in a microfuge tube. The 
following mixture (See Appendix) were then mixed and incubated overnight: 2 j.tl of 
solution A, 5 jtl of solution B, 3 ji1 of solution C, 30 ng DNA, 50 j.tCi 32P- d-CTP and 1 
tl Klenow. In order to stop the reaction and recover separate the labelled DNA, 50il of 
water and 5 jil tRNA were then added followed by phenol/chloroform extraction and 
ethanol precipitation. The pellet was dissolved in 150 jil of sterile water and boiled in a 
microfuge tube (make a hole in the lid) prior to adding to the hybridisation solution. 
(2.20) Labelling oligonucleotides with 32P-dATP 
Radiolabeled oligonucleotides were used for confirmation and identification of cDNA 
fragments (Chapter 6), in vitro transcribed RNA (Chapter 4) and bacterial colonies carrying 
the plasmid of interest (Section 4.3). 
Labelling of oligonucleotides was carried out at 37°C for 1.5 hours in a microfuge tube 
containing the following: 2 .ti of 10 X kinase buffer (supplied with the enzyme), 25 pmol 
oligonucleotide, 10 units of polynucleotide kinase, y32 ATP and 11 jil water. 5 il (5 jig) 
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of carrier E.coli tRNA was then added prior to ethanol precipitation. The pellet was 
resuspended in 100 jil of water prior to adding to the hybridisation solution. 
METHODS USED IN IN VITRO ANALYSIS 
(2.21) In vitro transcription 
Synthesis and analysis of in vitro capped RNA transcripts were carried out according to 
Sambrook et al., (1989). In vitro transcription was carried out for 2 hours at 37 °C in a 
sterile microfuge tube containing the following: 10 tI transcription 5X buffer (supplied with 
enzyme), 5 jtl 100 mM DTT, 50U RNasin ribonuclease inhibitor, 10 tl nucleotides (2.5 tl 
each of 10 mM ATP, CTP, and UTP plus 2.5 p1 of 1 mM GTP), 5 jtl 5 mM m7G(5')G, 5 
tg of linearized template DNA in TE buffer and 40 units of T3 polymerase. The reaction 
was then phenol/ chloroform extracted and subjected to formaldehyde gel electrophoresis. 
(2.22) Formaldehyde gel electrophoresis 
(1) Preparation of RNA samples 
RNA was stored under ethanol at -20°C and aliquots centrifuged when required. The dried 
RNA pellet was dissolved in 10p1 RNA buffer (lx MOPS, 50% formamide, 6.5% 
formaldehyde, 50 tg!ml ethidium bromide). Denaturation was carried out by warming to 
65°C for 15 minutes and subsequently placed on ice. Afterwards, 1!10 volume of lOx 
sample buffer (50% glycerol, 1 mM EDTA, pH8.0, 0.25% bromophenol blue, 0.25% xylene 
cyanol) was added to the sample, and the mixture was applied to the previously prepared 
formaldehyde gel. 
Preparation and running of a 1% formaldehyde gel. 
The gel cassette and chamber were rinsed in DEPC-treated water. Based on a 50 ml gel, 
500 mg agarose were melted in 5 ml lOX RNA running buffer and 36.25 ml DEPC-treated 
water. This solution was cooled to 65°C, 8.75 ml 37% formaldehyde were added while 
stirring, and then the gel was cast. MOPS buffer (1X) was used as running buffer and 
electrophoresis was carried out at 80 mA and continued until the bromophenol blue front 
had migrated 75% the length of the gel. 
Northern transfer to nylon membrane 
Upward capillary transfer was carried out overnight. The gel was first washed twice in 
DEPC-treated water, 15 minutes per wash, to removed as much formaldehyde as possible 
from the gel. Subsequently the RNA was transferred by the capillary action of the lOx SSC 
transfer buffer (1.5 M NaCl, 0.15 M sodium citrate, pH 7.0) being drawn upwards from a 
reservoir through the gel and then a nylon membrane (Hybond N) covering it, and into a 
stack of paper towels. This caused the RNA to be transferred from the gel to the membrane. 
Membranes were then fixed by UV irradiation to 0.4 J1cm 2 . Prehybrisation and 
hybridisation were carried out according to Section 2.14. 
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(2.23) Isolation of in vitro transcribed RNA from formaldehyde gels 
The easiRNA Kit (Biorad) was used to isolate and purify RNA from formaldehyde gels. 
RNA bands were excised from the gels after electrophoresis and weighed. Three volumes 
of RNA binding salt/acetic acid mixture were added to the gel slice and left for 10 minutes 
at 37°C. For every j.tg of RNA isolated, 2 j.tl of easiRNA Silica were added, mixed, and 
again left for 10 minutes at 3 7°C. The silica with bound RNA was pelleted by centrifugation 
in a microfuge (13000 rpm) for 1 minute. The supernatant was discarded and the pellet 
washed in 500 j.il ethanol. Finally the RNA was eluted in 20 jtl sterile, DEPC treated 
water. Aliquots of the purified RNA were analysed on formaldehyde gels to check the 
amount (by eye), hybridisation pattern and integrity of the RNA. 
(2.24) In vitro translation 
Translation of in vitro transcribed RNA was performed with the Flexi Rabbit Reticulocyte 
System (Promega). In vitro translation was carried out for 90 minutes at 30°C in a sterile 
microfuge tube containing the following: 33 j.il Flexi Rabbit Recticulocyte lysate (Promega), 
1 p1 amino acid (1 mM) mixture minus Methionine, 5 p1 35 S-Methionine (1,200 Ci/mmol 
at 10 mCi/ml), 1 p1 25 mM magnesium acetate, RNA substrate and sterile water making 
up the total volume to 50 p1. Prior to the addition RNA substrate was heated to 65°C for 
10 min and cooled immediately on ice, to the minimize the formation of secondary 
structures. A 10 p1 aliquot was transferred into 20 p1 SDS sample buffer (100mM Tris-HCI, 
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pH 6.8, 2% Beta-mercaptoethanol, 4 % SDS, 0.2% bromophenol blue and 20% glycerol) 
and heated for 2 minutes at 100 °C before loading onto an SDS-polyacrylamide gel. 
(2.25) Preparation and running of SDS PAGE 
CAT produced from in vitro translation was examined by SDS polyacrylamide gel 
electrophoresis (SDS-page) (Laemmli, 1970) using a Bio-Rad "Protean" mini-gel system 
The separating gel mix was poured into the assembled gel plates, followed by an overlay 
of 0.1% SD S, leaving space at the top for the stacking gel. The gel mix was left for 10 mm 
to polymerize and then the surface of the separating gel was rinsed with water. 
The remaining space was filled with stacking gel mix and immediately afterwards the 
comb was inserted. The wells were rinsed with 10 X SDS PAGE running buffer after 
polymerization. Typically, electrophoresis was carried out at a constant current of 15 mA 
during the stacking, and 30 mA therafter. Electrophoresis was usually performed until the 
bromophenol blue dye front had run off the bottom of the gel. Gels were dried on a 3 MM 
Whatman paper on a vacuum slab gel drier (Hoffmann Scientific) for 2 hours and exposed 
to BIOMAX X-ray film (Kodak) at room temperature for 16 hours. 
LiL•J 
(2.26) Slot Hybridization of RNA 
A piece of nitrocellulose was placed briefly in water and then soaked in 20 X SSC for 1 
hour. Two sheets of 3 MM paper, prewetted with 20 X SSC, were placed on top of the 
vacuum unit. The wet nitrocellulose was then placed on the bottom of the sample wells. 
Air bubbles between the upper section of the manifold and the nitrocellulose were smoothed 
away. All the slots were filled with 10 X SSC and gentle suction was applied until all the 
fluid had passed through the nitrocellulose filter. This procedure was then repeated. 
A sample (5 tl) of the in vitro transcribed RNA was mixed with the following and heated 
to 68°C for 15 minutes: 20 jil 100% formamide, 7p.1 formaldehyde and 2ji1 20 X SSC. 
Two volumes of 20 X SSC were added to each sample before the samples were loaded into 
the slots. After all the samples had passed through the filter, each of the slots were rinsed 
twice with 1 ml of 10 X SSC. The nitrocellulose was then allowed to dry completely at 
room temperature before baking for 2 hours at 80°C in a vacuum oven. 
Prehybridisation and hybrization were then carried out as in Section 2.14 
METHODS USED IN IN VIVO ANALYSIS 
(2.27) Maintenance of cells 
Mouse neuroblastoma cells (N2a) were obtained from ICN-Flow. Dulbecco's Modification 
of Eagle's medium (DMEM) was used as a growth medium and was supplemented with 
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10 % foetal calf serum and lx non-essential amino acids. Cells were grown to confluence 
and were subcultured 1/6. Cells were released from the surface of the flasks by the action 
of a solution of trypsin TVP (Phosphate buffered saline (PBS) Ca 2' and Mg 2 free, Chicken 
serum 2.5% Trypsin and 0.5 M EDTA). TVP was added at lml per 25 cm 2 flask and 
incubated at room temperature for one minute. At this stage the cells rounded up and 
detached from the bottom of the flask. The TVP was diluted by the addition of at least an 
equal volume of medium and clumps of cells broken up by repeated pipetting up and down. 
Fresh medium was added and the cells incubated at 37°C and in 5% CO 2 in a Heraeus 6000 
incubator. 
(2.28) Freezing cells 
Frozen stocks of cells were prepared by detaching the cells from the flasks as described 
above and collecting them by centrifugation at 3,000 rpm for 3 mins. The cells were then 
resuspended in 10 ml (per 75 cm 2 flask) of freezing mix (Freezing mix MEEM, 6ml DMSO, 
2 ml FCS) 2 ml and the centrifugation step repeated. The cells were then resuspended in 
5 ml of the freezing mix and aliquoted into 0.5 ml lots in Nunc screw top freezing vials, 
which were then transferred into a polystyrene container and kept overnight at -70°C before 
transfer to liquid nitrogen where they could be stored indefinitely. 
Before use, vials were removed from liquid nitrogen and quickly thawed at 37°C. The cells 
were diluted in 5 ml of medium and immediately collected by centifugation, before being 
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resuspended in 10 ml of media and plated out in a 25 cm 2 flask. This step had the result of 
removing the DMSO in the freezing mix, which is toxic to the cells when unfrozen. 
(2.29) Transfection of N2a cells 
Two techniques were commonly used for the transfection of N2a cells: 
Electroporation 
Calcium Phosphate precipitation 
Electroporation was used in Chapter 5 "In vivo transfection A" as the method to deliver 
constructs into N2a cells while calcium phosphate precipitation was used in "In vivo 
transfection B". Calcium phosphate precipitation was subsequently chosen because it was 
easier to use with a lot of samples. 
(1) Electroporation 
As described in Sambrook et al., (1989), N2a cells were washed twice with phosphate-
buffered saline (PBS), scraped with a scraper in 2 ml of cold PBS and pelleted in a 
microcentrifuge (13000 rpm) for 30 seconds. At least 20 tg of plasmid DNA dissolved in 
100 tl of TE buffer were then added to the cells. The plasmid DNA/ cell mixture was 
transferred into an cuvette and placed into the electroporator chamber. A charge of 0.15-
0.20 Coulombs was most efficient at producing a high number of transfected cells. The 
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plasmid DNA/ cell mixture was finally transferred into a 100 mm petri dish containing 6 
ml of medium and incubated for 48 hours at 37 °C with 5% Co 2 . 
(2) Calcium Phosphate precipitation 
The N2a cells were plated the day before transfection onto 100 mm petri dishes and were 
30-60% confluent on the day of the transfection.A minimum of 10 ug of plasmid DNA was 
dissolved in 500 j.tl of 2X HeBs and 50 jil of 2.5M CaCl were then slowly added. The 
mixture was left at room temperature for 20 minutes before gently pipetting onto a 10 cm 
dish of cells. After 48 hours the cells were harvested for CAT assays or RNA analysis by 
RT-PCR 
(2.30) Preparation of cell extracts for Chioramphenicol acetyltransferase assays 
and -Galactosidase Assays 
The methods were adapted from Sambróok et al., (1989). Transfected cells were washed 
twice in 4.5 ml PBS and scraped into 2 ml of cold PBS. The cells were then pelleted in a 
microcentrifuge for 20 seconds and resuspended in 100 jil of 0.25M Tris-HCl, pH 7.4. Lysis 
of the cells was achieved by three freeze-thaw cycles. Cellular debris was pelleted in a 
microcentifuge for 30 seconds and the supernatant removed for assay. 
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(2.3 1) CAT assay reaction 
Endogenous acetylase in the lysate was heat inactivated at 65 °C for 10 minutes. The assay 
was performed at 37 °C for 30 minutes by the addition of 50 ti of cell extract to a 
microcentrifuge tube containing 65 j.il of 0.25 M Tris-HC1, pH8, 5 jtl of 5mg/ml n-butyryl 
coenzyme A and 2 pA of 14C chioramphenicol (at 0.O5OmCi/ml). Termination of the reaction 
was achieved by adding 500 j.tl of ethyl acetate and votexing. The reaction mixture was then 
centrifuged in a microcentrifuge (13000 rpm) for 5 minutes, the upper organic phase was 
removed to a fresh tube and evaporated to dryness in a Speedvac. The residue was 
dissolved in 20 il of ethyl acetate and spotted onto a TLC plate. Separation of acetylated 
14C chloramphenicol took place in a pre-equilibrated tank containing chloroform 
methanol::97:3. Acetylated and non-acetylated products were scraped from TLC plates 
using the end of a pipette tip and placed into vials containing 1 ml of scintillation fluid, and 
the radioactivity was measured in a scintillation counter. 
(2.32) -Ga1actosidase Assay 
The pSV-13-galactosidase positive control plasmid (Promega) contains the open reading 
frame of the bacterial lacZ gene which encodes the 3-galactosidase enzyme. The SV40 
early promoter and enhancer are used to drive transcription of the lacZ gene. The pSV-3-
galactosidase positive control plasmid was used as an internal control for transient 
tranfection assays. 
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The following reaction mixtures were prepared in microfuge tubes: 25 jil of cell extract, 
3 p1 100 X Mg buffer, 50 tl ONPG at 4g ml - 'and 222 i.il 0.1 M sodium phosphate buffer 
at pH 7.5. The samples were vortexed and incubated at 37 °C for 30 mins. The reaction was 
stopped by the addition of 500 pA of I M sodium carbonate and the OD was measured at 
420nm. 
(2.33) Preparation of cytoplasmic RNA from tissue culture cells 
N2a cells were washed twice with phosphate-buffered saline (PBS), scraped with a scraper 
in 2 ml of cold PBS and pelleted in a microcentrifuge (13000 rpm) for 30 seconds. From 
this point on, all manipulations, were carried out at 4°C. The cells were lysed by 
resuspending the pellet in 200 t.t1 solution A (0.1 M NaCl, 10 M Tris-HC1, pH 7.9, 0.65% 
Nonidet P-40). Cellular debris and nuclei were pelleted in a microcentrifuge for 30 seconds. 
The supernatant was transferred to another tube containing an equal volume of solution B 
(7.0 M urea, 0.35M NaCl, 10 mM Tris-HCL, pH 7.4, 10 mM EDTA, 1% SDS) and 
phenol: chloroform (1:1). The resulting mixture was vortexed and centrifuged for 5 mins. 
The upper aqueous layer containing cytoplasmic RNA was removed and stored under 
ethanol until required. 
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(2.34) RT- PCR 
For Reverse Transcription (RT), 1 jig of cytoplasmic RNA isolated from transiently 
transfected cells or 3 jti of a stock solution containing in vitro transcribed RNA were 
incubated with a RT primer (Section 2.34a). for 10 min at 70°C in a total volume of 11 
p.1. The reaction was immediately placed on ice. The following was added and incubated 
for 1 hour at 42 °C: 200 units Superscript II, 1 mM dNTP and 40 units RNAsin 
(Pharmacia). The reaction was stopped and the cDNA purified by heating to 70 °C for 10 
minutes and ethanol precipitated twice. For PCR amplification, the cDNA pellet was 
dissolved in 50 p.1 sterile water and 25 p.1 were then used for amplification in a final 
volume of 100 p.1 containing lx PCR buffer (10 mM Tris-HC1 (pH 8.3), 50 mM KC1, 2.0 
mM MgC1 and 0.01% (w/v) gelatin), 200 j.tM deoxynucleotide triphosphates, 2.5 U Taq 
DNA polymerase. 
(2.34a) Primers used for Reversed Trasncription, Polymerase Chain 
Reaction and making radioactive oligonucleotides probes 
Primer 	 Sequence 
anchored OligoT CGTTTTTTTTTTTTTTTTTT 
Reverse primer 	CATCGATGACAAGCTTAGGTATCGATACCA 
TTCATCCGCTTATTATC 
Tailed Primer 	CATCGATGACAAGCTTAGGTATCGATA 
CAT start 	CTAAAATGGAGAAAAAAATCACTGG 
CAT ORF 	TAAGCACATGCGTATTTC 
PrP 3'UTR 	GTAGCGAGACCTCACTTATG 
130 11 	 ACACAGACGTCTCTTGATATTTCC 
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(2.35) Southern Blotting 
Separation of DNA fragments was carried out according to section 2.8. Upward capillary 
transfer was carried out overnight. The gel was first denatured in 500 ml denaturation 
solution (1.5 M NaCl and 0.5 M NaOH) and then neutralised in a solution containing 3 
M NaCl and 0.5M Tris-HC1 for 15 mins. Subsequently the DNA was transferred by the 
capillary action of the lOx SSC transfer buffer (1.5 M NaCl, 0.15 M sodium citrate, pH 7.0) 
being drawn upwards from a reservoir through the gel and nylon membrane (Hybond N) 
covering it, and into a stack of paper towels. This caused the DNA to be transferred from 
the gel to the membrane. Membranes were then fixed by UV irradiation to 0.4 J1cm 2 . 
Prehybridisation and hybridisation were carried out according to Section 2.14. 
(2.36) Unidirectional deletions 
The generation of ordered sets of deletions by this method relies on the uniform digestion 
rate of exonuclease III (Exo III) from appropriate DNA ends (Heniikoff et al., 1984). In 
order to make 5' protruding ends of DNA exonuclease resistant a method using alpha-
phosphothiorate nucleotides was used. A BamH I site between the CAT and the start of the 
PrP 3' UTR fragment was chosen on the plasmid pFr (Figure 15.) as the site resistant to 
Exo III. This restriction site was cleaved and filled in with a-phosphorothioate 
deoxyribonucleo side triphosphates as follows. 
1k 
The following reagents were added in the order listed to a microfuge tube, and incubated 
for 10 minutes at 37 0C: all four ct-phosphorothioate deoxyribonucleo side triphosphates to 
40 jiM each, dithiothreitol at 1 mM and Klenow fragment at 50 units/ml. The reaction 
mixture was ethanol precipitated, washed in 70% ethanol, air dried and the pellet dissolved 
in sterile water. Hine II was then used to digest a second site on the plasmid pFR, which 
produced an exonuclease III sensitive 3' end. The DNA was then reprecipitated and 
position 620 	 1620 1932 	 2620 	 3620 	 4228 	4620 
1 111111 liii 11111 liii! 11111 111111111111111 flhPlilti trill iiit 1111111, .111111 	 11111111 Iii 1111111111111 
Barn H1 1-Jinc 11 
pFr 
Direction and initiation of exonuclease digestion 
Figure 15. Unidirectional Deletion strategy For SV40, t and ORF see Fig. 16 
In order to create the deletion mutants, 10 jig of doubly cut plasmid DNA was dissolved 
in 60 jil Exo III 1X buffer (66 mM Tris-HC1 and 0.66 mM MgC1 2). Exo III (500 units) was 
added and incubated at 37 °C. Samples (2.5 jil) were removed every minute and each placed 
into a microcentrifuge tube containing 7.5 jil of Si nuclease mix (for 25 time points: 172 
jil sterile water, 27 jil Si buffer and 60 units Si nuclease). Si nuclease digestion removes 
single stranded DNA and was carried out for 15 minutes at room temperature. The reaction 
was stopped by adding ijil of Si stop buffer (0.3M Tris base, 0.05M EDTA) and ethanol 
precipitated before being added to a ligation reaction as in Section 2.11. An aliquot of the 
ligated products was used to transform E.coli according to Section 2.13 and the appropriate 
clones (a series of deletion mutants) selected by restriction analysis (Section 2.6) and DNA 
sequencing (Section 2.18). 
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Chapter 3 Sequencing the sheep PrP 3'UTR 
(3.1) Introduction 
In a study of PrP genotype, an association of natural and experimental scrapie was found 
with an EcoRI Restriction Fragment Length Polymorphism (RFLP). The polymorphic 
EcoRI site lies in the 3' UTR and gives rise to two alleles el and e3. 
PrP-el was shown to be associated with disease in more than 30 different breeds 
(Hunter et al., 1992). Around 90% of the 167 diseased animals tested carried el with 
60% homozygotes. 
The studies undertaken in this thesis used a Suffolk sheep PrP clone containing the 
disease associated el fragment and was supplied by Wilfred Goldmann (Goldmann et 
al., 1990). The 3'UTR of this allele (el) had not been sequenced and sequencing was 
therefore the first step of analysis. The el allele was shown to encode glutamine at 
position 171 in the PrP open reading frame while the e3 allele produces arginine at this 
position (Goldmann et al., 1990). The ci association with disease could well be due to 
the linked missense mutation affecting position 171. The sequence of the e3 allele 3' 
UTR is known and published (Goldmann et al., 1990). 
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(3.2a) Sequencing of the 3' UTR of the el allele of the Suffolk sheep PrP 
gene 
A Pvu II (Ca 3.8Kbp) DNA fragment containing the entire PrP 3'UTR of the el allele 
was isolated from plasmid p71 which originated from a larger PrP A phage subclone 
p32/21 (Goldmann et al., 1990). The fragment was ligated into chimaeric CAT 
constructs, downstream of the CAT ORF and SV40 promoter. The PrP 3'UTR from this 
construct pEYR (Section 5.2h) was sequenced on one strand (Methods Section 2.17) and 
an alignment was made with the PrP 3' UTR of the e3 allele (Goldmann et al., 1990) 
(Figure 15). 
Figure 15. Sequence of the PrP gene 3' UTR (el upper, e3 lower) 
The PrP 3'UTR sequence of the el alle, (up per) is shown aligned with the published 
sequence of the e3 allele (lower) an iff n 4ces are double underlined (Goldmann et 
al., 1990). The numbering of nucleotides is according to Goldmann et al. (1990) where 
position 1 corresponds to the 5' end of the mature mRNA and 840 is the start of the 3' 
UTR. Large lettering denote potential polyadenylation signals with any downstream G/T 
rich regions often found near strong signals denoted by underlining on the el sequence. 
ATTTA "instability" motifs are denoted in lower case. Restriction sites is noted in 
italics. Bold lettering denotes sequences that differ between el and the published 
sqeuence. 
PrPORF 	 3'UTR 
801 ATCCTCCTCPTCTCTTTCCTCATTTTTCTCATAGTAGGATAGGGGCAACC 850 
1111111111111111111111 	11111111111 	liii 	1111111 	HI 
801 ATCCTCCTCATCTCTTTCCTCATTTTTCTCATAGTAGGATAGGGGCAACC 850 
851 TTCCTGTTTTCATTATCTTCTTAATCTTTGCCAGGTTGGGGGAGGGAGTG 900 
	
I 	liii 	11111 	I 	II 	11111 	I 	11111 	1111 	11111 	I II 
851 TTCCTGTTTTCATTATCTTCTTAATCTTTGCCAGGTTGGGGGAGGGAGTG 900 
901 TCTACCTGCAGCCCTGTAGTGGTGGTGTCTCATTTCTTGCTTCTCTCTTG 950 
901 TCTACCTGCAGCCCTGTAGTGGTGGTGTCTCATTTCTTGCTTCTCTOTTG 950 
AccI 
951 TTACCTGTATAATAATACCCTTGGCGCTTACAGCACTGGGAAATGACAAG 1000 
III 	II 	II 	11111 	III 	11111 	111111111 	III 	II 	I 	I I 
951 TTACCTGTATAATkATACCCTTGGCGCTTACAGCACTGGGAAATGACAAG 1000 
rl 
1001 CAGACATGAGATGCTGTTTATTCAAGTCCCATTAGCTCAGTATTCTpTG 1050 
I 	III 	III 	liii 	II 	11111111 	111111111 	111111111 
1001 CAGACATGAGATGCTatttaTTCAAGTCCCATTAGCTCAGTATTCTAATG 1050 
1051 TCCCATCTTAGCAGTGATTTTGTAGCAATTTTCTCATTTGTTTCI\AGC 
111111 	II 	I 	liii 	III 	II 	11111111111 	1111 	11111111 
1051 TCCCATCTTAGCAGTGATTTTGTAGCAATTTTCTCATTTGTTTCI\AGAAC 
1101 ACCTGACTACATTTCCCTTTGGGAATAGCATTTCTGCCAAGTCTGGAAGG 
III 	I 	JIll 	111111 	111111111 	11111111 	II 	1111111 
1101 ACCTGACTACATTTCCCTTTGGGAATAGCATTTCTGCCAAGTCTGGAAGG 
1151 AGGCCACATAATATTCATTCAAAAAAACAAAACTGGAAATCCTTAGTTCA 








1201 TAGACCCAGGCTCCACCCTGTTGAGAGCATGTGTCCTGTGTCTGCAGAGA 1250 
II 	II 	1111 	I 	111111 	111111111 	III 	liii 	II 	I 	III 
1201 TAGACCCAGGGTCCACCCTGTTGAGAGCATGTGTCCTGTGTCTGCAGAGA 1250 
1251 ACTATAAAGGATATTCTGCATTTTGCAGGTTACATTTGCAGGTAACACAG 1300 
11111111111 	11111111 	1111 	III 	II 	III 	II 	11111 
1251 ACTATAAAGGATATTCTGCATTTTGCAGGTTACATTTGCAGGTAACACAG 1300 
1301 CCATCTATTGCATCAAGAATGGATATTCATGCAACCTTTGACTTATGGGC 1350 
111111 	I 111111 	I I 	II 	III 	I 	11111111 	I 	1111 
1301 CCATCTATTGCATCAAGAATGGATATTCATGCAACCTTTGACTTATGGGC 1350 
1351 AGAGGACATCTTCACAAGGAATGAACATAATACAAAAGGCTTCTGAGACT 1399 
1351 AGAGGACATCTTCACAAGGAATGAACATAATACAAAAGGCTTCTGAGACT 1400 
1400 AAAAAATTCCAACATATGGAAGAGGTGCCCTTGGTGGCAGCCTTCCATTT 1449 
1401 AAAAAATTCCAACATATGGAAGAGGTGCCCTTGGTGGCAGCCTTCCATTT 1450 
1450 TGTATGTTTAAAGCACCTTCAAGTGATATTCCTTTCTTTAGTAACATAAA 1498 
1451 TGTATGTTTAAAGCACCTTCAAGTGATATTCCTTTCTTTAGTAACATAAA 1500 
1499 GTATAGATAATTAAGGTACCTTA ATTAAA CTACCTTCTAGACACTGAGAG 1548 
11111111111111111111111 	111111 	11111111111111111111 
1501 GTATAGATAATTAAGGTACCTTA ATTAJA CTACCTTCTAGACACTGAGAG 1550 
KpnI 	Pad 
1549 CAAATCTGTTGTTTATCTGGAAACCCAGGATGATTTTGACATTGCTTAGG 1597 
1551 CAAATCTGTTGTTTATCTGGAACCCCAGGATGATTTTGACATTGCTTAGG 1600 
1598 GATGTGAGAGTTGGACTGTAAAGAAAGCTGAGTGCTGAAGAGTTCATGCT 1647 
1601 GATGTGAGAGTTGGACTGTAAAGAPAGCTGAGTGCTGAAGAGTTCATGCT 1650 
79 
1648 TTTGAACTATAGTGTTGGAGAAAACTCTTGAGAGTCCCTTGGACTGAAAG 1697 
liii 	III 	11111111 	11111111111 	I 11111111111 	I liii 	I 
1651 TTTGAACTATAGTGTTGGAGAAAACTCTTGAGAGTCCCTTGGACTGAAAG 1700 
1698 GAGATCAGTCCTGAATATTCATTGGAAGGACTGATGCTGAAGCTGAACT 1747 
11111111111 	11111111 	1111111111 	II! 	1111111 	111111 
1701 GAGATCAGTCCTGAATATTCATTGGAAGGACTGATGCTGAAGCTGAAACT 1750 
1748 CCAATACTTTGGTCACCTGATGGGAAGAACTGAAGGCAGGAGGGATGCTA 1797 
1751 CCAGTACTTTGGTCACCI'GATGGGAAGAACTGAAGGCAGGAGGGATGCTA 1800 
= 	Bst Eli 
1798 GGAAAGACTGAAGGCAGGAGGAGAAGGGGACGACAGAGGATGAGATGGCT 1847 
111111 	11111111111 	11111 	II 	II 	11111111 	1111 	11111 
1801 GGAAAGACTGAAGGCAGGAGGAGAAGGGGACGACAGAGGATGAGATGGCT 1850 
1848 AGATGGCATCATGGACTCAATGGACATGAGCTTAAGTAAACTCCAGGAGT 1897 
111111 	11111 	II 	1111 	liii! 	II 	III 	11111 	1111111111 
1851 AGATGGCATCATGGACTCAATGGACATGAGCTTAAGTAAACTCCAGGAGT 1900 
1898 TGGCAATGGACAGGGAGACCTGGCGTCCTGCAGTCCATGGTGTCGCAGAG 1947 
1901 TGGCAATGGACAGGGAGACCTGGCGTCCTGCAGTCCATGGTGTCGCAGAG 1950 
Pst I 
1948 TCGGACACGATTGAGTGACTAAATTGAGGTGACCCAGatttaACATAGAG 1997 
I 	I 	I 11111111111 	I 11111111 	1111111111 	II 	II 	liii 
1951 TCGGACACGATTGAGTGACTAAATTGAGGTGACCCAGatttaACATAGAG 2000 
1998 AATGCAGATACAAAACTCATATTCATTTGATTGAATCTTTTCCTGAACCA 2047 
111111 	I 	11111111 	I 	I 	II 	111111 	111111111111111111 
2001 AATGCAGATACAAAACTCATATTCATTTGATTGAATCTTTTCCTGAACCA 2050 
2048 GTGCTAGTGTTGGACTGGTAAGGGTATAACAGCATATATAGGTTATGTGA 2097 
I 	II 	I 	1111 	1111 	1111111! 	I 1111 	II 	11111111111 	I 
2051 GTGCTAGTGTTGGACTGGTAAGGGTATAACAGCATATATAGGTTATGTGA 2100 
2098 TGAAGAGATAGTGTACATGAAATATGTGCATTTCTTTATTGCTGTCTTAT 2147 
111111111 	11111111111! 	11111111111 	1111 	11111111111 	I 
2101 TGAAGAGATAGTGTACATGAAATATGTGCATTTCTTTATTGCTGTCTTAT 2150 
2148 AATTGTCAAAAAAGAAAATTAGGTCCTTGGTTTCTGTAAAATTGACTTGA 2197 
III 	1111111111111111111111 	11111111111 	I 1111111111 
2151 AATTGTCAAAAAAGAAAATTAGGTOCTTGGTTTCTGTAAAATTGACTTGA 2200 
2198 ATCAAAAGGGAGGCatttaAAGA AATAAA TTAGAGATGATAGAAATCTGA 2247 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIII 	111111111111111111! 	I 
2201 ATCAMAGGGAGGCatttaATGA AATAAA TTAGAGATGATAGAAATCTGA 2250 
224 8TCCATTCAGAGTAGTAAAGAAATTCCATTACTGTTATTAAACAAGGTAT 2297 
111111 	III 	I III 	III 	1111111111 	111111 	I 	I 
2251TCCATTCAGAGTAGAAAAAGAA TTGCAT ACTGT ATTAA GAAG TCA 2299 
2298 AATTATTCCCTGAATTGTTCAATATTGTCACCTAGCAGATAGACACTATT 2347 
I 	III 	1111111 	I 11111111111! 	II 	111111111 	III 	11111 
2300 AAT ATTCC TGAATTGTTCAATATTGTCACCTAGCAGATAGACACTATT 2343 
2348 CTGTACTGTTTTTACTAGCTTGCACCTTGTGGTATCCTATGTAAAAACAT 2397 
11111 	1111111111111111111111 	11111 	III 	III 	I 	II! 	II 
2344 CTGTACTGTTTTTACTAGCTTGCACCTTGTGGTATCCTATGTAAAAACAT 2393 
2398 ATTTGCATATGACAAACTTTTTCTGTTAGAGCAATTAACATCTGAACCAC 2447 
II 	II 	III 	111111 	11111111111 	liii 	I 	III 	1111111 
2394 ATTTGCATATGACAAACTTTTTCTGTTAGAGCAATTAACATCTGAACCAC 2443 
2448 CTAATGCATTACCTGTTTTTGTAAGGTACTTTTTGTAAGGTACTAAGGAG 2497 
1111111 	II 	11111111 	1111 	11111111 	11111111111 	1111 
2444 CTAATGCATTACCTGTTTTTGTAAGGTACTTTTTGTAAGGTACTAAGGAG 2493 
2498 ATGTGGGTTTAATCCCTAGGTCAGGTAAATCCCCTAGAGGAAGAAATGGC 2547 
1111111 	III 	liii 	11111111 	III 	II III 	I 	I I 	1111111 
2494 ATGTGGGTTTAATCCCTAGGTCAGGTAAATCCCCTAGAGGAAGAAATGGC 2543 
2548 AACCCACTCCAGTATTCTTGCCAGGAAIATCCAGTGGGCAGAGGAGCCTG 2597 
111111111! 	II 11111111111 	liii 	I 
2544 AACCCACTCCAGTATTCTTGCCAGGAAAATCCAGTGGGCAGAGGAGCCTG 2593 
2598 GCAGGGTACAGTCTAGAGCATGGGGTTGCAAAGAGTGAGACAAGACTTG 2647 
111111 	111111 	liii 	II 	III 	11111 	I II 	111111 	liii 
2594 GCAGGGTACAGTCT GAGCATGGGGTTGCAAAGAGTGAGACAAGACTTG 2641 
264 8AGCTACTGAACAATAAGGACAATI\AATGCTGGGTCGGCTAAAAGGTTCAT 2697 
III 	I 	111111111 	III 	111111 	I 1111111111 	11111111 
264 2AGCTACTGAACAATAAGGACAATAAAT GCT GGGTCGGCTAAAAGGTT CAT 2691 
2698 TAGGTTTTTTTTCTGTAAGATGGCTCTAGTAGTACTTGTCTTTATCTTCA 2747 
II 	1111111111111 	11111111111 	I III! 	111111 	1111 
2692 TAGGTTTTTTTTCTGTAAGATGGCTCTAGTAGTACTTGTCTTTATCTTCA 2741 
2748 TTCGAAACAATTTTGTTAGATTGTATGTGACAGCTCTTGTATCAGCATGC 2797 
III 	11111111111111 	11111111111 	111111111 	11111 	III 
2742 TTCGAAACAATTTTGTTAGATTGTATGTGACAGCTCTTGTATCAGCATGC 2791 
2798 ATTTGAAAAAAACATCACAATTGGTAAATTTTTGTATAGCCATCTTACTA 2847 
1111111111 	11111111111 	11111111111 	1111111111111111 
2792 ATTTGAAAAAAACATCACAATTGGTAAATTTTTGTATAGCCATCTTACTA 2841 
2848 TTGAAGATGGAAGAAAAGAAGCAAAATTTTCAGCATATCATGCTGTACTT 2897 
11111 	III 	11111111111 	I 111111111 	111111111111111 
2842 TTGAAGATGGAAGAAAAGAAGCAAAATTTTCAGCATATCATGCTGTACTT 2891 
2898 ATTTCAAGPAAGATPACCAAAATGCAAAAATGTATTTGTGAAGTGTATGG 2947 
11111 	III 	1111111 	111111 	II 	111111 	II 	1111 
2892 ATTTCAAGAAAGATAACCAAAATGCAAAAATGTATTTGTGAAGTGTATGG 2941 
2948 AGAAGGGGCTGCAACTGATCAAGCTTGTCAAAGTAGTTTGTGAAGTTTCG 2997 
11111 	III 	111111 	II 	I 	1111111 	I 	111111111 	I I 	II 
2942 AGAAGGGGCTGCAACTGATCAAGCTTGTCAAAGTAGTTTGTGAAGTTTCG 2991 
3998 TGCTGGAGATTTCTTATTGGACGATGCTCCACAGTTGGATATACCAGTTG 3047 
11111111111 	III 	11111111111 	11111 	III 	11111 	I III 	I 
2992 TGCTGGAGATTTCTTATTGGACGATGCTCCACAGTTGGATATACCAGTTG 3041 
3048 AAGTTGATAGTGATCAAATTGAGATATTGAGAATAATCGATGTTATACCA 3097 
11111111111 	II 	11111111111 	I 1111111 	I 	11111111 	I I 
3042 AAGTTGATAGTGATCAAATTGAGATATTGAGAATAATCGATGTTATACCA 3091 
3098 CGCGGGAGATAGCTGACATACTCAAAATATCCAAATAGAACCTTGAAAAC 3147 
11111 	11111111111 	I I 	11111111111 	liii 	11111111111 	I 
3092 CGCGGGAGATAGCTGACATACTCAAAATATCCAAATAGAACCTTGAAAAC 3141 
3148 CATTTGCACCATCTCAGTTATGTTAATCACTTTGATGTTTGAGTTCCAOA 3197 
111111 	1111111111! 	I I 	11111111111 	liii 	II 	1111111 
3142 CATTTGCACCATCTCAGTTATGTTAATCACTTTGATGTTTGAGTTCCACA 3191 
3198 TAAGCAAAAAAACAACAACAAAAAAAAATACAACCTTGACCATATTTGCG 3247 
1111111 	I 	11111 	11111111 	III 	II 	11111 	111111 	II 
3192 TAAGCAAAAAAACAACAACAAAAAAAAATACAACCTTGACCATATTTGCG 3241 
3248 CATGCAGTTCTCTACTGAAATGATTGAAAACACTTTGTTTTTAAAAACAG 3297 
I 	I 	111111 	II 	III 	I 	liii 	III 	III 	liii 	1111111 
3242 CATGCAGTTCTCTACTGAAATGATTGAAAACACTTTGTTTTTAAAAACAG 3291 
3298 ATTTTGATTAACAGTGGGTACGATACAATAACGTAGATGGAAGAAATTGT 3347 
11111111111 	I I 	1111111 	II 	I I 	liii 	I 	11111 	II 
3292 ATTTTGATTAACJAGTGGGTACGATACAATAACGTAGATGGAAGAAATTGT 3341 
3348 AGGGTGAGCAAAATGAACCACACCACCAAAGGCCAGTCTTCCTCTAAAGA 3397 
I 	II 	I 	1111111 	1111 	II 	I liii 	II 	111111! 	1111111 
3342 AGGGTGAGCAAAATGAACCACACCACCAAAGGCCAGTCTTCCTCTAAAGA 3391 
3398 AGATGTGTGTATGGTGGGATTGGAAAGTAATCCTCTATTATGGATTCTTC 3447 
1111111111 	11111111111 	11111111111 	1111111111 	111111 
3392 AGATGTGTGTATGGTGGGATTGGAAAGTAATCCTCTATTATGAATTCTTC 3441 
3448 TGGAAAACACTGCTCCTAATTAGACCAACTGAAAACAGCACTCAACGAAA 3497 
11111 	11111111111 	I 11111111111 	11111111111 	11111111 
3442 TGGAAAACACTGCTCCTAATTAGACCAACTGAAAACAGCCTCAACGAAA 3491 
3498 AGCATCCAGAATTAGTCAATAGAAAACATAATCTTCCATCAGGATAACGC 3547 
I 	II 	1111111 	11111 	II 	III 	III 	I 	11111111111 	111111 
3492 AGCATCCAGAATTAGTCAATAGAAAACATAATCTTCCATCAGGATAACGC 3541 
3548 AAGACTACATATTTCTTTGATGACCCAGCATGGCTGGAGTTTCTGATTCA 3597 
1111111111111111111111 	11111111111 	11111111111 	111111 
3542 AAGACTACATATTTCTTTGATGACCCAGCATGGCTGGAGTTTCTGATTCA 3591 
3598 TCTGTTGTATTCAGACGTTGCATCTTTGGATTTTTTCCatttaTTTCAGT 3647 
11111111111 	I 	I II 	11111111111 	I III 	11111111111 
3592 TCTGTTGTA TCAGACGTTGCATCTT GGATTTTT C atttaTT CAGT3635 
3648 CTACAAAATTATCATAATGGAAAAAATTTCCATTCCCTAGGAAGATGTAAA3 697 
II 	11111 	I 	I III 	I 	J J 	I 	III 	III 	I 	liii 	II 
3636 CTACAAA TTAT ATA TG AAAA TT CAT CCTTGTAAGATGTAA 3675 
Acc I 
3698 GTGCATCTGGAAAATTTCTTTGCTCAAAAAGATAAAAAGTTTTGTGAACA 3747 
I 	II 	II 	I 	II 	liii 	I 	I I 	II 	I 	liii 	I 	1111111111 
3676 GTGCATCTGGAAAATTTCTTTGCTCAAAAAGATAAAAAGTTTTGTGAACA 3725 
3748 CAGAATTATGACGTTGCCTGAAAAATGGCAGAAGGTAGTGGAACAAAAGA 3797 
	
1111111 	111111 	111111111 	I III 	111111111 	I 	I 
3726 CAGAATTATGACGTTGCCTGAAAAATGGCAGPAGGTAGTGGAACAAAAGA 3775 
3798 GTGACTATGTTGTTTGGTAAAGTTCTTAGTGAAAATGAAAAATGTGTCTT 	3847 
1111 	II 	11111 	III!! 	II 	1111111111 	1111111111! 	I 
3776 GTGACTATGTTGTTTGGTAAAGTTCTTAGTGAAAATGAAAAATGTGTCTT 3825 
3848 TTATTTTTatttaAACACCAAAGGCACATTTTAGCAACCCAATACTGAIT 3897 
11111111111 	1111111 	III 	I 	I 	II 	liii 	liii 
3826 TTATTTTTatttaAACACCAAAGGCACATTT GCACACCAA CTGTAA 3867 
3898 ACTAAAGGAAACTCTTCTGTGTGTTGTCCTTACAGTGTGCACTGATAGTTT 3947 
II 	I 11111 	I II 	III 	11111 	I III 	I 	111111 
3868 TCTAA GAA CCTCGGTGTCCTAGCCTTACAGTGTGCACTGATAGTTT 3917 
3948 GTATAAGAATCCAGAGTGATATTTGAAATACGCATGTGCTTATATTTTTT 	3997 
II 	1111 	11111111 	11111111111111 	11111111111 	II 
3918 GTATAAGAATCCAGAGTGATATTTGAAATACGCATGTGCTTATATTTTTT 	3967 
3998 ATATTTGTAACTTTGCATGTACTTGTTTTGTGTTAAAAGTTTATAAATat 	4047 
I 	I 	1111111111! 	liii 	III! 	I 	II 	11111 	III 	II 	II 	I 
3968 ATATTTGTAACTTTGCATGTACTTGTTTTGTGTTAAAAGTTTATAAATat 	4017 
4048 ttaATATCTGACTAAA ATTAAA CAGGAGCTAAAAGGAGTATCTTCCACGG 4097 
1111 	1111 	111111 	111111 	III 	1111 	111111111! 	I 1111111 
4018 ttaATATCTGACTAAA ATTAAA CAGGAGCTAAAAGGAGTATCTTCCACGG 4067 
4098 AGTTGTCTGGCTGTGTTCACCAGATGTGCACACAATGTTGGCAGTCT 	4144 
1111111111111111111111 	1111111111111111111111 	III 
4068 AG TGTCTGGCTGTGTTCACCAG TGTGCACACCATGTTGGCAG.CT 	4111 
4145 TCATTTGGGGGGTTAATATGAGAAAAGTGACACATTCAGTCCTCACACTG 	4194 
11111111111 	11111111111 	11111111111 	11111111111 	111111 
4112 TCATTTGGGGGGTTAATATGAGAAAAGTGACACATTCAGTCCTCACACTG 	4161 
4195 CCAATTGCAGGAGGAGGGCTACTCCTGATCCTGCTTCAGCCTTATTCCCA 	4244 
1111111111111111111111 	11111111111 	11111111111 	111111 
4152 CCAATTGCAGGAGGAGGGCTACTCCTGATCCTGCTTCAGCCTTATTCCCA 	4201 
IN 




(3.3) Results and Discussion 
The PrP 3' UTR of the ci allele was sequenced from the construct pEYR (Section 5.2b). The 
PrP 3'UTR sequence of the el allele was aligned with the published sequece of the e3 allele 
(Goldmann et al.. 1990) Many seeming differences were originally found. These differences 
were further investigated by resequencing the e3 allele from constructs bslO and p23.4. and 
most of them were found to reflect apparent sequencing errors in the published sequence 
(noted in Figure 15). The genuine sequence differences identified between the e3 and ci PrP 
3' UTR are shown in Table 4. In total there were only six confirmed differences. 
Table 4. Confirmed differences between the e3 allele and ci allele sequenced 
in this study. 
Position Polymorphism 
1015 A  
1458 A - Adel 
1751 G  
2613 Adel 	A 
2614 Adel -* A 
3440* A -->G 
Adel = single base deletion * EcoRl polymorphic site 
In both alleles four alternative polyadenylation signals (ATTAAA or AATAAA) are present, 
upstream of the consensus sequence ATTAAA (position 4064) which is known to generate 
a 4.6kb mRNA (Table 5). These alternatives are candidates for generating the short PrP 
transcript (2.1kb) found in the peripheral tissues of sheep (Hunter et al., 1994; Iketa et al., 
1995). The alternative polyadenylation signal at position 1522, unlike the other 3 alternative 
polyadenylation signals but like that at 4064,, contains G/T-rich stretches downstream. Of 
the poly A signals recognised, only that at 1522 would be likely to produce a polyadenylated 
mRNA of circa 2.1 kb. 
Table 5. Position and sequence of potential alternative polyadenylation signals 
in the PrP 3' UTR. 






Five "instability motifs" ATTTA were found in the el and six in the e3 3' UTR 
sequence (Table 6). The functional consequence of these differences between the PrP 
3' UTRs is not known. 
Table 6. Positions of the "instability motifs" in the e3 PrP 3' UTR 
(Goldmann et al., 1990) and the el allele. 
Instability motifs 
ATTTA 
e3 3'UTR el 3' UTR 
1016 1 X 
1985 1 / 
2213 / 1 
3636  
3856  
4046 / 1 
X - site not present 
In summary, the two PrP 3' UTRs have been shown to contain polymorphisms, potential 
alternative polyadenylation signals and ATTTA instability motifs. The following 
chapters will attempt to address the importance of the PrP 3' UTR. 
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Chapter 4 
Effects of the 3' UTR of PrP upon the in vitro translation of a linked CAT 
reporter message 
(4.1) Introduction 
The PrP 3' UTR sequence (chapter 3) was found to contain potentially interesting 
sequence elements eg. instability motifs 'ATTTA' (Table 6) and polymorphisms (Table 
4). The potential for the 3' UTR to affect gene expression was investigated (this chapter) 
using a cell free system and (Chapter 5) using intact cells. Chimaeric CAT constructs 
including different parts of the 3' UTR of PrP were in vitro transcribed and translated in 
order to assess whether the 3' UTR can alter expression at the translational level. 
In vitro translation (IVT) systems were initially used to identify and characterise mRNA, 
but now IVT is a tool for addressing basic questions about the mechanism and regulation 
of protein synthesis. Researchers wishing to express cloned genes in an in vitro system 
frequently use rabbit reticulocyte lysate (RRL) (Pelham and Jackson 1976). Unlike 
prokaryotic systems where transcription and translation are coupled, RRL has traditionally 
been a translation-only system requiring the addition of RNA templates and, prior to IVT 
analysis, in vitro transcription reactions employing T3, T7 or SP6 RNA polymerases are 
widely used to synthesize large amounts of specific RNA from recombinant vectors 
containing appropriate promoters. 
The RRL translation system has played an important role in the investigation into the 
effects of untranslated regions from mRNA transcripts upon subsequent translation. RRL 
is pretreated with micrococcal nuclease to destroy endogenous mRNA and contains all 
the necessary components for translation of exogenously added transcripts. Incorporation 
of a radiolabelled amino-acid enables one to assess protein levels, for example, by 
scanning autoradiograms of SDS polyacrylamide gels using a densitometer or measuring 
radioactivity incorporation by liquid scintillation counter. 
Translation of human interferon mRNA was shown to be affected by its 3' UTR (Kruys 
et al., 1987) using the RRL system. The sequence responsible for the observed 
translational repression was rich in AUs, and was called an AU-rich element (Kruys et 
al., 1988). AU-rich elements repressed translation when placed at any region within the 
3'UTR but not when placed in the 5'UTR. In vitro transcribed ferritin RNA was also 
translationally regulated in RRL and this was controlled by its 3' UTR (Dickey et al., 
1987). Further analysis showed that a 28 nucleotide structure termed the "iron regulatory 
element" in the 5'UTR of ferritin mRNA interacted with a 90 KDa protein under low iron 
concentration and blocked initiation of translation in cells. (Rouault et al., 1988, 1989; 
Walden et al., 1989). It was thus hypothesized that ferritin can undergo a number of 
stages of translational control involving both the 3' and the 5' UTR (Harfford and 
Klausner 1990). In contrast to the previous two examples, in vitro transcribed Lox mRNA 
was translationally repressed through sequences in its 3' UTR only when the repressor 
protein Lox BP was added to the RRL (Ostareck-Lederer et al., 1994). 
Models that have been put forward to explain translational regulation involve a protein-
mRNA interaction and cytoplasmic polyadenylation which are elements absent from the 
RRL system (Zamore and Lehmann 1996). Moreover, Recent data suggest that 
translational regulation can be obscured in RRL due to the lack of competition for the 
translation machinery (Tanguay and Gallie 1996). Nevertheless, the simple in vitro 
translation system may be useful in terms of gaining results that may be further 
investigated in intact cells. 
E:IJ 
(4.2) Experimental approach 
To determine if the 3'UTR of sheep PrP can have an effect upon in vitro translation of 
chloramphenicol acetyl transferase (CAT) mRNA, reporter gene constructs were made 
containing various sections of the PrP 3' UTR downstream of the CAT gene. Two 
constructs contained the entire PrP 3' UTR, one in reverse orientation, and a third 
construct contained the 3'UTR with a 2746 bp internal deletion. Chimaeric CAT 
transcripts were produced from the corresponding plasmid by in vitro run-off 
transcription, and the sizes of the transcript were predicted from the length between the 
T3 polymerase promoter and the recognition site for the restriction enzyme used to 
linearize the plasmid. The corresponding transcript were then isolated from formaldehyde 
gels. An aliquot of each gel-purified RNA was subjected to Northern transfer analysis to 
check the concentration, hybridisation pattern and integrity of the transcript. A positive 
control construct containing only the CAT gene fragment was used to establish a dose-
response curve for this assay. The effects of increasing in vitro transcribed RNA upon the 
yield of CAT defined the limits of the experimental assay. Equimolar amounts of in vitro 
transcribed RNAs containing CAT fused to the 3'UTR of sheep PrP differing in length 
and orientation were in vitro translated using the RRL (Promega). The concentration of 
RNA was calculated and checked by spectrophotometry, formaldehyde gel electrophoresis 
and slot blotting. 35 S methionine labelled CAT was measured by scanning autoradiograms 
of SDS gels with a densitometer. 
(4.3) Construction of plasmids 
Construction of plasmids was carried out using standard procedures (Chapter 2) and 
involved the following steps: preparation, isolation and ligation of the vector and insert 
DNA, transformation of E. coli with the ligated products, screening of transformants by 
restriction analysis and partial sequencing. The numbering of nucleotides was as described 
in Chapter 3. 
(a) pTCAT 
The construct pTCAT contains no PrP 3' UTR and was made (Figure 16) by digesting 
pCAT Basic (Promega) with MaeI (restriction sites at position: 2267 and 3291) and 
isolating a 1024 bp fragment containing the entire open reading frame of CAT and "t" 
which is mainly the intron plus flanking sequences, whose consequent splicing is 
important for expression of the CAT fusion mRNA in vivo. The insert was blunt ended 
using Kienow fragment polymerase and subsequently ligated into the HindlI site of 
pT3T7a-19 (Gibco), such that the T3 promoter was located upstream from the start site 
of the CAT gene. Partial sequencing from the intron and restriction analysis confirmed 
the identity of this clone. 
Mae I 
ligation 




Mae I digestion 
t: 31 6bp of UTR of SV 40 small t antigen gene containing the intron 
T3, T7 promoters 
Figure 16. Schematic representation of the construction of plasmid pTCAT. 
The CAT ORF fragment was removed from the plasmid pCAT basic by Mae I 
restriction and subsequently ligated into the Hind II site of pT3T7a -19. 
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(b) pRAR and pRAW 
The construct pRAR contains the full length el PrP 3' UTR. pRAR (Figure 17) was 
constructed by digesting p71 (Goldmann et al., 1989) with PvuII and isolating a 3825 
bp (position 432-4256) fragment containing the entire 3' UTR and 400 bp of the PrP 
open reading frame. This fragment was ligated into the Smal site of pTCAT. Colonies 
were screened for inserted fragments in both orientations by colony hybridization. pRAW 
contains the same fragment as pRAR, but in the opposite direction as determined by 
restriction analysis. 
TcAT 








Pvu H digestion 
Pm 11 
____ 3 end of the PeP 0 R (408bp) 
1: 31 6bp of the SV40 I antigen UTR containing the intron 
T3, 17: promoter 
Figure 17. Schematic representation depicting the cloning strategy fo 
pRAR The PrP 3'UTR fragment was removed from p71 by Pvu II restriction and wa 
subsequently ligated into the Sma I restriction site of the plasmid pTCAT. 
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(c) pRAD 
The construct pRAD contains the PrP 3' UTR with a 2734 bp deletion. pRAD was 
constructed (Figure 18) by digesting pRAR with AccI overnight and religating, resulting 
in the deletion of 2746 bp (positions 901-3646) from the PrP 3'UTR. Restriction analysis 
confirmed the identity of this construct. 
2734 bp 
Ace I digestion 	 ligation 
T3 J7: promoters 
3' end of the PrP ORF 408bp 
t: 316bp of the SV40 t antigen UTR containing the intron 
Figure 18. Schematic representation depicting the cloning strategy for 
pRAD. A 2746 bp fragment was removed from pRAR by Acc I restriction and 
subsequent religation. 
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(d) Summary of constructs 
Reporter gene constructs were made containing various sections of the el PrP 3' UTR 
downstream of the CAT gene (Figure 19). pRAR and pRAW contain the full length 3' 
UTR in the forward and reverse orientation respectively (Section 4.3b). pRAD has a 
2746 bp deletion (position 901-3646) within the 3' UTR (Section 4.3c). pTCAT contains 
no sheep PrP 3' UTR (Section 4.3a). 
	
position 432 840901 	 3646 	4256 
IllIlIlIll 111111111 IPIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIlIIIIIIIIIIII 
pRAR 	 T3 CAT t ORF 	PrP 3'UTR 
84 901 3646 	4256 
pRAD 	 T3 CAT t ORF PrP 3'UTR 
4256 	3646 	 432 
pRAW 	 T3 C=tIPrP 3'UTR 	 ORF 
pTCAT  
ORF : 3 end of the PrP protein coding region (0.4kb) 
t: 316 bp of the SV40 t antigen UTR containing the intron 
T3: promoter 
Figure 19. Summary of constructs used to investigate the PrP 3'UTR 
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(4.4) Production of RNA 
(a) In vitro transcription 
The Chimaeric CAT constructs shown in Figure 19 were used in the following in vitro 
transcription and translation reactions. In vitro transcription from constructs pRAD and 
pTCAT produced single major species of transcript of approximately the expected sizes 
(2086 and 1024 nucleotides: Figure 20, lanes a and d respectively) in relation to RNA 
size markers. In contrast, pRAW and pRAR yielded not only transcripts of expected size 









Figure 20. Formaldehyde gel analysis of in vitro transcribed RNA from 
chimaeric CAT constructs. The plasmid constructs used for RNA transcription were 
as follows: lane a ,pRAD; lane b, pRAW; lane c, pRAR and lane d, pTCAT; lane e, 
RNA markers. Transcripts visualised with ethidium bromide. 
(b) Isolation of transcripts 
All full length transcripts were purified from 1% formaldehyde gels. An aliquot was 
subjected to 1% formaldehyde gel electrophoresis (Figure 21) and Northern analysis. 
Hybridisation with an oligonucleotide anti-sense probe directed against the CAT 
ORF gave a positive signal with RNA species from all four constructs (Figure 22A) 
while hybridisation with an oligonucleotide anti-sense probe directed against 
sequences just upstream of the main poly A signal took place only with transcripts 
produced from constructs pRAD and pRAR (Figure 22B lane c and d respectively) 
because pRAW has the PrP 3' UTR inverted and pTCAT contains no PrP 3' UTR 
sequences. These results show that the transcripts recovered from the formaldehyde 
gels exhibited homogeneity, the expected size, and correct hybridisation pattern 








Figure 21. Formaldehyde gel analysis of gel purified in vitro transcribed 
RNA from chimaeric CAT constructs. The plasmid constructs used for RNA 
transcription were as follows: lane a: pRAW lane b: pTCAT, lane C: pRAD and lane 




a 	 b 	c 	d 
B 
a 	 b 	c 	d 
Figure 22. Northern analysis of gel-purified in vitro transcribed RNA. 
Aliquots of gel-purified in vitro transcribed RNA were separated on formaldehyde gels 
(Figure 21), before blotting onto Hybond N membranes. These were then hybridized 
sequentially with the following oligonucleotide probes: (A) directed against the CAT 
ORF; (B) directed against sequences just upstream of the main poly A signal. 
Constructs used for RNA transcription were as follows: lane a: pRAW, lane b: pTCAT, 
lane C: pRAD and lane d: pRAR. 
97 
(4.5) Effect of increasing RNA concentration upon the translational 
efficiency of CAT. 
Increasing amounts of in vitro transcribed RNA from the plasmid pTCAT were in vitro 
translated (Figure 23). A dose response curve was obtained using TCAT RNA to assess 
the effect of an increase in RNA concentration upon the translation of CAT protein. In 
vitro translation of RNA containing the CAT or luciferase protein coding regions the 
latter a positive control supplied with the in vitro translation kit produced the appropriate 
sized protein bands, 27 and 64 Kda respectively (Figure 23 lanes a-d and lane e 
respectively) as judged by molecular weight markers. Increasing pTCAT RNA 
concentration resulted in increased amounts of CAT protein translated and this 
relationship was linear between 0.2-1.0 tg of RNA (Figure 24 and Appendix Table 7). 
Higher concentrations of RNA caused a decrease in translational efficiency and so an 
aliquot of 0.2j.tg of TCAT RNA and as nearly as possible equal molar concentrations 




a 	b 	c 	d 	e f 
Figure 23. Representative autoradiogram showing the effect of increasing 
the concentration of in vitro transcribed RNA upon in vitro translation. After 
90 mins at 30 °C. the newly systhesized 35 S methionine labelled CAT was measured by 
scanning autoradiograms of SDS gels. Lane a: 2tg of pCAT RNA, b:ltg, C: 0.5j.ig. d: 














0 	0.5 	 1 	 1.5 	 2 	 2.5 
Micrograms of TCAT RNA 
Figure 24. Dose response curve: effect of increasing the concentration of in 
vitro transcribed RNA produced from the construct pTCAT upon in vitro 
translation yield. Error bars represent standard errors from the means of three 
independent experiments. (See also Appendix Table 7). 
(4.6) Relative Molar concentrations of mRNA by slot blot 
hybridisation 
Accurate estimates of the relative molar concentrations of the mRNAs were required in 
order to make precise comparisons between RNAs of different lengths. Densitometry of 
autoradiograms from Northern- or slot blotted RNA has been used by others to follow 
relative (Mallet et al., 1983; Young and Anderson 1985 and Thompson etal., 1986) and 
absolute (Denman et al.,1991) amounts of mRNA. Hybridization was carried out with 
an oligonucleotide probe directed against the CAT open reading frame 
(GTAGCGAGACCTCACTTATG). Relative molar concentrations of full length in vitro 
transcribed RNAs were obtained by scanning an autoradiogram of a hybridised slot blot 
and dividing by the OD for TCAT: 
Relative concentration = OD of experimental RNA hybrid 
of RNA 	 OD of TCAT RNA hybrid 
Values were determined by obtaining the means from three experiments. An example of 
a slot blot autoradiograph is shown in Figure 25 and exact results are given in the 
Appendix (Table 8) 





Figure 25. Sslot blot hybridization analysis. 
Autoradiogram of a typical slot blot used to assess ralative molar concentrations of CAT 
mRNA. Lane a: pRAR, b: pRAD, c: pRAW, d: pTCAT. Column 1: Undiluted sample, 
Column 2: Same as column 1 but samples were diluted by 50% with IX SSC. 
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(4.7) The presence of the sheep PrP 3' UTR downstream of the CAT gene 
does not significantly affect RNA translation in RRL 
In vitro produced CAT mRNAs containing different lengths and orientations of the PrP 
3'UTR downstream were assessed for their ability to be in vitro translated. The 
translatability of transcripts was measured in arbitrary units by the following equation: 
Translatability = CAT Protein 
CAT RNA 
= O.D of autoradiographs of 35 S labelled CAT protein bands after PAGE (Figure 26) 
Relative molar concentration of RNA (Section 4.6) 
The presence or absence of various lengths and orientations of the sheep PrP 3'UTR, 
downstream of the CAT ORF, had little or no effect upon the levels of methionine 35 S 
labelled CAT produced in vitro, as measured by scanning autoradiograms eg(Figure 26) 
of SDS gels with a densitometer. The experiment was repeated three times and values 
for translatability were averaged (see Figure 27 and Appendix, Table 9). pTCAT, with 
none of the PrP 3' UTR produced a mean value for translatability of 201 whereas the 
construct with the full PrP 3'UTR in the correct orientation (pRAR) had a translatability 
value of only 138. The other two constructs, with either a large deletion in the PrP 3' 
UTR (pRAD) or the whole 3'UTR in reverse orientation (pRAW) had higher 
translatability values (182 and 166, respectively). Although there was a suggestion of a 
negative effect on translation of CAT by the intact PrP 3'UTR in pRAR, the effect is not 
statistically significant (see error bars in Figure 27),as was confirmed by t-test analysis. 
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a 	 b 	 c 	 d 
Figure 26. Effect of the PrP 3' UTR upon the in vitro translation of CAT. 
In vitro transcribed RNA differing in the 3 UTR length and orientation were compared 
in their ability to produce CAT protein. After 90 mins at 30 °C, the newly synthesized 35 S 
methionine-labelled CAT was measured by scanning autoradiograms of SDS gels. 
(Constructs used for RNA syn thesis; lane a: pRAW, lane b: pRAD, lane C: pRAR and 
lane d: pTCAT.) 
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position 432 	 3646 	 4256 
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---IT3ICAiI 1 10 R II 	PrP 3UTR 
901 
84 	3646 	42.6 
pRA[) HaE PrP 3'IJT 




ORF 	3' end of the PrP protein coding region (0.4kb) 
316 bp of the SV40 I antigen UTR containing the intron 
T3, T7: promoter 
Figure 27. Effect of the 3'UTR of sheep PrP upon in vitro translation of CAT. In vitro transcribed RNA containing 
the full length of the 3'UTR of sheep PrP in the sense orientation (pRAR) or inverted orientation (pRAW), a 2.7kb 
deletion derivative of the 3UTR(pRAD), or no 3'UTR of sheep PrP (pTCAT) were compared in their ability to 
produce CAT. After 90 nii9is at 30 C, the newly synthesized [35]S methionine-labelled CAT was measured by 
scanning autoradiograms of SDS gels. Values from 3 independent experiments have been pooled. Error bars 
represent standard errors from the mean. (See also Appendix Table 9) 
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(4.8) Conclusion 
To identify sequences within the 3' UTR of PrP which might affect translation, reporter 
gene constructs were made containing various sections of the 3' UTR downstream of the 
CAT ORF (Section 4.3d). Two constructs contained the entire PrP 3' UTR, one in 
reverse orientation. A third construct contained the 3' UTR with a large deletion. A 
control construct contained only the CAT gene with no PrP 3' UTR. 
In vitro transcription from constructs containing the full length PrP 3' UTR produced full 
length RNA products (pRAW: 4820; pRAR 4760 nucleotides) in addition to smaller 
RNA species (approximately 2100 and 800 nucleotides) which are most likely the result 
of premature termination of RNA synthesis (Figure 20). In vitro transcription reactions 
were fractionated on formaldehyde gels (Section 4.4a) and the expected intact transcript 
were isolated and purified (Section 4.4b). Northern hybridisation analysis of 
formaldehyde gel suggested that the constructs all expressed mRNA containing both 
the CAT sequence and the appropriate 3' UTR (Figure 22A,B). 
A dose response curve was performed with TCAT RNA to assess whether an increase 
in RNA concentration had an effect upon translational efficiency (Section 4.5). The 
effect of increasing TCAT RNA concentration upon in vitro translation was linear 
between 0.2-1.0 ug of RNA (Figure 24). Evidently the higher concentrations caused a 
decrease in translational efficiency. These results are compatible with the findings of 
Polayes (1994) and Krowczynska (1993), who showed that at high concentrations of 
mRNA the translational efficiency decreased, and attributed this in part to the presence 
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of inhibitory contaminants in the mRNA preparations. Purity of a transcript is especially 
important when it is used in in vitro translation systems. Trace amounts of ethanol, 
phenol, salt or excess cap analogue (used during the synthesis of capped mRNA) can 
cause a dramatic decrease in translation efficiency. 
Molar concentrations of RNA were quantified by scanning autoradiographs of a slot blot 
(Section 4.6) and checked by spectrophotometry and formaldehyde gel electrophoresis 
analysis. 0.2.tg samples of TCAT RNA and effectively equal molar concentrations of 
the other 3 species of RNA were used to assess the effect of the 3UTR of PrP upon in 
vitro translation. 
The results show that the 3'UTR of sheep PrP has no major effect upon the in vitro 
translation of CAT in RRL (Section 4.7). The presence or absence of various lengths 
and orientations of the sheep PrP 3'UTR, downstream of the CAT ORF, had no 
significant effect upon the levels of methionine 35 S labelled CAT as measured by 
scanning autoradiogram of SDS gels with a densitometer. Initially it was planned that 
CAT protein would be quantified by measuring CAT activities, i.e the amount of 
functional protein. This would give a more accurate assay. However, in practice the 
results obtained by CAT activity measurements (not shown) were low and unreliable. 
The reasons for this were not fully understood. The stability of the RNA in the 
translation reaction was not quantified, but the RNAse inhibitor added to the reactions 
should efficiently counteract any selective degradation of RNA (Ostareck-Lederer et al., 
1994). 
At least two plausible explanations can be put forward to explain these results. Either 
the PrP 3' UTR does not contain sequences that can alter expression at the post- 
105 
transcriptional level or additional factors are required which are not present in the RRL 
system. It had been hoped that the in vitro translation studies might provide, in a 
relatively easy way, results which could be followed up in the more difficult systems 
utilising intact cells to study gene expression. The next Chapter describes experiments 
of the latter sort. 
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Chapter 5 Effect of the sheep PrP 3'UTR upon the expression of CAT in 
neuroblastoma cells 
(5.1) Introduction 
Results described in Chapter 4 showed that there were no significant differences in CAT 
translational efficiency caused by addition of PrP 3' UTR sequences in a cell free 
translation system. These results were followed up in a system that utilizes intact cells to 
direct synthesis of CAT mRNA and protein. Thus the principal question addressed was 
whether the sheep PrP gene 3' UTR can alter expression of a reporter gene in intact 
neuronal cells of mouse origin. 
Delivery of foreign DNA into intact cells allows the study of control of gene expression. 
The types of analysis can be quite varied, including analysis of cis-acting mediators 
(promoters and enhancers), trans-acting mediators (eg. transcription factors), mRNA 
processing and translation, and the development of gene delivery methods. To provide 
accurate quantitative results, sequences of interest are normally fused to reporter genes 
eg. CAT, Beta-galactosidase, Luciferase or human growth hormone. Most commercially 
available reporter constructs are specifically designed to analyse promoter and enhancer 
regions. As yet there is not an equivalent construct for analysing 3' UTRs and so these 
have to be made for each project. At least two studies have investigated the potential of 
non-coding sequences to alter expression of PrP at the translation level in cell lines 
(Caughey et al., 1988; Scott et al., 1988). Only one of these studies provided satisfactory 
evidence that the non-coding sequences (from mouse PrP mRNA) could alter expression 
- 	 107 
(Caughey et al., 1988). It is not known whether the 5' or the 3' UTR was responsible 
for this change in translation, nor whether these sequences were sufficient alone to alter 
expression. 
By fusing the PrP 3'UTR to the CAT ORF one can address the question of whether the 
3 'UTR of sheep PrP alone can alter gene expression by itself. Results may have relevance 
for understanding variation in translational control in at least three different areas: during 
disease (Denman et al., 1992), between the two different PrP transcripts (Hunter et al., 
1994 ; Horiuchi et al., 1995) and between different tissues (Horiuchi et al., 1995). 
(5.2) Experimental Approach 
Two sets of experiments were carried out to determine if the 3'UTR of sheep PrP can 
alter expression of CAT in neuroblastoma (N2a) cells of mouse origin. Reporter gene 
constructs were made containing various sections of the PrP 3'UTR downstream of the 
CAT gene and the SV 40 promoter. A positive control construct contained the SV 40 
3' UTR. 
The first set of experiments ('In vivo transfections: A'; Sections 5.3-5.9) tested the idea 
that deletion of 3'-UTR sequences may result in differences in the translatability of CAT 
reporter transcripts in N2a cells. The translatability of CAT rnRNA was measured by 
dividing the amount of protein produced by the amount of RNA present. CAT activity 
and CAT transcripts were quantified from cell lysates that had previously been 
transfected with chimaeric CAT constructs differing in the PrP 3'UTR. The measurement 
of CAT is a standard procedure that involves incubating cell lysate with ' 4C 
chloramphenicol and acetyl Coenzyme A. The amount of acetylated 14C chloramphenicol 
is proportional to the amount of CAT protein. The amount of CAT mRNA is measured 
met 
by semi-quantatitive RT PCR. 
The second set of experiments ("In vivo transfections: B," Sections 5.10-5.13) was 
designed to assess if the PrP 3'UTR can alter expression of CAT either at the 
transcriptional or post-transcriptional level. Constructs were introduced into N2a cells 
by calcium phosphate precipitation and transfection efficiency was normalized by co-
transfection with the pSVlacZ plasmid. 
Routine methods used for "In vivo transfections: A and B" are described in Chapter 2. 
Procedures that are not standard will be discussed in the relevant section. 
(5.3) "In Vivo Transfections: A." Constructs used in N2a cells to 
investigate post-transcriptional effects of the PrP 3'UTR. 
(a) pEYD 
To produce pEYD, a 2806bp deletion (positions 840-3646) was made within the PrP 
3'UTR. pEYD was constructed (Figure 28) by digesting the pCAT Control plasmid 
(Promega) with Sea I and isolating a 1781bp fragment containing 309 bp of the 
ampicillin gene, the entire SV40 promoter and 659bp of the CAT ORF. pRAD (Section 
4.3d) was restricted with Sea I and a 3228bp fragment isolated and ligated to the 178 lbp 
Sea I fragment so that both the CAT and ampicillin genes were repaired, with the 
introduction of the SV40 promoter immediately upstream of CAT ORF in the proper 
orientation (plasmid pFA). Removal of the Barn HI - Ace I fragment from pFA led to 
the construction of pEYD by removal of all of the PrP ORF and part of the 3' UTR 
leaving the sequence from position 3646-4256 intact (Figure 28 and 31). Plasmid 
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d o uble digestion
pEYD 
arn HI and Ace I 






) ) 3.228kb T3, SV 40: T3, SV40 promoters 
t :3 I6bp SV40 small t antigen3' UTR containing the small intron 
/ Part of the PrP protein coding region ORF 
Figure 28. Schematic representation depicting the cloning strategy 
for plasmid pEYD. 
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(b) pEYR 
pEYR contains the full length 3'UTR of the PrP gene and part of the PrP protein coding 
region ORF (positions 640-4256). pRAR (4.3b) was digested with AccI and a 2746bp 
fragment isolated and inserted into the AccI site of pFA. The resultant construct pFR was 
restricted with BamHI and HindII the BamHI end filled in, and the product, religated 
leading to the removal of a 300bp fragment and producing construct pEYR (Figure 29 and 
Figure 31). Plasmid construction was confirmed by restriction analysis and partial 
sequencing. 
Ace 1 	












O digestion Barn w ligation 	(EYR o. OA 
13, SV40: T3, SV40 Promoters 
Part of the PiP protein coding region ORF 
t: 31 6bp SV40 small t antigen UTR containing the intron 
Figure 29. Schematic representation depicting the cloning strategy for 
plasmid pEYR. 
(p) pEYP 
To make pEYP a 1090 bp (position 840-1929) deletion was made in the PrP 3'UTR. 
pEYP was constructed (Figure 30) by digesting pFR (Figure 29) with Psil and Ba,,, HI, 
blunting the ends, and religating, leaving position 1930-4256 of the 3' UTR intact 
(Summarised in Figure 31). Plasmid construction was confirmed by restriction analysis 









SV 40 promoter 
(: 316hp of the SV 40 t antigen UTR containing the intron 
part of the Pri' protein coding region ORF 
Figure 30. Schematic representation depicting the cloning strategy 
for plasmid pEYP 
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(5.3d) 	Summary of constructs 
Reporter gene constructs containing various sections of the el PrP 3' UTR downstream 
of the CAT gene are shown in Figure 31. pEYR contains the full length PrP 3'UTR 
(Section 5.3b) while pEYP (Section 5.3c) and pEYD (Section 5.3a) have 1090bp and 
2806bp deletions respectively. pCAT control contains the SV 40 3' UTR. 
	
position 620 	 1930 	3646 	 4256 
640 840 
I 	I 	 PstI 	AccI 
pEYR 	 I SV 40ICATIIIORFI PrP 3'UTR 
19 0 	 4256 
pEYP ATtfPrP 3'UTR 
3646 	 4256 
pEYD 	 ATt PrP 3UTR 
pCAT Control 	 sv 4ØCATtSV 403 UTR 
t: 316bp of the SV 40 t antigen UTR containing intron 
ORF: PrP protein C-terminal coding region 
Figure 31. Summary of constructs used to investigate the PrP 3'UTR. 
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(5.4) Northern Hybridisation of CAT transcripts 
Attempts were made by Northern blot hybridization to detect CAT RNA transcripts from 
cells that had been transfected with chimaeric CAT constructs. Cytoplasmic RNA from 
one petri dish (100mm) was isolated from cells harvested after 48 hours using the NP-
40/urea method (Section 2.33) and subjected to formaldehyde gel electrophoresis to verify 
the quality and yield of RNA (Figure 31A). However a radiolabelled probe targetted 
against the ORF of the CAT gene produced no signal on autoradiographs after 1 week 
(not shown). In addition to absorbance ratios, RNA quality was evaluated by the 
formaldehyde agarose gel electrophoresis which showed the characteristic 2:1 ethidium 
bromide staining ratio of 28S to 18S RNA, indicating no significant degradation (Figure 
31A) 
Figure 31A. Formaldehyde gel electrophoresis of total cytoplasmic RNA 
isolated from N2a cells transfected with chimaeric CAT constructs. N2a cells 
were transfected by electroporation with chimaeric CAT constructs. 
(Lane a: pEYR, Lane b: pEYP, Lane C: pEYD, Lane d: pCAT control, Lane e: mock 
transfected.) 
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(5.5.a) Semi Quantatitive RT-PCR 
Since the attempts to analyse CAT mRNA by Northern hybridisation were unsuccessful, 
semi-quantative RT-PCR was used to measure the relative concentrations of CAT mRNA 
from transfected cells in a method modified from that of Knuchel et al., 1994 (Figure 32, 
B). The relative abundance of CAT mRNA (target) among the samples can be determined 
by comparing the ratio of the amount of amplified target to an amplified competitor in 
each sample. The internal competitor consists of RNA transcribed in vitro from the 
plasmid pDRA I which has a 339bp deletion within the ORF of CAT (Figure 32, A). 
pDRA I was made by partial digestion of pTCAT (Section 4.3a) with Dra I and 
subsequently religating. Clones with the 339bp deletion (133 bp downstream of the start 
site of CAT ORF) were found by restriction analysis and double stranded sequencing. 
During RT-PCR, target and competitor sequences are amplified to a level consistent with 
their relative abundance at the start of the amplification reaction. To counteract intrinsic 
differences in the efficiency of reverse transcription and polymerase chain reaction 
between different samples, the CAT mRNA sequence (target) to be quantified competes 
for the same reverse transcription primer (tailed anti-sense primer) and PCR primers 
(Section 234a) with the in vitro transcribed competitor RNA fragment (Figure 32, C) 
during RT-PCR. 
Before this method could be used, it was necessary to develop and optimise it for use 
with the RNA of interest. The following Sections describe these necessary steps. 
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Figure 32 Semi quantatitive RT-PCR method. 
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(5.5.b) Dose reponse: effect of increasing the amount of target RNA upon 
the semi-quantatitive RT-PCR assay 
It was first necessary to optimise the RT-PCR assay. In a dilution series CAT RNA (the 
target RNA) transcribed from a chimaeric CAT construct in N2a cells was added to a 
constant amount of competitor RNA transcribed from pDRA I in RT-PCR reactions. The 
amplification products were analysed by agarose gel electrophoresis and Southern 
blotting. The relative amounts of target and competitor products in each sample were 
compared by measuring the optical density. 
The molar ratio of target and competitor products were judged from agarose gel 
electrophoresis and Southern blots to be equal, when between 0.5 and 1 tg of target RNA 
was used in the dilution series (Figure 33, lanes 3 and 4). However the presence of one 
template in large excess, when the amount of cytoplasmic RNA added was below O.lpig 
(Figure 33, lane 2) or above 5g  (Figure 33, lanes 5 and 6), inhibited product formation 
from the relatively underrepresented template. The positive controls consisted of RT-PCR 
reactions that were carried out using only RNA from transfected cells (Figure 33, lane 
7) or only in vitro transcribed competitor RNA (Figure 33, lane 1). These produced one 
fragment in each case, sized at around 800 bp and 500 bp respectively. The negative 
control consisted of PCR without the addition of reverse transcriptase (RT) which 
produced no signal, as expected (Figure 33, lane 8). Therefore in order to quantify CAT 
mRNA from transfected cells. lj.tg  of target RNA and 3M1  of in vitro transcribed 
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Figure 33. Dose Response Relationship- Effect of increasing target RNA 
upon the RT-PCR using a constant amount of competitor. 
Increasing amounts of target RNA isolated from transiently transfccted cells after 48hrs 
and were mixed with a constant amount of competitor (in vitro transcribed RNA 
containing the ORF of ('AT with a internal 337 nucleotide deletion.). RT-P('R was 
carried out with Lane 1: 3tl competitor. Ojig target RNA. Lane 2: 3iI competitor. O.lp.rg 
tarct RNA, Lane 3'.3u1 competitor. 0.5ig target RNA. Lane 4: 3.t1 competitor. I .Ojig 
target RNA. Lane 5: 3tl competitor. 5pg target RNA, Lane 6: 3t'1  competitor. 7.0tg 
target RNA, Lane7: Op.l Competitor. 7ig target RNA. Lane 2: tt'1  competitor. 7pg target 
RNA, no RT. 
(5.5.c) Southern blot analysis of PCR DNA fragments 
In order to confirm the identity of RT-PCR fragments, samples (l.ig) of cytoplasmic 
RNA were isolated from the N2a neuroblastoma cells that had been transfected with 
chimaeric CAT constructs and were used in semi-quantatitive RT-PCR assays. PCR 
products were electrophoresed on agarose gels (Figure 34) and blotted onto a 
nitrocellulose membrane. Hybridisation was carried out with two probes. The first probe 
was antisense to the mRNA strand, 206 nucleotides downstream of the CAT ORF start 
site, and was specific for the target fragment produced from cytoplasmic RNA as the 
corresponding region had been deleted from the plasmid pDRA I (competitor). This 
probe hybridised only to the circa. 800bp target fragment (Figure 35A). The upstream 
PCR primer was used as the second probe and hybridised to both target and competitor 
500bp DNA fragments, as expected (Figure 3513). The results demonstrate that target 
and competitor DNA fragments had the correct size and hybridization patterns. 
a 	b 
	
C 	d 	c 	I 	 g 	 h 
Figure 34. Agarose Gel analysis of PCR fragments. Target RNA prepared from 
N2a cells transiently transfected with the chimaeric CAT constructs and in vitro 
transcribed competitor RNA were subjected to RT-PCR. Lane (a) 1 kb DNA markers, (b) 
+ve control: competitor RNA (c) -ye control: mock transfection (d) pEYR (e) as in d, but 
no reverse transcriptase (I) pEYD (g) pEYP (h) pCAT control. Competitor RNA was also 
present in reaction (d) through (h). 
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Figure 35 Southern blot analysis of RT-PCR fragments 
Target RNA prepared from N2a cells transiently transfected With the chimeric CAT 
constructs and in vitro transcribed competitor RNA were subjected to RT-PCR. After 
(Figure 34) gel electrophoresis, and Southern blotting, the DNA fragments were 
characterised by differential hybridisation: (A) Probe 1: Anti-sense CAT ORE Primer (B) 
Probe 2: Upstream PCR primer. Lane (b) +ve control: competitor RNA (c) -ye control: 
mock transfection (d) pEYR (e) as in d but no reverse transcriptase (f) pEYD (g) pEYP 
(h) pCAT control T: target fragment, C: competitor fragment 
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(5.5.d) Relative concentration of target mRNA 
Quantification of the RT-PCR products was carried out by scanning an autoradiograph 
from a Southern blot (Figure 36). The ratio obtained between the OD value of the target 
and competitor gave the relative concentration of CAT mRNA from transfected cells. The 
upstream PCR primer was used as a probe which hybridised to both target and competitor 
DNA fragments. From each 100mm petri dish of N2a cell,s 2/3rds, were used in semi-
quantatitive RT-PCR analysis and the rest were used in CAT activity assays (Figure 40). 
- 	 - 
- 	-,• f MITITM 
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Figure 36. Quantification of CAT mRNA by RT-PCR. 
Target RNA prepared from N2a cells transiently transfected with the chimaeric CAT 
constructs and in vitro transcribed competitor RNA were subjected to RT-PCR. After gel 
electrophoresis, and Southern blotting, the DNA fragments were quantified by scanning 
autoradiographs. Lane: (a) pCAT control, (b) pEYP, (c) pEYD, (d) As in e but no reverse 
transcriptase, (e) pEYR, (f) -ye control: mock transfection and (g) +ve control competitor 
RNA.T: target fragment, C: competitor fragment 
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(5.6) CAT Assay: Dose Response Curve 
A dose response curve was performed in order to assess the linearity of the CAT assay 
and to find the point at which there is a direct correlation between with the amount of 
lysate in the assay and the percentage acetylation of 14C chloramphenicol. Lysates from 
N2a cells transiently transfected with pCAT control were incubated with 14C 
chloramphenicol and acetyl Co-enzyme A for 20mins. The products were extracted with 
ethyl acetate and separated by TLC on silica plates using a chloroform: methanol :: 97:3 
solvent system. 
There are usually 3 radioactive spots visible when the TLC plate is exposed to X ray 
film and developed. The spot that has migrated the least distance from the origin 
consists of nonacetylated chloramphenicol partitioned into ethyl acetate (Figure 37, row 
1). The two faster- migrating spots are modified forms of chloramphenicol that have 
been acetylated at either one or the other of the two potential sites (Figure 37, row 2 and 
3). To quantitate the % 14C chloroamphenicol acetylation, the acetylated and 
nonacetylated chloramphenicol products were scraped off TLC plates, the radioactivity 
measured by liquid scintillation counting and the results calculated. 
Using increasing amounts of lysate from transfected cells the linearity of the CAT assay 
was found to be between S and 60 percent acetylation of 14  C chloramphenicol (Figure 
37 and 38). A representative CAT assay is shown in Figure 37 and detailed results in 
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Figure 37. Representative autoradiograph of TLC showing the effect of 
increasing lysate upon the acetylation of 14C chioramphenicol. 
Increasing amounts (2, 5, 10 and 20.t1) of cell lysate from cells transiently transfected 
with the construct pCAT were used to assess the linearity of the CAT assay. Lysate 
from mock infected cells was used as a negative control. Row 1: Non acetylated, Rows 
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Figure 38. CAT assay: Dose Response Curve. Effect of increasing lysate upon 
the acetylation of ' 4C chloramphenicol. Values were determined from 3 experiments. 
Error bars represent standard errors from the mean. (See also Appendix Table 10) 
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(5.7) The Effect of deletions' in the PrP 3' UTR on translational efficiency 
of CAT transcripts 
Cells were transfected with various chimaeric CAT constructs (Figure 31) and harvested 
48 hours post transfection. One third of the cells were used in CAT assays and the rest 
to isolate cytoplasmic RNA for the RT-PCR reaction. The translational efficiencies of 
the CAT transcripts in N2a cells were assessed by examining the ratio of CAT activity 
to cytoplasmic CAT mRNA expressed. 
Translational efficiency = CAT protein 
CAT RNA 
_ 	% 14C chloramphenicol acetylation 
(OD Target / OD Standard) 
Comparisons were made with constructs containing the full length PrP 3'UTR (pEYR, 
Section 5.3b) or derivatives with a 1090bp deletion (pEYP, 5.3c) or a 2806bp deletion 
(pEYD, Section 5.3a). CAT activity from lysates that had been transfected with pEYD 
or pCAT control (Figure 39, b and d respectively) consistently produced higher 
percentages of 14C Chloramphenicol acetylation than lysates from pEYR and pEYP 
(lanes c and a respectively). When values for translational efficiency (translatability) 
were calculated from three experiments, the pCAT control gave a figure of 61 and the 
full length PrP 3' UTR (pEYR) reduced the translational efficiency to 33.6. Deleting 
1090bp from the 5' region of the 3' UTR (pEYP) did not alter this significantly (31.3) 
but deleting 2806bp (pEYD), leaving only the most distal 600bp of UTR did have an 
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effect, as the translational efficiency returned to a levels (67.6) equivalent to the pCAT 
control (Figures 39, 40 and Appendix Table 11). It may be that the 2734bp deletion 
from the PrP 3'UTR may have affected the stability of CAT mRNA or translational 
efficiency and it is not known if these effects are sequence specific or due simply to the 





(a) 	(b) 	(c) 	(d) 	(e) 
Figure 39. 	Quantitfication 	of CAT activity by TLC 
Representative results depicting an autoradiogram of a CAT assay performed by TLC. 
lane a: pEYP, Lane b: pEYD, Lane C: pEYR, Lane d: pCAT control (e) mock 
transfection. 1: Non-acetylated 2 and 3: acetylated, 14C chloramphenicol 
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Figure 40. Effect of the 3'UTR of PrP upon the expression of CAT as measured by CAT assay 
Equal molar amounts of plasmid DNA were used to transiently transfect N2a cells by electroporation. After 48 hours, the cells were harvested 
for CAT assays and RNA analysis by semi-quantitative RT-PCR. Values were determined from 3 independent experimental data. Error bars 
represent standard errors from the mean. (See also Appendix Table 11). 
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(5.8) Levels of CAT niRNA in transiently transfected N2a cells 
Semi-quantitative RT-PCR analysis did not show any significant differences in ('AT 
mRNA produced by any of the chimacric ('A'l' constructs during the period between 
transfection and harvesting of the cells (Figure 41). Target (('AT mRNA) (-dervived) 
DNA fragments were first detected after 36 hours (Lanes d, h, rn, q) and their intensities 
were unchanged at 48 hours (Lane e, i, ii and r). Target fragments could not he detected 
before or 24 hours after transfection (Lanes b and c, f and g, k and 1. o and p). 
Differences in CAT activity may not he attributed to differences in RNA levels. 
— — — - - 
— - - - 
Figure 4l; Levels of CAT niRNA 
Lanes a, j: I kb DNA markers. Semi-quantitative RT-PCR was carried out with 
cytoplasmic RNA from cells that had been transfected with constructs at 0. 24, 36 or 48 
hours earlier. The constructs used were pCAF control (lane h-e). pEYI) (lane f-i). 
pEYR (lane k-n) and pEYP(lane o-r). 
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(5.9.) Conclusion and Discussion 
Results from Chapter 4 using a cell free system suggested that there were no marked 
differences in translatability of mRNA from a CAT reporter gene attached to various 
sections of the el PrP gene 3'UTR. In this chapter the results were followed up using 
intact N2a cells to direct synthesis of CAT mRNA and protein from similar reporter 
gene constructs. To determine if the 3'UTR of sheep PrP could have an effect upon the 
expression of CAT in this system, three reporter gene constructs were made containing 
various sections of the PrP 3'UTR downstream of the CAT gene and the SV 40 
promoter (Section 5.3). A positive control construct contained the SV 40 3' UTR. By 
measuring the enzymatic activity of CAT, and CAT mRNA levels, it is possible to 
determine if sequences within the PrP 3' UTR gene can alter expression. CAT activity 
was quantified by TLC (Section 5.7) and RNA levels measured by semi quantitative RT-
PCR (Section 5.5d). 
A dose response curve was made to assess the effects of increasing lysate from 
transfected cells upon the acetylation of 14C chioramphenicol (Section 5.6). The linearity 
of the CAT assay was shown to lie between 5 and 60% acetylation of 14C 
chloramphenicol. Attempts to probe for CAT mRNA by Northern hybridisation were 
unsuccessful. This confirms personal communications from Promega, in whose 
laboratories CAT mRNA had previously been shown to be difficult to detect in similar 
experiments. 
A dose response experiment was then carried out to assess the effects of increasing 
cytoplasmic RNA inputs upon the semi-quantitative RT-PCR analysis of CAT transcripts 
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(Section 5.5). When low (0.1 jig) or high (> 5 jig) concentrations of cytoplasmic RNA 
were used, inhibition of product formation from the underrepresented template was seen. 
When the concentration of RNA was between 0.5 jig and lug a clear signal was present 
for both the target and competitor DNA band. This parallels the results from Goswami 
et al., (1994) where it was shown that when a competitor RNA was used to quantitate 
target RNA, the presence of one template at a 10-fold to 100 fold higher level almost 
completely inhibited product formation from the underrepresented template. The 
translatability of CAT transcripts was assessed by dividing the % 14C chloramphenicol 
acetylation, determined by TLC, by the optical density value from scanning 
autoradiographs of Southern blots of RT-PCR products. The data suggest that the sheep 
PrP gene 3'UTR reduces expression of CAT mRNA at the translational level in N2a 
cells (Section 5.7). This conclusion is based upon the following observations. CAT 
mRNA from constructs pEYP and pEYR showed about two-fold lower translatability 
when compared with pEYD or the pCAT control (Figure 40 and Appendix Table 11). 
pEYR encodes the full length (3616bp) PrP 3'UTR (840-4256) while pEYP and pEYD 
encode only the most distal 2326bp (1930-4256) or 610bp (3646-4256) (Figure 31). 
pCAT control contains the SV 40 3'UTR and was used as a positive control. 
Analysis of CAT mRNA over the transfection period (48 hours) showed no significant 
differences in RNA produced from the different constructs, judged by RT-PCR analysis 
(Section 5.8). This further confirms that the reduced CAT activity produced by pEYR 
and pEYP can not be attributed to differences in the level of CAT mRNA. 
Two hypotheses can be put forward to explain the restoration of translational efficiency 
by the deletion in pEYD. Firstly, the increase in translational efficiency may be a 
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function of specific sequence difference. The nucleotides between positions 1930 and 
3646 may therefore be of particular interest, as these sequences are the only differences 
between the construct pEYP and pEYD. This region of DNA contains three el/e3 
polymorphisms at positions 2613, 2614 and 3440, three possible polyadenylation signals 
at 2221, 2284 and 2668 and three ATTTA instability motifs at position 1985, 2213, 
3636 and is not conserved among other PrP genes. Alternatively, the observed increase 
in translatability in the shorter transcript may simply be a function of mRNA length: the 
shorter the mRNA, the more protein is produced. 
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In vivo transfection: B 
(5.10) Experimental Approach 
In an attempt to address whether the increase in translatability of CAT transcripts 
was dependent upon mRNA sequence or simply a function of mRNA length, a 
further series of deletion constructs was made. The new constructs, in addition to the 
three made previously (Summarised in Figure 30) were introduced into N2a cells by 
calcium phosphate precipitation. Transfection efficiency was normalized by co-
transfection with the pSVlacZ plasmid, and the effects of the PrP 3' UTR upon the 
expression of CAT were again assessed. In this way it was hoped to validate and to 
extend the previous findings. 
(5.11) Constructs used in the second series of in vivo transfections. 
The Erase-a-base system was used to generate a nested set of deletions within the 
3'UTR of the el PrP gene. The system is based on the procedure developed by 
Henikoff (1984), in which exonuclease III (Exolil) is used to digest DNA 
unidirectionally from a 5' protruding or blunt end restriction site.The other DNA end 
is protected from digestion by using a restriction site which generates a four-base 3' 
overhang, or by filling a regressed 3' end using alpha phosporothioate nucleotides. 
The uniform rate of digestion of Exolli allows deletions of predetermined lengths to 
be made by simply removing timed aliquots from the reaction to tubes containing S1 
nuclease, which removes the remaining single-stranded tails. The low pH and the 
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presence of zinc cations in the exonuclease and Si nuclease buffer effectively inhibit 
further digestion by Exo III. After neutralisation and heat inactivation of the Si 
nuclease, Klenow DNA polymerase is added to blunt the ends, which are then ligated 
to circularize the deletion-containing vectors. The ligation mixtures are used directly 
to transform competent cells (Method detailed in Section 2.36). Clones containing 
unidirectional deletions from position 620 to 3940 were selected by DNA sequencing 
(Figure 42). 
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t: 31 6bp SV 40 1 antigen UTR containing the intron 
0 RF: 220bp C -terminal - coding region of PrP 
Figure 42. Constructs used to investigate the transcriptional and/or post-
transcriptional effects of the ci PrP 3' UTR. (In Vivo transfections B) 
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(5.12) P Galactosidase Assay: Dose Response Curve. 
The pSV-3-galactosidase positive control plasmid (pSVlacZ) was used as an internal 
control for the In vivo B transient transfection assays and it was therefore necessary to 
carry out a dose response study. Lysate from cells transfected with pSVlacZ was 
incubated with ONPG at 37 °C for 20 mins and then the absorbance was measured at 
420nm. The linearity of the P Galactosidase Assay was found to be between OD 











50 	 100 	 150 ul of lysate 
Figure 43. Effect of increasing pSVlacZ lysate upon the hydrolysis of  
ONPG. Values were determined from 3 independent experiments. Errors bars represent 
standard errors from the mean. (See Appendix Table 12) 
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(5.13) Effects of the PrP gene 3' UTR upon the expression of CAT 
Constructs with the intact PrP 3' UTR or deletion derivatives lacking bp from 620 up 
to 2030 (Figure 44 lane f-h) showed low normalized CAT activity, while deletions that 
extended to position 2700 or beyond showed higher activity (Lanes a-e). The increase 
in the expression of CAT shown in Figure 45 (and Appendix Table 13) appears to be 
due to removal of specific sequences between 2030 and 3048, although the less likely 
possibility that it is simply correlated with shortening of the UTR cannot be excluded. 
However, extrapolating from the results reported for the pEY plasmids in section 5.8, 
a post-transcriptional effect(s) seem(s) very likely. 
.s... .. 
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Figure 44. Effects of the PrP gene 3'UTR upon the expression of CAT at the 
transcriptional and/ or post-transcriptional level. Lysates from N2a cells that had been 
transfected with chimeric CAT constructs with progressive deletions in the PrP 3' UTR 
were assessed for their ability to acetylate 14C chloramphenicol. lane a: p3940, lane b: 
pEYD, lane C: p3398, lane d: p3048, lane e: p2700, lane f: p2030, lane g: pEYP, lane 
h: pEYR, lane i: mock, lane j: pCAT control. 
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Figure 46. Effect of the PrP 3' UTR upon the translation of CAT in N2a cells. Lysates of N2a cells that had been transfected with 
chimaeric CAT constructs containing nested deletions in the PrP 3' UTR were assessed for their ability to acetylate 14C chloramphenical. 
Experiments were repeated 3 times using different DNA preparations. Normalised by co-transfection with pSVlac Z anad assays for beta 
galactosidase. 
136 
(5.14) Conclusion and Discussion 
Previous results showed that deletion of 2746 bp from the PrP 3' UTR could increase the 
expression of an upstraem CAT reporter gene (as measured by CAT activity) at the post-
transcriptional level compared with that observed in the presence of the full length 3'UTR. 
Confirmation and extension of this result came from a further deletion series of constructs 
(Section 5.11). A different method of transfection and normalisation was used in order to 
rule out any artefacts resulting from the techniques involved. Calcium phosphate 
precipitation was used to introduce the DNA into N2a cells and co-transfection with the 
plasmid pSVlacZ was used to normalise transfection efficiency. A dose response curve was 
performed for 13 Galactosidase to assess the effects of increasing the amount of lysate from 
transfected cells upon the hydrolysis of ONPG. The linearity of the assay was shown to be 
between OD 0.14 and 0.73. (Section 5.12). 
It had been found already that CAT mRNA from constructs pEYD and pCAT showed a 
significant increase in translatability when comparisons were made with pEYP and pEYR 
(Section 5.9). These results clearly are consistent with the new set (Figure 45). More 
generally the constructs with an intact PrP 3'UTR or with proximal deletions extending from 
position 620 to as much as 2030 (Figure 44 lanes f-h) showed low normalized CAT activity 
while deletions that extended to position 3940 showed higher activity (Lanes a-c). 
increase in the expression of CAT shown in Figure 45 (and Appendix Table 13) appears 
to be due to removal of specific sequences between 2030 and 3048, although the less likely 
possibility that it is simply correlated with shortening of the UTR cannot be excluded. 
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However, extrapolating from the results reported for the pEY plasmids in section 5.8, a 
post-transcriptional effect(s) seem(s) very likely. 
These results raise the interesting possibility that different lengths of the PrP gene 3' UTR 
may result in different levels of expression. In sheep brain, PrP protein is encoded primarily 
by a 4.6 kb mRNA transcript, while in peripheral tissues an additional 2.1 kb mRNA 
transcript is present. (Hunter et al., 1994; Horiuchi et al., 1995). At the time this work was 
started, it was thought that the two PrP transcripts differed in the length of the PrP 3' UTR 
and that an upstream polyadenylation signal might be used to generate the smaller 
transcript. 
If so, allowing for the fact that the 2.1kb mRNA would include a significant length of poly 
(A), it is clear that it would not incorporate the inhibitory sequences (or unspecific length 
effect) discovered in Chapter 5. The following chapter will explore the polyadenylation 
signal used in generating an alternative polyadenylated PrP transcript. 
138 
Chapter 6 Investigations into the potential alternative polyadenylation 
signal at position 1522. 
(6.1) Introduction 
In sheep brain, PrP protein is encoded by a 4.6 kb mRNA transcript, while in peripheral 
tissues an additional mRNA transcript of apparent size 2.1 kb is present (Hunter et al., 
1994; Hoiruchi et al., 1995). The origin of the smaller transcript was not certain known 
at the start of these studies but oligonucleotide hybridisation experiments suggested that 
it originated from alternative polyadenylation (Hunter et al., 1994). In Chapter 3 four 
potential polyadenylation signals were shown to be in both the el and e3 alleles present 
within the sequence of the long 3'UTR, Chapter 3, at positions 1522, 2221, 2284 and 
2668 (Table 5). In this chapter the ability of the potential polyadenylation (poly A) 
signal at position 1522 to function in 3' end processing was investigated. Of the potential 
poly A signals recognised, only that at 1522 would be likely to produce a 
polyadenylated mRNA of circa 2.1 kb. 
In eukaryotic cells, most mRNAs are post-transcriptionally modified, by, for example, 
S'capping, intron splicing and 3'-end processing. The 3'-end processing involves 
cleavage of an mRNA precursor (pre-mRNA) and the addition of 200 -300 adenosine 
nucleotides at the cleavage site (polyadenylation) (review Wickens, 1990). All eukaryotic 
mRNAs, with the exception of histone mRNAs, have a poly (A) tail (review Wickens, 
1990). 
In eukaryotes mRNA processing occurs in the nucleus immediately after transcription 
and polyadenylation, or 3' end processing of mRNAs is absolutely essential for gene 
expression. mRNAs that are not correctly polyadenylated are unable to be correctly 
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expressed. This leads, for instance, to a number of diseases including leukaemias, 
anaemias and thalassaemias (Review: Cooper, 1993). In addition, polyadenylation can 
function as a mechanism for the control of gene expression; for example, the switch in 
expression of immunoglobulins from membrane-bound proteins to secreted proteins in 
B-cells of the immune system is controlled by a change in the site of polyadenylation 
(Peterson, 1994). 
In mammalian genes, two well defined cis-acting sequences present in the 3' UTR are 
important for 3'-end processing (figure 47). The highly conserved polyadenylation (poly 
A) signals AAUAAA or AUUAAA are present in 85% and 14% (respectively), of all 
vertebrate mRNAs approximately 10 to 30 nt upstream of the polyadenylation site 
(Wilusz et al., 1989; Sheets et al., 1990). The second cis-acting sequence is less well 
conserved and consists of either G ± U- or U- rich sequences approximately 1 to 30 nt 
downstream of the poly (A) site (McLauchlan et al., 1985; Gil and Proudfoot, 1987). 
Such sequences are present downstream of the potential polyA signal at 1522 in the 
sheep PrP 3'UTR, as well as the major signal at 4064 (Figure 15). A third cis- acting 
element, an upstream enhancer, has recently been found 3' to the poly (A) signal and is 
thought to increase poly (A) site efficiency (Moreira et al., 1995). The two key 
components responsible for the recognition of the pre-mRNA substrate are the cleavage 
and polyadenylation specificity factor (CPSF) (Wahle and Keller 1992) and the 
cleavage stimulation factor (CstF) (Gilmartin and Nevins 1989; Takagaki et al., 1990). 
The 3-processing complexes that form around the poly (A) sites of pre-mRNAs also 
contain the cleavage factors (CFI and CFII) that carry out the endonucleolytic cleavage 
step (Figure 47). Surprisingly, poly (A) polymerase is also required for the cleavage of 
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most pre-mRNA5. Once cleavage has occurred, polyadenylation ensues in a closely 
coupled fashion. CPSF and poly (A) polymerase remain bound to the upstream cleavage 
product and carry out the next step, the addition of a short tract of poly (A) of 
approximately ten adenosine residues (Bienroth et al., 1993). The polyadenylation 
complex is then joined by an additional component, the poly (A) binding protein II 
(PABII) which binds to the oligo (A) tail (Wahie and Keller 1992). This causes a rapid 
burst of processive synthesis of a poly (A) tail of approximately 250nt. 
poly (A) signal 	 G/U 
poly (A) signal 
C PS F AP 	
cleavage 






AAAAAAAAAAAAAAA (4) 	I A Poly (A) signal 
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Figure 47. Schematic representation of the steps involved in the mammalian 
pre-mRNA 3' end processing reaction. 
(I )Representation of the polyadenylation signal and G+U rich region at the 3' end of a 
primary transcript. (2)Complex of proteins that associate with polyadenylation signals 
to mediate cleavage and polyadenylation. (3) poly (A) polymerase (PAP) adding an 
oligo (A) tail to the cleaved mRNA. (4)Rapid burst of processive systhesis of a poly (A) 
tail caused by the binding of PABII to the oligo (A) tail (Terms defined in text). 
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(6.2) Experimental approach 
Previous studies (oligonucleotide hybridisation) had suggested that the 2.1kb mRNA 
contained the protein coding region in full and was shorter than the 4.6kb mRNA simply 
because the 3' UTR was shorter. Probes directed against the extreme 3' end of the 4.6kb 
3' UTR did not hybridise to the 2.1kb mRNA (Hunter, unpublished) and sequencing data 
suggested that an upstream poly A signal was used to generate the 2.1kb mRNA. An 
attempt had been made to identify which upstream signal was used and one candidate at 
position 1253 (TATAAA whose sequence is indeed not classic for a poly A signal) had 
been discounted by the use of Si mapping experiments (Goldmann et al., unpublished). 
However, the sequence at position 1523 (ATTAAA) is the second most common signal 
used in polyadenylation, and was investigated in this chapter in parallel with other studies 
using RT-PCR and sequencing (Goldmann et al., unpublished). 
The ability of the position 1522 signal to direct polyadenylation in N2a cells was tested. 
The experimental approach involved introducing into N2a cells chimaeric CAT constructs 
containing the potential poly A signal for 3' end processing, with additional contructs 
which carried general or specific deletions affecting the putative poly (A) signal (Section 
6.3). It was reasoned that if the poly A signal is functional in 3' processing, then 
transcripts of the correct size should be produced and site directed mutations should 
abolish 3' end processing of transcripts originating from this region (Section 6.4). 
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(6.3) Construction of plasmids 
(a) pABstEli 
pBstEH contains the 5' end of the PrP gene 3' UTR and terminates at position 1761. 
pABst Ell was made by restriction and removal of a 2000 nucleotide Sst I -Bst Ell 
fragment from the plasmid pEYR (Section 5.3b). The DNA ends were made blunt ended 
with Klenow fragment polymerase and religated. This construct does not contain the 
polyadenylation signal used to generate the full length 4.6kb PrP transcript (position 
4064), but does contain the potential alternative signal at position 1522 (Figures 48 and 
53) 
poly (A) 
2nd poly (A) 	 2nd poly (A) 
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3 I6bp of the SV40 t antigen UTR containing the intron 
3' end of the PrP ORF (200bp) 
Figure 48. Schematic representation depicting the cloning strategy for 
plasmid pABst Eli. A fragment was removed containing the established poly (A) site 
(position 4069) from the plasmid pEYR, which subsequently was religated, leaving only 
the 2nd putative poly (A) site at 1522. 
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N pAKpnI 
pAKpnT contains the 5' end of the PrP gene 3'UTR and terminates at position 1519. This 
construct was made by restriction and removal of a 2400 nucleotide Kpn I fragment from 
the plasmid pEYR (Section 5.3b). This construct does not contain the polyadenylation 
signal used in the 4.6 kb PrP transcript (position 4071),n or the potential alternative signal 
at position 1522 (Figures 49 and 53). 
2nd poly (A) 
poly (A) 
2nd poly (A) 
poly (A) 
Ligation 
pEYR 	 CA  
restriction 
SV40 SV40 promoter 
316bp of the SV40 I antigen UTR containing the intron 
3 end of the PrP ORF (200bp) 
Figure 49. Schematic representation depicting the cloning strategy for 
plasmid pzxKpn I. A fragment was removed containing the established poly (A) site 
(4064) and a 2nd potential site (1522) from the plasmid pEYR. 
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(c) pSVTC 
pSVTC contains no 3' UTR. pSVTC was constructed (Figures 50 and 53) by digesting 
pCAT Control plasmid (Promega) with Sea 1 and isolating a 1781bp fragment insert 
containing 309 bp of the ampicillin gene, the entire SV40 promoter and 659bp of the CAT 
ORF. pTCAT (Section 4.3) was restricted with Sca I and a 2228bp fragment was isolated. 
The I 781 bp and 2228bp fragments were ligated so that both the CAT and ampicillin genes 
were repaired with the introduction of the SV40 promoter upstream of CAT in the proper 
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Figure 50. Schematic representation depicting the cloning strategy for 
plasmid pSVTC. The T3 promoter from the plasmid pTCAT was replaced with the 
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(d) pA2, pA3 and pA5 
p\2, pA3 and pA5 contains 2, 3 and 5 bp deletions respectively, within the potential 
polyadenylation signal at position 1522 (Figures 51 and 53). The signal at position 1522 
from plasmid pzBstEII was mutated by Pacl restriction, treatment with T4 DNA 
polymerase and Kienow and subsequently religated. Clones containing mutations within 
the hexanucleotide signal were identified by double stranded DNA sequencing (Figure 
52). 
Pac I recognition 
sequence 	 Puiative polyadeylatton 
signal 
GGCTACTTA AT TA A ACTA CCTT 
CCGATGAATTAATTTOATGGAA 
position 1525 





CCATGGAA ATTTGATGOA A 
ligation 





2nd poly (A) 
S\ 40 SV 40 promoter 
3) 6bp of the SV40 t antigen UTR containing the iniron 
3 ' end of the PiP ORE 
Figure 51. Schematic representation depicting the cloning strategy for 
plasmids pA2, pA3 and pA5. 
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 Figure 52. Sequencing autoradiographs of the potential poly A signal and the deletions 
from mutant chimeric CAT plasmids produced by restriction of pRst Eli, blunting the 
ends with T4 DNA polymerase and religation. The sequences of 4 mutant clones are 
presented alongside the wildtype sequence. ('lone I (pi\l3stEll) contains the wild type 
hexanucleoticle sequence while clone 2 (pA3) 3 (pA2) and 4 (pA5) contains 3, 2 and 5 









ATTAAA 	 pL\ BstEII 
2nd poly (A) 
	






\ 3 end of the PrP orf (200bp) 
3 l6bp of the SV40 t antigen UTR containing the intron 
Deletion 
SV40 SV40 promoter 
Figure 	53. 	Summary of 	constructs 	used 	to investigate alternative 
polyadenylati 	n sites 
and, pA5 , pA 	pA Constructs 	pBstEII has the complete poly A site 2, 
have no, 	5, 2 and 3 	base pair 	deletions 	respectively within 	the hexanucleotide 
ATTAAA region. While p A Kpn I and pSVTC have 400bp and 1Kb deletion 
with respect to pABstEll and to p01 A signal. 
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(6.4) Investigation into the alternative polyadenylation signal at position 
1522 
To address whether the potential alternative polyadenylation signal at position 1522 was 
functional in mRNA 3'end processing, a series of fragments with deletions in this region 
were generated as described above. The deletion (Section 6.3e) fragments were inserted 
downstream of the CAT reporter gene, itself under control of the SV40 promoter. These 
chimeric constructs were introduced into N2a cells by calcium phosphate precipitation 
(Section Section 2.29). After 48 hours incubation, cytoplasmic RNA was isolated from 
the transfected cells and the CAT trancripts analysed by RT-PCR (Section 2.34). In each 
assay, cytoplasmic RNA from mock transfected cells was used as a control. The CAT 
mRNA transiently expressed from the pABstEIl construct had evidently been subjected 
to 3' end processing and gave rise to I major band of the expected size (approx. 700bp) 
when reversed transcribed using an anchored oligo dT primer and PCR amplified using 
a specific downstream 3' UTR primer (A030) (Figure 53 lane b). This construct contains 
the 5' end of the PrP 3'UTR terminating at position 1716 (Section 6.3a). The constructs 
that terminate within the PrP 3' UTR at position 1519 (pAKpn I Section 4.3b) or do not 
contain any 3' UTR (pSVTC, Section 4.3c) seem to abolished 3' end processing, since 
no DNA band was present in the RT-PCR assay (Figure 53 lanes c and d respectively). 
Constructs that contain specific deletions in the potential polyadenylation signal at 
position 1522, pAS and pA3 (Section 4.3d) also produced no DNA product probed 
(Figure 54 Lane h and i) as judged from agarose gels and Southern blots with a 
labelled oligonucleotide BO 11. However when the polyadenylation signal was changed 
from ATTAAA to TATAAA, in pA2 (Section 4.3d) 3' end polyadenylation in this 
region was retained, as judged from the RT-PCR assay (Figure 54, lane j). 
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a 	b 	c 	d 	e 	f 	g 	h  
Figure 54. Polyadenylation of transcripts 
(A) RNA transcribed from the chimaeric CAT constructs were reverse transcribed using 
an anchored oligo T primer then, PCR amplified and separated on 1.6% agarose (B) The 
gel was blotted onto a membrane using, probed with a 32P labelled oligonucleotide BO  I 
(ACACACAGACGTCTCTTGATATTTCC) and exposed to X-ray film over night. 
(Lane a: No template, Lane b: pABstEll, lane c: pAKpnI, Lane d: pSVTC, Lane e: As 
(i) but no Reverse transcriptase, Lane f: 1Kb markers, lane g: As (j), but no Reverse 
transcriptase, Lane h: pAS, Lane i: pA3 and Lane j: pA2.) 
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(6.5) Effect of mRNA 3' end processing upon gene expression 
Abolition of 3' end processing has been shown in the previous section by mutation in 
the poly A signal at position 1522. This section will extend these results and measure 
the consequences for CAT protein production. Calcium Phosphate was used to introduce 
DNA into mouse neuroblastoma cells. After 48 hours lysates from neuro2a cells 
transiently transfected with chimaric CAT constructs (Section 6.3) were harvested and 
incubated with 14C chloramphenical and acetyl Co-enzyme A for 20mins. The reaction 
was extracted with ethyl acetate and separated by TLC on silica plates using a 
chloroform: methanol :: 97:3 solvent system (Section 2.31). 
CAT activty was abundant in cells transfected with the constructspz\BstEII and pA2 
which contains the recognisable polyadenylation signal at position 1522 (Figure 55 lanes 
h and e respectively; Figure 56). CAT transiently expressed from the plasmid pz\BstEII 
produced the highest CAT activity . Other constructs, terminating in the PrP 3' UTR 
before position 1522 (ptKpnI and pTCAT) or having specific short deletions 
inactivating that polyadenylation signal 1525, (pA3 and pA5) produced low CAT 
activity (Figure 55 lanes f, b, d and c respectively; Figure 56). However, when the 
polyadenylation signal was changed to TATAAA (pA3), CAT activity remained strong 
(Figure 55 lane e; Figure 56, Appendix Table 14). The experiment was done 3 times 
and co-transfection with the pSVlacZ plasmid accounted for differences in transfection 
efficiency by allowing parallel assays for beta galactosidase as described previously). 
The results are summarised in Figure 56 and Table Appendix Table 14. 
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Figure 55. Effect of mRNA 3' end processing upon gene expression 
Representative results depicting an autoradiogram of a CAT assay performed by TLC. 
In all cases except for lane i and j transfected neuroblastoma cells were harvested after 
48 hours. The constructs used were Lanes a: Mock transfection, Lane b: pSVTC, Lane 
C: pA5, Lane d: pA3, Lane e: pA2, Lane f: pAKpnI, Lane g: pSVlac Z, Lane h: 
pABstEll, Lane i: pABstEll (24 hours), Lane j: pABstEll (36 hours). Row 1: Non-
acetylated; Row 2 and 3: acetylated ' C chloroamphenicol. 
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pSVTC 
pLKpnI 
mAAA1 	- j pA3 
TATAAA 	
2 pL 
CCTTAA 	 I p5 
Pacf 
AUAAA 	 BstEII 
2nd poly (A) 	21(b 
Kpnl 	BstEIl 	poly(A) 
Position 
4071 
SV40: SV40 promoter 	3' end of the PrP orf (200bp) 
J Deletion 
316bp of the SV 40 t antigen UTR containing the intron 
Figure 56. Effect of the putative alternative polyadenylation signal of PrP upon 
the translation of CAT. Transfection efficiency was normalized by co-transfection with 
a plasmid containing the beta-galactosidase ORF. Values were determined from 3 independent 
experiments. Error bars represent standard errors from the mean. Constructs pABst Eli, pA5, 
pA2, pA3 have no, 5, 2 and 3 base pair deletions respectively within the hexanucleotide 
ATTAAA region. While pAKpn I and pSVTC have 400bp and 1Kb deletions with respect to 
pABstEIl. 
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Figure 57. An autoradiograph of a TLC plate depicting the CAT activity from cells 
transfected with the constructs lane a: pEYD, lane b: pABsLEI!, lane C: pFYR, lane 
d: pCAT control. lane e: mock transfected. Row I: non-acetylated 2: and 3 acetylated 
' 4C chioroamphenicol. 
1,CAT Cont,n? 
-f V4oICATI $V tORI- 
Figure 58.Comparison of the constructs pEYR and pBstEll in their ability to produce 
CAT activity. (See also Appendix Table 15) 
posIIinn60 	1930 	1646 	4256 
pFYR 	-I SV4OCAT PPYtfTR 	 I- 
Hsi EII 	 svICAP 3'LrTR
Ii 
3&'5 	3V 
pEVO 	 sv IcA1n9R l 
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(6.6) Comparison of the constructs pEYR and pAL3stEIt in their ability to 
produce CAT activity 
A comparison was made between the constructs pABstEll (Section 6.3a) and pEYR 
(Section 5.3h) in their ability to produce CAI' activity. The construct pFYR 
encodescontains the full length PrP 3' UTR which is present in the 4.6kb PrP transcript 
of 4.6 kb in length found in sheep brain. The construct pABstEll terminates 200bp 
downstream of the polyadenylation signal at position 1522 and encodes only the 3' LJTR 
contained within the short PrP (2.1 kb) transcript found in peripheral tissues of sheep. 
The constructs pCAT control, containing the SV40 3' UTR, and pEYD which has a 
2806 bp deletion in the PrP 3' EJTR (Section 5.3a) were used as positive controls. 
Results shown in Figure 57 and 58 shows that the constructs pCAT control, pEYI) and 
pABstEll (Figures 58 and 57 lanes d, a, b respectively) produce similar levels of CAT 
activity and all higher than the construct pEYR which encodes the whole PrP 3' UTR 
(Figure 57 lane c). 
Based on the evidence from section 5.9, the difference between pEYR and pEYL) (and, 
by extrapolation, probably pABstEll) is due to a posttranscriptional effect. Due to 
constraints of time this experiment was only carried out once but will be repeated by 
others before publication. 
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(6.7) Conclusion 
Numerous mutagenesis experiments as well as the analysis of naturally occurring 
mutations have confirmed that the sequences (AATAAA or ATTAAA), typically located 
10-30 nucleotides upstream of the poly (A) site, are essential for 3'-end formation of 
polyadenylated RNA (Review: Wahie and Keller, 1992). The variant TATAAA has also 
been shown to have at least partial ability to act as a polyadenylation signal (Russnak 
and Ganem 1990). 
If 3' end processing employing the polyadenylation signal ATTAAA at position 1523 
of the PrP gene 3' UTR were taking place then by RT using an anchored oligo dT 
primer, followed by PCR amplification using a specific downstream primer A030, a 
700bp cDNA fragment should be produced. This was confirmed (Section 6.4). Deletion 
and site directed mutagenesis analysis further confirmed that the polyadenylation signal 
ATTAAA at position 1522 can be used in 3' end processing in N2a cells (Section 6.4). 
Constructs that terminated in the PrP 3' UTR upstream of position 1522 (Section 6.3b 
and c) produced no cDNA product and therefore seemed not to have been 
polyadenylated. Constructs that contained specific deletions in the polyadenylation signal 
at 1522, pA5 and pM (Section 6.3.d) also produced no cDNA product as judged from 
agarose gels and Southern blots. However, when the polyadenylation signal was changed 
from ATTAAA to (pA2) TATAAA (known to be partially functional in other systems: 
see above) 3' end processing in this region was retained. Southern blotting with a 
labelled oligonucleotide B011 confirmed the identity of the DNA fragments. The overall 
results strongly suggest that the polyadenylation signal at position 1522 can be 
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functional in 3' end processing in N2a cells. 
CAT activity was abundant in cells transfected with the constructs pABstEll and pA2 
which contain functional polyadenylation signals at position 1522. In contrast the other 
mutated chimaeric CAT constructs which do not have poly A signals, produced only low 
CAT activity (Figure 56) possibly due to the use of cryptic sites along the plasmid 
backbone 
These results strengthen the hypothesis that the short PrP transcripts seen in 
peripheral tissues of sheep originate from alternative polyadenylation of transcripts 
from a single PrP gene. The use of the polyadenylation signal at the position 1522 
would produce a shorter PrP transcript similar to the size seen in vivo. Recently, in 
a follow up to this work the shorter 2.1 kb sheep transcript has been RT-PCR 
amplified and sequenced and the poly (A) tail shown to start approximately 16bp 
downstream of the poly(A) signal at position 1522 (Goldmann et al., unpublished). 
Thus in agreement with the literature, poly(A) addition occurs between 10 and 30 
nucleotides downstream of the polyadenylation signal (Review: Whale and Keller 
1992). The constructs pABstEll and pEYR in N2A cells produce CAT mRNAs 
carrying the PrP 3' UTR of the 2.1kb and 4.6kb transcripts respectively. A 
comparison was made between the construct pABstEIl and pEYR in their ability to 
produce CAT activity. The results showed that pCAT control, pEYD and pABstEll 
produce similarly high levels of CAT activity whereas pEYR, with the full length 
PrP 3'UTR, produces lower levels of CAT (Figure 57). These results raise the 
interesting possibility that the two PrP transcripts in sheep, differing in the lengths 
of their 3 UTR may also differ in their expression of PrP protein. 
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Summary and Discussion 
(7.1) 	Summary 
This project was designed to investigate the potential of the sheep PrP gene 3 UTR to 
control gene expression. Interest in this region of the PrP gene resulted from the 
following studies of sheep PrP genetics (Hunter et al., 1991), PrP mRNA (Hunter et al., 
1994b) and protein (Horiuchi et al., 1995). There is an EcoRI RFLP which has good 
association with the incidence of both natural and experimental scrapie (Hunter et al., 
1989, 1991) and is located in the 3' UTR region of the PrP gene. However, the 
association between el and disease may be due to the linked missense mutation affecting 
codon 171. Since the amino acid changes in the PrP protein does not always account for 
SJct k net kizf 
PrP predisposition to scrapie (Hunter, 1996),, variation in the 3' UTR can affect mRNA 
localisation inside cells, and might therefore affect the pattern of PrP glycosylation with 
possible consequences for disease susceptibility (Jansen, 1995). 
Furthermore, in sheep brain there is a single PrP mRNA of 4.6 kb, whereas in peripheral 
tissues (eg, spleen, kidney), the 4.6 kb mRNA is accompanied by a smaller (2.1 kb) PrP 
mRNA (Hunter et al., 1994b; 1-loriuchi et al., 1995). This differ in the length of the 3' 
tJ1R (Figure 14) therefore lacking several features which are present in the 4.6 kb mRNA 
including repetitive sequences and a highly conserved region at the 3' end of the UTR. 
The existence of both transcriptional and post transcriptional control of PrP expression 
in sheep was suggested by the finding that the brain expresses PrP mRNA at a level 
about fivefold higher than the kidney, and moreover produce at least fortyfold more PrP 
protein. 
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Functional polyadenylation signal in neuroblastoma cells 
Deletions 	The deletions shown relieved inhibition of CAT expression by the 
3UTR in neuroblastoma cells. In the transfection experiments (A) 
the results indicated a translational effect: in experiments (B) this 
point was not examined. 
Figure 57. Summary of results 
Expression might be important in at least three respects: the development of disease, 
differential expression from the two PrP transcripts and tissue specific expression. 
Results from this thesis have shown that the PrP gene 3' UTR is more polymorphic than 
was thought previously, can alter expression at the translational level of a reporter gene 
in neuroblastoma cell lines but not in cell free systems and contains a polyadenylation 
signal at position 1522 which is functional in 3' processing in the same cell line, when 
the polyadenylation signal at 4064 is deleted (Figure 57). 
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(7.2) 	Cell Free System 
The effect of the PrP 3' UTR upon translation was investigated initially using a cell-free 
translation system. Two constructs contained CAT fused to the entire PrP 3'UTR, one 
in reverse orientation. Another construct contained the 3'UTR with a 2.8kb section 
deleted. A control construct contained only the CAT gene with no PrP 3'UTR. In the 
rabbit reticulocyte cell-free system, expression of CAT protein was not significantly 
affected by any of the PrP 3'UTR sequences tested. It was also confirmed that all the 
constructs yielded expected 3'UTR sequences, when transcribed in vitro for the 
translation tests. It is thought possible that in vitro transcribed RNAs that differ by 
several knt in the 3' UTR would show differences in translational efficiency simply due 
to differences in the length of the 3' UTR. It has been shown that increasing the length 
of an artificial 3' UTR from 4 to 104 nucleotides increases both the translational 
efficiency and stability of an in vitro transcribed transcript (Tanguay and Gallie, 1 996) 
and this effect is due simply to lengthening of the 3' UTR, independently of the 
sequence. This effects is thought to involve a passive mechanism. Ribosomes (or 40S 
Subunits) that transit a long 3' UTR following termination might be prevented from 
diffusing away from the mRNA and therefore might be more likely to reinitiate on the 
same mRNA than a ribosome that has already dissociated from a short Y UTR. if the 
effect of a long 3' UTR serves to raise the local concentration of ribosomes, this model 
would predict that the effect of a long 3'UTR would be lost if the availability of 
ribosomes were no longer limiting. In other words, the extent to which the 3' UTR could 
raise the local concentration of ribosomes would be inconsequential in an environment 
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in which the concentration of available ribosomes was already high. These are the 
conditions that prevail in an in vitro lysate in which endogenous mRNA levels are low 
and translation is relatively non-competitive. Thus an unspecific PrP 3'UTR length effect 
might exist in vivo, and yet be undectable in vitro. Moreover, factors required for 
3'UTR-dependent regulation might be missing or inactive in the in vitro system (not 
least a heterologous reticulocyte system): for example polyadenylation complexes, or 
specific 3'UTR-binding proteins. However, the use of in vitro lysate had been sucessful 
in showing translation regulation for transferrin (Dickey et al., 1987), interferon (Kruys 
et al., 1987) and Lox (Ostareck-Lederer et al., 1994) mRNA. 
(7.3) 	Intact Cells 
The second experimental approach involved a study of chimaeric CAT constructs in 
intact N2a cells (Chapter 5). In the first (A) series of such experiments both CAT 
mRNA and enzyme activity were measured, to determine if the PrP 3' UTR sequences 
are controlling expression at the post-transcriptional level. 
One construct (pEYR) contained the full length PrP 3'UTR which terminates at position 
4256, beyond the major polyadenylation signal. Other constructs had progressive 
deletions from the start of the PrP 3'UTR (at position 840) to position 1930 (pEYP) and 
3646 (pEYD). The control construct contained part of the SV40 3' UTR. CAT protein 
was produced at approximately two fold higher levels by the construct pEYD (and the 
control) than by pEYP and pEYR (judging by the activity of the CAT protein). Analysis 
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of mRNA levels showed that these were similar with all constructs and therefore the 
data suggest that the 3' UTR of sheep PrP can reduce expression of CAT mRNA at the 
translational level, at least in these N2a cells. It is not known if the increase in 
translatability produced by the deletion in pEYD results from removal of specific 
sequences or is simply due to the shortening of the PrP 3' UTR, but the former seems 
likelier. The nucleotides between the position 1930 and 3646 may be of particular 
interest as these sequences are the only differences between the construct pEYP and 
pEYD. This region of DNA is not conserved amongst PrP genes of other species, but 
in sheep it includes 3 polymorphisms (el versus e3) at positions 2613, 2614 and 3440 
and three ATTTA instability motifs at positions 1985, 2213, and 3636. 
Further constructs were made by unidirectional deletions in the PrP 3'UTR (Figure 43) 
for the second series (B) of transfection experiments. The results confirmed and 
extended the above data, in that constructs with deletions from the start (position 840) 
of the PrP 3' UTR to position 2030 gave lower expression of protein (CAT activity) 
when compared with those carrying deletions extending to position 3048 or beyond. 
Thus these results narrows down potentialy interesting region to between 2030 and 3048. 
This region may carry negative regulation signal(s), conceivably involved in binding 
proteins. Very little is known about the mechanism by 'vhich proteins bound to mRNA 
3' UTR sequences alter translation. There are currently at least three hypotheses for such 
mechanisms of translational control. The first suggests that binding of specific proteins 
to the cis-acting 3' UTR signals, such as the CPE/ACE motifs in vertebrate oocyte 
mRNAs, is central to the mechanism of control of polyadenylation and translation 
initiation. For many developmentally important mRNAs, this type of translationally 
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silent ribonucleoprotein particle permits stockpiling of mRNAs during gametogenesis in 
a number of organisms (Standart and Jackson 1994). The second model suggests that the 
binding of a specific protein to a 3 'UTR acts as a nucleation signal for other proteins 
to bind to the mRNA, wrapping it up in a particle (mRNP) in which the RNA is 
inacessible to the translational machinery. Possible candidates for these structural 
proteins are the so-called Y-box proteins (Sommerville et al., 1996). A third hypothesis 
is that the 3' UTR serves as a transient reservoir of ribosomes (or 40S subunits) for 
recruitment. The high degree of functional codependence between the cap and poly (A) 
tail previously observed (Gallie 1991) suggested an interaction between these termini 
during translation. Recent evidence suggests that two elongation factors eIFs known to 
bind to the cap structure, i.e., eIF-4F and eIF-4B, also bind to poly(A) and may form 
part of the basis for the interaction for the interaction between the cap and the poly(A) 
tail (Gallie and Tanguay 1994). A consequence of this model would be that the 
interaction maintains the physical proximity of the termini during translation and thereby 
increases even further the local concentration of ribosomes for reinitiation. The poly(A) 
tail-mediated form of regulation might be an active mechanism in which a biochemically 
based interaction between the termini is used to promote reinitiation (Tanguay and 
Gallie 1996). It is not known whether any of these mechanisms are involved in 
regulation of sheep PrP gene expression. Future studies could include gel-shift assays 
to find out if the region from 2700-3048 in the 3' UTR specifically binds proteins. 
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(7.4) 	Upstream polyadenylation signal 
By deletion and site directed mutagensis analysis it has been shown in this thesis that 
the polyadenylation signal ATTAAA at position 1525 can be used in 3' end processing 
in neuroblastoma cells. Constructs that do not contain this sequence do not produce any 
polyadenylated product. Conversion of the hexanucleotide sequence to TATAAA 
maintains 3' processing but not when changed to TTTAAA or CCTTAA. 
The use of the polyadenylation signal at the position 1522 in sheep would produce a 
shorter PrP transcript similar to the size seen in vivo. The shorter transcript has been 
subsequently, RT-PCR amplified and sequenced, the poly (A) tail was shown to occur 
approx. 16 bp downstream of the poly (A) signal at position 1525 (Goldmann et al., 
unpublished). This is in an agreement with the literature, poly (A) addition naturally 
occurs between 10 and 30 nucleotides downstream of the polyadenylation signal 
(Review: Whale and Keller 1992). These findings are consistent with the work of Singh 
et al., 1996 in which the protein BICP27 was shown to stimulate Bovine herpesvirus 
(BHV) 3' end processing. Two chimeric. CAT constructs differing only in the poly (A) 
signal, one containing HGH (human growth hormone) and the other BHV-1 were 
transiently introduced into insect cells. It was shown that the poly (A) signal of BHV-1 
was inefficient in 3' end processing and consequently exhibited low CAT ativity. 
However, upon co-transfection with the BICP27 open reading frame, CAT activity was 
stimulated 7 fold. It was concluded that since these two plasmids differed only with 
respect to the poly (A) signal present, that the increased CAT activity from the chimeric 
CAT construct containing the poly (A) signal of BHV reflected enhanced 3' end 
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processing. 
There are suggestions that polyadenylation stabilises transcripts and enables transport 
from the nucleus to the cytoplasm and high translational efficiencies (Tanguay and 
Gallie 1996). Many transcription units contain multiple polyadenylation sites, and the 
choice between them can play an important role in gene regulation (eg. Skadsen and 
Knauer 1995) and tissue specific expression (eg. Thekkumkara et al., 1992). Poly (A) 
sites vary in strength: when transcription units are engineered so that they differ only 
in their poly (A) sites, different steady state levels of mRNA result (eg., Carswell and 
Alwine 1989; Gimmi et al., 1988). When two sites are placed in tandem into the same 
transcription unit, one is used more often than the other. Although with two identical 
sites the upstream site has been preferred (Luo and Carmichael 1991), a strong poly(A) 
signal downstream can outcompete a weaker signal upstream (eg., Levitt et al., 1989). 
Why is one site more efficient than another? The in vitro system is still only partially 
defined, and its rate-limiting step is unknown. However sequences flanking the 
polyadenylation signal may play a part in influencing the site used (Moreira et al., 
1995). Moreover, the in vitro system is limited to the investigation of 3'-processing as 
an isolated event, whereas in vivo the process is coupled to transcription and splicing. 
Thus, the determinants of poly (A) site strength might well be different under the two 
circumstances. Transcriptional pause sites enhance the use of upstream poly (A) sites 
in vivo and the strength of a site is correlated with the stability of the processing 
complexes it forms in vitro, either in nuclear extract or with partially purified fractions 
(Prescott and Falck-Pedersen 1992 and 1994; Gilmartin et al, 1992; Weiss et al., 1991). 
Upstream elements are as variable and can have similar effects (Gilmartin et al, 1992; 
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Moreira et al, 1995). Even sequences surounding the AAUAAA element can influence 
poly(A) site strength (Prescott and Falck-Pedersen 1994; Gilmartin et al, 1992). The 
exact sequences that increase the use of one polyadenylation site over another are not 
fully understood. The potential implications of these results are discussed later (7.8). 
(7.5) 	 Sequence Analysis 
Five polyadenylation signals were identified within the 3' UTR of the PrP gene (Table 
5), only two of which are now known to be used (Goldmann et al., personal 
communication and this thesis). 
The findings of unused polyadenylation signals is not unique and has also been shown 
for the alpha-subunit of the eukaryotic initiation factor-2 (eIF-2 alpha). This is a 
single-copy gene expressing two mRNAs by alternative polyadenylation, 1.6 and 4.2 kb 
in size. Cloning and sequencing of the. cDNA for the 4.2 kb mRNA revealed four 
polyadenylation sites within the 3' UTR of eIF-2 alpha, of which only two were found 
to be used in human and mouse tissues (Miyamoto et al., 1996). 
Five copies of the pentamer AUUUA are present in the full length PrP 3' UTR of the 
el allele and only one of these is present in the 2.1 kb PrP transcript (Figure 57). 
Attempts made to investigate the ability of the PrP 3' UTR to alter the expression of 
a reporter gene in cell free systems and intact cells from Chapter 4 and 5 are discussed 
in Section 7.5 and 7.6 respectively. The finding of AUUUA motifs is interesting because 
they have been shown to be central to mRNA stability (Zubiaga al., 1995), localisation 
(Veyrune et al., 1996) and translational regulation (Wymore et al., 1996). 
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For example, in transfected fibroblasts the c-myc 3' untranslated region is able to 
localise beta-globin reporter sequences to the perinuclear cytoplasm (Veyrune et al., 
1996). Constructs containing deletions within the 3' untranslated region identify the 
region between bases 194 and 280, which contains a ATTTA sequences, as critical for 
localisation. Transfection with constructs containing a mutated ATTTA sequence within 
the 194-280 base region showed that this conserved sequence is required for targeting 
of both c-myc mRNA and a chimaeric transcript of beta-globin linked to the c-myc 3' 
untranslated region. 
In addition, labile mRNAs from cytokine and immediate-early genes often contain 
AU-rich (AT-rich on the DNA molecule) sequences within their 3' untranslated region 
(UTR) (Gehrke et al., 1994). These AU-rich sequences appear to be key determinants 
of the short half-lives of these mRNAs. Evidence suggests that the pentamer AUUUA, 
which previously was suggested to be the minimal determinant of instability present in 
mammalian AREs (AU rich elements), cannot direct rapid mRNA deadenylation and 
decay. Instead, the nonamer UUAUUUAUU is the essential AU-rich sequence motif that 
destabilizes mRNA (Zubiaga al., 1995). 
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(7.6) Sequence Differences between the el and e3 alleles of the sheep PrP 
gene 3' UTR 
The Eco RI RFLP in the 3' UTR of the sheep PrP gene was shown to be loosely 
associated with experimental and natural scrapie (Hunter et al., 1991) although the 
linkage could well be due to the linked missense mutation affecting codon 171. The 
effects, if any, of addition polymorphisms found in the 3'UTR (Chapter 2) upon 
translation are currently not known. The allele tested in this thesis was the el allele, the 
one associated with incidence of scrapie. It would now be simple to insert the 3' UTR 
of the other allele, e3 (associated with disease resistance) into the chimeric constructs 
and compare its effects upon gene expression. 
There are 6 copies of the ATTTA instability motif in the e3 allele, but only 5 in the el 
allele due to the polymorphism at position 1016 that results in a A toG substitution 
(Table 4). By site directed mutagensis it would be possible to repair the ATTTA 
pentamer at position 1016 from the construct pEYR which contains the full length PrP 
3' UTR (Section 5.3b) and thus examine the functional importance of this polymorphism. 
Differences in protein levels may be linked to disease susceptibility. The level of PrP 
proteins have been shown to be directly linked to disease susceptibility (Manson et al., 
1995). Studies on transgenic mice carrying different copy numbers of PrP genes and 
expressing PrP at different levels have shown that susceptibility to clinical disease, as 
evidenced by incubation time and disease progression, is correlated to PrP expression 
levels (Prusiner et al., 1990). It has been found that PrP null mice (Bueler et al., 1992), 
which are devoid of PrP protein, are completely resistant to scrapie and that mice 
carrying one copy of the PrP gene, contain about half the amount of PrP, show a very 
long incubation times as compared with wild-type mice (Bueler et al., 1993). 
Transcripts that only differ in their 3' UTR can and have been shown in some genes to 
produce different protein levels. For example the casein gene has two alleles, which 
differ in that one has a 150b insertion in the 3' UTR, also differ in gene expression. The 
allele with the insertion has been associated with increased protein levels (Perez et al., 
1994). 
Differences in the 3' UTR can often result in more complex phenotypes. Breast cancer 
cell lines were found to be inhibited from traversing the cell cycle following the 
introduction of wild-type prohibitin transcripts. Functional mapping experiments showed 
that the 3' UTR is sufficient alone to inhibit cell cycle progression, indicating that the 
anti-proliferative activity of the prohibitin transcript is localised to this region (Jupe et 
al., 1996). 
The presence of a second PrP transcript found in the peripheral tissues of sheep raises 
the possibility of functional differences between the two different PrP mRNAs due to 
the extended sequences. The functional significance of the PrP 3' UTR was investigated 
in chapter 4, 5 and 6 and its potential relevence to PrP expression is discussed below. 
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(7.7) Sequence Differences between the 4.6 and 2.1kb PrP transcripts 
Sheep PrP mRNA is expressed, from both the el and e3 alleles, in peripheral tissues as 
two transcripts of 4.6 and 2.1 kb. Results presented in this thesis suggest that the shorter 
PrP transcript terminates using the polyadenylation signal at position 1525 while the 4.6 
kb transcript ultilizes a signal much further downstream at position 4071 (Goldmann et 
al., 1991). It is not known if both transcripts are translated or if the two mRNAs are 
functionally different. Results presented in Chapter 6 suggest that they may produce 
different amounts of protein depending on the length of the 3' UTR. 
DNA sequence analysis has shown the 4.6 kb PrP mRNA will contain 6 'AUUUA' 
instability motifs present in the extended 3' UTR but the 2.1 kb PrP transcript will contain 
none of these. Such 'AUUUA' motifs have been shown to be central to post 
transcriptional control of gene expression (Section 7.6). Additional sequences present in 
only the 4.6kb mRNA are repetitive sequences and a highly conserved region right at the 
3' end of the UTR (Goldmann et al., 199 l).Similar findings have been reported for the 
mouse voltage-gated K+ channel gene Kvl.4, which is expressed in brain and heart as 
a 4.5- and 3.5 kb transcripts. Both mRNAs begin at a common site 1338 bp upstream of 
the initiation codon and contain 3477 and 4411 nucleotides, respectively. The 3.5-kb 
transcript terminates at a polyadenylation signal 177 bp 3' of the stop codon, while the 
4.5-kb mRNA utilizes a signal 94 bp further downstream. The extended region in the 3' 
UTR of the longer transcript contains five AUUUA repeats which were shown to inhibit 
translation (Wymore et al., 1996). The implications of these findings are discussed later 
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(7.8.) 	Possible consequences of alternative polyadenylation and 
translation regulation 
PrP gene coding region variation does not account for all observed differences in scrapie 
incidence in sheep, CJD in humans and doesn't seem to be linked at all in BSE infected 
cattle. As mentioned in Section disease incidence in Suffolk sheep is linked to 
mutations at codon 171 while in Cheviots linkage is found with codon 136. Thus 
differences outside the PrP open reading frame may be of interest. 
(7.8a) 	Expression of PrP in sheep 
Iketa et al., 1995 have shown there to be both an increase in transcriptional and 
translational expression of sheep PrP in the brain compared with other tissues. There are 
appears to a 5 fold difference in the mRNA level between sheep brain and peripheral 
tissues and consequently, potentially a five fold difference in transcription. Additionally, 
the same comparisons made at the PrP protein level suggested that PrP mRNA was 
potentially translated aprroximately 8 fold more efficiently. The regions for this control 
are not apparent but this thesis has shown that PrP 3' UTR deletions can alter expression 
at least 2 fold of a reporter gene in neuroblatoma cells. The results from Chapter 6 using 
reporter gene constructs and neuroblatoma cells of mouse origin would predict that 
peripheral tissues would produce PrP protein more efficiently. The apparent discrepancy 
between these findings and with sheep tissues is not fully understood but may arise 
because of the use of cells of mouse origin and not sheep. 
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(7.8b) 	Alternative polyadenylation and differential expression of PrP 
The presence of two PrP transcripts in peripheral tissues and one in brain of sheep raises 
some interesting possibilities. This different expression patterns in sheep peripheral and 
brain cells may have implications for natural scrapie which must result from a peripheral, 
rather than an intracerebral, infection. Understanding how the differential expression is 
controlled is basic information vital to the understanding of the natural disease as, 
whatever the nature of the infectious agent, its interaction with the endogenous PrP 
protein is required for successful infection. 
The expression pattern of the PrP gene is different in mice from that seen in sheep. 
Unlike sheep scrapie, mouse scrapie is not tranmitted between animals even when in 
the same cage, nor is it maternally transmitted. Maternal transmission of scrapie is 
supposed to occur in sheep and the sheep placenta is highly infectious. The 
importance of the 2nd peripheral mRNA potentially translated more efficiently in 
sheep may be linked to these facts. There are may be at least two controlling 
mechanisms operating in the sheep. One has the results in the higher levels of the 
PrP mRNA and protein in the brain than in peripheral tissues and the other, possibly 
working through the differentail expression from the two mRNA, would have the 
effect of the slightly increasing the peripheral levels of protein expression although 
not so high as that seen in brain. In this respect, it is interesting that although the 
bovine PrP gene has similar structure to that of the sheep, cattle only produce the full 
length 4.6kb mRNA and not the "extra" peripheral 2.1kb mRNA (Hunter, 
unpublished). There is much less abnormal PrP produced in cattle spleen in BSE 
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affected animals and much lower levels of infectivity compared with sheep spleen 
(Review, Hunter 1996). It may there fore be the 2.1kb mRNA in sheep spleen which 
produces enough PrP protein to allow the infectious agent to replicate in this tissue. 
Other forms of translational control by the 3' UTR of other genes are poorly 
understood. A form of lysosomal storage disease aspartylgiucosaminuria has been 
described resulting from a homozygous deletion of most of the 3' UTR part of 
aspartyiglucosaminidase mRNA. This deletion caused the synthesis of a stable, 
truncated but polyadenylated mRNA with a completely intact coding region, which 
was nethertheless not translated in vivo, whereas no defect in translational efficiency 
could be demonstrated in vitro (Ikonen et al., 1992). Another example is provided by 
the mRNA for the Alzheimers disease amyloid protein precursor (APP), which has 
two forms produced by alternative polyadenylation. Fusion of each 3' UTR of the 
APP mRNA to CAT had shown that the long 3'UTR was translated significantly 
more efficiently (Sauvage et al 1992). The extended sequences appeared to be 
responsible for this increase in translational efficiency independent of mRNA length. 
The results presented in Chapter 5 may play a part in differences seen in translation 
efficiency between peripheral and neuronal tissues. This will be tested (in a new PhD 
project) by the use of chimeric constructs already produced for their ability to express 
protein in neuronal and non-neuronal sheep cell lines. 
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The potential of regions other than the 3' UTR to affect expression (7.9-
7.11) 
(7.9) 	 5' UTR 
The 5' UTR of the sheep PrP gene (131bp) consists of exon I and exon II and 10 
bases of exon III (Westaway et al.,1994). This is another region which might 
regulate translation efficiency. Leader sequences of mRNA molecules encoding 
proteins with a strictly regulated expression, however are often larger than the 
average of 140 nucleotides (Kozak 1987; Pesole et al., 1994) contain upstream AUG 
codons and/ or are expected to form stable secondary structures by virtues of a high 
G + C content (Kozak 1989; Gray and Hentze 1994). A large number of mRNA 
molecules for proteins involved in growth and development fall in this category. 
Many of these long leaders have been shown to be detrimental to translation in cells 
(Kozak 1991). How can the translational efficiency of these "diffircult" leaders 
containing lots of secondary structure be improved ? One way is to increase the 
limiting factor for translation initiation eIF-4E, so that these highly structured leaders 
get a chance of entering translation (Kormilas et al., 1992). Ornithine 
aminotransferase and growth regulating proteins like cyclin Dl and transcription 
factors have been shown to be induced by eIF-4E overexpression (Rosenwald et al., 
1993). Other methods include the addition of proteins that can bind specifically to 
the leader and thereby alters its conformation. Alternatively, a tightly bound RNA 
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binding protein can mimick secondary structure by obscuring the cap or stalling the 
scanning complex in the early stages, thereby hampering translation. The prototype 
for this idea is the translational regulation of ferritin expression by iron (Melefors and 
Hentze 1993). 
Thermodynamically stable elements of secondary structure have been found in the 
5' region including the ORF for PrP genes (Luck et al., 1996), however their 
functional significance is not known. It would be interesting to insert the PrP 5'UTR 
into the chimeric CAT constructs already produced in this thesis and assess whether 
it has potential to alter translation either alone or in conjunction with the 3'UTR. 
(7.10) 	 Coding Region 
Regulation of translation by sequences in the protein coding region is not a 
widespread phenomenon. Mechanisms that have been put forward have involved the 
presence of "ribosomal pause" sites, probably caused by secondary structures in the 
coding region. The TAR (trans-activator region) sequence of the human HIV 
(Okamoto et al., 1986) contain target sequences for trans-activator protein, Tat, which 
interacts with the TAR at the uridine rich bulge in the TAR RNA stem region 
(Dingwall et al., 1990). Wills and Hughes (1990) reported that the PrP mRNA of a 
range of species contained stem-loop structures. In the protein coding sequence of 
PrP mRNA, TAR-like stem-loop structure is present which have the pentanucleotide 
CUGGG in the loop and a so called uridine- and adenine bulge in the stem. In fact 
three CUGG sequences are located on the coding region of the mRNA at the nt 
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positions +170, +194 and +218. The nuclear beta galactoside-specific lectin CBP 35 
(carbohydrate binding protein with a molecular mass of 35 kDa), which has been 
identified in nuclear ribonuclearprotein (RNP) complexes from a variety of 
mammalian tissues and cells, was among those proteins which bound to PrP RNA 
and PrPC.  This association has led to the hypothesis of a possible role for prion 
replication (for example, involved in PrP conversion) and/ or for translation 
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Figure 60. Proposed stem-loop structure of human PrP mRNA from the 
coding region ase +167 to +219. The characteristic CUGGG motif in the loop 
and two on the flanks are underlined and the uridine- and adenine bulge is labelled. 
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Introns 
Almost all protein-coding genes in vertebrates have intervening sequences or introns 
and artificial constructs lacking introns are often poorly expressed. Introns can 
increase the yield of mature mRNA up to 50 fold by facilitating 3'-processing (Huang 
and Gorman 1990; Chiou et al., 1991; Nesic et al., 1993; Nesic and Maquat 1994) 
and a strict coupling of poly (A) site choice and recognition of the final intron in 
vivo has been reported (Liu and Mertz 1993). In vitro, 3' processing is stimulated by 
an upstream intron (Niwa et al., 1990), and splicing of a 3'-terminal intron is partially 
dependent on the downstream poly (A) site (Niwa and Berget 1991). The 3'-splice 
site is responsible for coupling to 3'-processing both in vitro (Niwa et al., 1990) and 
in vivo (Nesic et al., 1993; Nesic and Maquat 1994; Luo and Carmichael 1991). In 
contrast insertion of a 5'-splice site upstream of a polyadenylation (Niwa et al., 
1992). Histone genes are among the few genes that lack introns and they are also the 
only genes which undergo a different form of 3' processing. As a particularly striking 
example of the coupling between splicing and 3'-processing, the insertion of introns 
into histones genes interferes with the histone-specific pathway of 3'end formation 
and induces the use of a cryptic polyadenylation site further downstream (Pandey et 
al., 1990). 
Transgenic mice expressing lacking both intron I and II precluded expression of PrP. 
These results, in agreement with earlier data (Scott et al., 1989), show that the 
presence of at least one intron is essential for the efficient (Brinster et al., 1988) and 
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or tissue-specific (Lozano and Levine, 1991) expression of some trangenes. However, 
recent results has shown that a PrP mini-gene functioning perfectly well without an 
intron (Race et al., 1995). These contradictory results cannot be fully understood. 
(7.12) 	 Gene Therapy 
Despite all the scientific research into TSEs, there is no cure for these 
neuro degenerative diseases. Since gene targeted mice with ablated PrP genes are 
resistant to scrapie prions (Bueler et al., 1993; Prusiner et al., 1993), one therapy 
would use the anti-sense approach. Despite the progress that has been made in 
attempting to develop efficient and safe gene vectors, none of the presently available 
vectors fulfills the stringent requirements that are necessary for human trials (Karparti 
et al., 1996). Other difficulties involve delivering antisense polynucleotides to all 
neurons of the CNS (Zon, 1995) 
Other approaches include the design of "molecular glue" that would cross the blood 
brain barrier and bind to the hydrophobic core of PrPC.  Such a pharmacotherapeutic 
would stabilize the surrounding alpha helix and thus , might be effective in 
preventing PrPSC  formation. An alternative approach is to design molecules that could 
bind to the interaction surface of the infectious PrPSC  and thus terminate its ability to 
interact with and convert PrPC.  The approaches that have been put forward may be 
rather optimistic. More important studies must involve analysing the molecular and 
biochemical mechanism for infection since only then can efficient and effective 
targets be identified. Because PrP null mice are resistant to scrapie and yet otherwise 
unaffected, it may be possible to breed sheep or cattle that are resistant to this 
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disease, either by PrP gene disruption or, because this methodology has not been 
implemented for animals other than mice, by the introduction of transgenes 
expressing PrP antisense RNA. Moreover, the fact that PrP hemizygous (PrP ") mice 
show prolonged scrapie incubation times argues that a moderate reduction of P rPC 
systhesis, as might be achieved by therapy with antisense oligonucleotides, would 
extend the preclinical phase. Since people at risk for inherited prion diseases can now 
be identified decades before neurologic dysfunction is evident, the development of 
an effective therapy is imperative. Other areas of interest for treatment include the 
use of Amphotericin B, which has been shown to prolong the incubation period of 
the disease and to delay the accumulation of the protease-resistant protein (PrP) in 
the central nervous system of scrapie-infected hamsters (Adjou et al., 1995) 
(7.13) 	Final conclusion and future work 
The work in this thesis has suggested that the ideas which has prompted the study 
in the first place may be worth pursuing. PrP protein coding region variation does not 
alone account for all observed differences in scrapie incidence and the fact that the 
non-coding 3' untranslated region has the potential to control gene expression may 
have some importance in disease regulation. Present and future studies will analyse 
this potential using sheep cell lines, will look at the cellular localisation of protein 
produced from both the known sheep PrP transcripts, and will compare the 
translational effects of the el and e3 3'UTRs. 
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tl of TCAT RNA OD Mean Standard error of the 
mean 
0.2 579 457 63 
425 
367 
0.5 520 603 78 
529 
760 
1 1299 928 222 
532 
955 
2 1765 1261 269 
1174 
845 
Effect of increasing TCAT RNA concentration upon the translation efficiency of CAT 
(Figure 24). 
Table 8. 
Construct RNA levels OD, (arbitrary units) Mean 
pRAR 195, 175, 131 167 
pRAD 150, 163, 192 168 
pRAW 163, 170, 178 170 
pTCAT 127, 141, 161 143 
Relative molar Concentrations of RNA assessed by Slot blot hybridisation. The molar 
concentrations of in vitro transcribed RNA were compared by scanning the OD from 
autoradiographs of slot blots according to Section 4.6. Mean values were determined 




Construct Protein levels Protein levels mean Standard 
(optical density) divided by (arbitrary 
errors of 
mean RNA units) 
the mean 
levels 
pRAR 184, 158, 138, 153, 132, 115, 138 7  
176,176 147,147 
pRAD 222, 118 1  311, 188, 100, 264, 182 26 
220, 169 186, 174 
pRAW 191, 143, 248, 159, 119, 264, 166 15 
215, 206 162, 187 
pTCAT 262, 74,285, 262, 74,285, 201 38 
159,225 159, 225  
Effects of the PrP 3' UTR upon the translation of CAT (Figure 27). 
35 S-CAT protein levels measured by scanning autoradiographs of SIDS 
polyacrylamide gels and the values were divided by the RNA levels from Table 8, 




ul of lysate % chioroamphenicol 
acetylation 
Mean standard error of 
the mean 
2 4.2, 4.1, 3.9 4.1 .09 
4 5.8, 5.8, 5.7 5.8 .04 
12 25.6, 29.1, 30.0 28.2 1.4 
20 50.6, 52.1, 50.6 1 	51.1 .5 
Effect of increasing lysate upon the 
dose response curve (Figure 38) 




Construct % CAT RNA Levels CAT/RNA Mean Standard Error of the 
conversion mean 
pEYP 22 920/1162 28 31.3 2.6 
17 672/1455 37 
25 1378/1706 31 
pEYD 43 780/1189 65 67.6 7.5 
36 702/1607 82 
46 1344/1624 56 
pEYR 17 672/1455 48 33.6 7.9 
22 92011162 21 
25 1378/1706 31 
pCAT 46 767/1203 61 61 2.9 
control 42 877/1333 58 
50 1248/1652 66 
Effect of the PrP 3' UTR upon the translation of CAT in N2a cells. (Figure 40) 









error of the 
mean 
10 0.15, 0.13, 0.16 0.14 0.01 
20 0.30, 0.33, 0.34 0.32 0.012 
40 0.76, 0.72, 0.73 0.73 0.012 
80 1.32, 1.04, 	1.01 1.12 0.09 
160 1.41, 1.45, 	1.30 1.38 0.04 
Effect of increasing lysate volume upon the hydrolysis of ONPG-
Dose response curve for beta galactosidase (Figure 43). 
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Appendix Table 13. 
Construct % choramphenicol 
acetylation 
(normalised) 
Mean Standard error of the 
mean 
pCAT control 97, 87, 143 109.0 15.9 
pEYR 66,40,44 50.0 5.7 
pEYP 52,50,39 46.6 3.3 
p2030 28, 60, 60 49.3 10.6 
p2700 79, 50, 116 81.6 17.4 
p 3048 152, 130, 88 123.3 17.6 
p3398 144, 140,131 138.3 4.4 
pEYD 125, 135, 110 123.3 7.2 
p3940 151, 114, 140 135.0 10.4 
Effect of the PrP 3' UTR upon the expression of CAT (Figure 45). 
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pABstEll 77, 59, 49 61 8 
p2 31, 16, 15 20 5 
pAKpnI 5, 9, 2 5 2 
pSVTC 2,5,6 4 1 
pA3 2,5,7 5 1.5 
pA5 4,7,7 6 1 
Effect of the putative alternative polyadenylation signal of PrP 
upon the translation of CAT (Figure 56.) 
Table 15 





pCAT control 79 
Comparison of the constructs pEYR and pABstEl in their ability 
to produce CAT activity (Figure 58) 
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Appendix 
Solutions (Apart from those supplied by manufacturers of kits or enzymes) 
Agarose Gel loading dye 
0.25% bromophenol blue 
0.25% Xylene cyanol FF 
30% glycerol in water 
Alkaline lysis buffers 
Solution 1 
50mM glucose 
25mM Tris.Cl pH8 





60 ml SM potassium acetate 
11.5 ml glacial acetic acid 




Sm! 10% Acetic acid 
170 jtl Bind-Silane 
214/A 
Denaturation solution 
1.5 M NaCl 
0.5 M NaOH 
50 X Denharts solution 
0.5g Ficoll 
0.5 g Polyvinylpyrrolidine 
0.59 Bovine serum albumin (BSA) 
water to 50 ml. 
DEPC treatment 
Diethylpyrocarbonate (DEPC) was added to water at a final concentration of 0.1%, 
leave overnight in a fume hood and autoclaved before use. 
Dialysis tubing 
Cut tubing into suitable lengths and boil for 10 mins in 1 litre in 10 % sodium 
carbonate. Discard the buffer and boil X 3 in 1 litre water. Store in TE. 
0.5M EDTA (pH 8) 
186.lg EDTA.H 20 pH 8 dissolve in 1 litre water and 20g NaOH Pellets 
H20 to 1 litre 
2X HeBs 
50mM HEPES 
280 mM NaCl 





Polyacrylamide gels for sequencing 
For an 8% gel: 
7m1 Acrylamide solution 
9M Urea 




15 ml 6X SSC 
0.1% SDS 
1X Denhardts 
5 mg boiled sheared herring sperm DNA 
33 ml sterile water 
10 X RNA running buffer 
20.92 MOPS (3 -(N-morpholino) propane sulphonic acid) 
8.33 M sodium acetate 
lOml 0.5 M EDTA in 500m1 at pH 7. 
RNA Loading dye 
100 j.tl 10 X RNA running buffer 
200 t1 formamide 
120 t1 formaldehyde [37/40% w/v] 
SDS-page separating buffer 
Tris 8.2g 
4m1 10% SDS 
pH to 8.8 with HCI 
H 2O to 100 ml 
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SDS-page stacking buffer 
Tris 6.06g 
4m1 10% SDS 
pH to 6.8 with HC1 
H 20 to 100 ml 




SDS sample buffer 
100 mM Tris-HC1, pH 6.8 
2 % Beta-mercaptoethanol 
4%SDS 
0.2 % bromophenol blue 
20 % glycerol 
Solutions for Random primer extension using d-CTP 
Solution A: 
470 j.tl of solution 0, 
9 pA mercaptoethanol, 
12.5 .tl 2mM dATP, dTTP, dGTP. 
Solution 0: 
1 .5 g Tris base, 
0.25g MgC12 .6H 20 
added to 10 ml H 20 at pH8. 
Solution B: 
6.5 g HEPES (N-2-Hydroxyethyl piperazine-N'-2 -ethane sulphonic) 
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12.5m1 dH 20 pH 6.6 
Solution C: 
Random hexamer primers pdN 6 (Pharmacia) at 50 jig m1' 
20 X SSC 
175.3g NaCl 
88.2g sodium citrate in 1 litre water 
10 X TAE 
900mM Tris-acetate 
10 mM EDTA pH 8 
lox TBE Tris-borate 
400mM Tris-borate 
10 mM EDTA pH 8 
TE pH 7.4 
lOmI IM Tris.HC1 pH 8.0 
2ml 0.5M EDTA 
11 20 to I litre 
TfbI 
30 mM rubidium chloride 
100 mM calcium chloride 
10 mM manganese chloride 




10 mM calcium chloride 
75 mM rubidium chloride 
10 mM gicerol, altered to pH 6.5 with dilute NaOH 
Tryp sin TVP 
2m1 Phosphate buffered saline (PBS) Ca 2+ and Mg2 free 
2ml Chicken serum 
2.5% Trypsin 
0.5 M EDTA 
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